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Abstract 
Bioprinting allows cells and materials to be deposited to create tissue pre-cursors. 
However, the quality of the bioprinted constructs depends on bio-inks, which need 
optimisation to enable repeatable processes, achieve physiological cell densities and 
tailored structures. 
The primary aim of this research was to develop reliable bio-inks for printing single cells 
and cells in gels.  
A novel bio-ink formulation has been developed to allow reliable inkjet bioprinting of 
small cell numbers, allowing single cell deposition. Poly-L-lysine (PLL) was investigated 
as temporary speckled coating, which would allow to avoid nozzle blockage during the 
printing process. Different PLL concentrations were evaluated, with 10 µg/mL exhibiting 
the highest viability and metabolic activity similar to control samples on three different 
cell lineages. At the optimised concentration, fast internalisation and metabolisation of 
PLL was observed with no subsequent effect on cell behaviour. Repeatable inkjet cell 
printing was achieved, whilst maintaining cell function. 
High cell density cell-laden hydrogels were produced using a bioprinting technique called 
Reactive Jet Impingement (ReJI), developed at Newcastle University as part of a related 
project. A protocol for using ReJI to produce a collagen-alginate-fibrin (CAF) gel was 
established and used to create cell-laden gels. The fabricated hydrogels exhibited rapid 
solution uptake and porous structures, both essential for cell migration. When culturing 
mesenchymal stem cells in the CAF gel a cell density of 40 million cells/ml supported 
faster osteogenic differentiation than a cell density of 4 million cells/ml. Additionally, 
increased cell density produced more organised tissue structures and increased expression 
of osteogenic biomarkers, indicative of accelerated bone tissue formation.  
This research has developed and characterised the performance of two bio-inks for two 
bioprinting techniques. It is concluded that careful consideration of the processing 
techniques and bio-ink formulation can allow for the creation of effective cell printing 
techniques for both single cells and cell-laden hydrogels. 
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Chapter 1. Introduction 
The evolution of science and technology has increased the human life expectancy. 
However, living longer brings consequences – tissues and organs start failing, cells may 
mutate and originate cancers and the immune system becomes weak allowing a simple flu 
to be deathly. To try to address these problems, tissue engineering and regenerative 
medicine seek to revolutionise the way medicine is undertaken. The possibility to 
promote tissue regeneration, produce tissues for replacements or increase the efficiency of 
drug screening tests, is the subject of much research, directed at using new techniques to 
closely mimic human body characteristics, resulting in a more biomimetic approach 
(Vacanti and Langer, 1999; Akter, 2016). 
Two-dimensional (2D) cell culture systems have been reported to not be able to simulate 
the human environment. Gene expression, metabolic activity, cell physiology and 
morphology and spatial organization are all affected by cells being 2D  rather than three-
dimensional (3D), which present a major drawback when evaluating medicines and other 
substances (Edmondson et al., 2014; Duval et al., 2017). Lately, 3D cell culture 
techniques, such as spheroids, organoids, organs-on-chip or scaffold-based cell cultures, 
have been developed and show the ability to emulate natural cell-cell interactions on a 
much smaller scale (Di Maggio et al., 2011; Huh et al., 2011; Thoma et al., 2014; 
Thakuri et al., 2017; de Souza, 2018; Mosaad et al., 2018; Vacanti and Langer, 1999; 
Huh et al., 2011). However, these 3D cell culture systems present problems over 
reliability and repeatability, but also in terms of tissue complexity, which makes them not 
ideal for high-throughput applications (Friedrich et al., 2007; Breslin and O’Driscoll, 
2013; van Duinen et al., 2015; Junaid et al., 2017). 
Since the commercialisation of the first automatic printers in the late 70’s, printing 
technology has developed rapidly from 2D to 3D in which is used successive layers of 
material to form 3D shapes (Kolesky et al., 2014; Murphy and Atala, 2014). This recent 
technology is revolutionising both industry, and the consumer sector, in the way the 
products are being produced - consumers may quickly fabricate their personalized 
products in a range just limited by machine and material characteristics – rapid 
prototyping (Rengier et al., 2010). Researchers have been using 3D printers to develop 
cheaper, personalised and biocompatible scaffolds, or even modifying the 3D printing 
 2 
 
technology to fabricate 3D functional living human tissue and organs – bioprinting 
(Mironov et al., 2007; Sachs, 2016). This way, bioprinting allows to address the reported 
limitations of manual 3D cell culture systems.  
After the first report and patent, accomplished by Boland and colleagues in 2003 (Wilson 
and Boland, 2003), bioprinting has seen constant progress, emerging as an influential 
field for biomedical research. Bioprinting involves additional complexity than 3D 
printing, as printed materials are made of biological matter. Through combining 
biocompatible materials, cells and growth and differentiation factors, the so-called bio-
inks, microtissue production is one significant aim (Donderwinkel et al., 2017). Inkjet  
microvalve, extrusion-based, and laser-assisted bioprinting represent the main strategies 
behind the field, however, each presents its very own advantages and limitations (Tasoglu 
and Demirci, 2013; Seol et al., 2014). Nozzle clogging due to cell aggregation and not 
allowing high cell densities, slow process and low cell viability due to high shear stress, 
or low repeatability with high maintenance costs, respectively, are the main drawbacks of 
the technologies above (Murphy and Atala, 2014). Additional disadvantages are 
represented by the limited number of bio-inks currently available due to the material 
compatibility with cells and bioprinting techniques (Gudapati, et al., 2016; Ozbolat and 
Hospodiuk, 2016; Hospodiuk et al., 2017). These must obey tight characteristics, such as 
non-toxicity, mechanical integrity or controlled biodegradability rate. 
Although very recent, the bioprinting field has developed quickly. Some flaws are still 
observed, namely in terms of the relationship between bio-inks and the equipment itself, 
which reduces the reliability and repeatability of the process. However, microtissues or 
organ-like structures, such as ears, muscle tissue, mini-livers, kidney’s structures and 
brains have been developed during the last few years (Homan et al., 2016; Kang et al., 
2016; Kizawa et al., 2017; Thomas and Willerth, 2017; Grix et al., 2018).  
 
1.1 Aim and objectives of the work 
This research has the aim to develop bio-inks to allow 1) reliable and repeatable inkjet 
bioprinting and 2) emulation of tissue complexity by manufacturing high-cell density 
microtissues through the reactive jet impingement (ReJI) process (a process developed at 
Newcastle University). Two major issues have been identified to accomplish the research 
purposed: 
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1) Inkjet bioprinting is limited by nozzle blockage originated from cell aggregation. 
These issues cause poor reliability of the process, short experiment times and only allows 
the use of low cell density bio-inks, which are not ideal for printing tissue-like structures.  
2) High-cell density bio-inks are desirable for controllable printing of microtissues, 
however, not many bioprinting techniques allows this due to technical problems. Inkjet 
and microvalve are limited by nozzle blockage and respective low cell density bio-inks; 
extrusion-based bioprinting do not allow tight control of cell numbers, plus poor cell 
viability is evidenced when printing high-cell density bio-inks. 
These problems have been addressed by formulating a novel polycationic coating-based 
bio-ink, that inhibits natural cell aggregation, and, this way, avoids nozzle blockage, 
allowing reliable and repeatable inkjet printing for at least 60 minutes. On the other hand, 
to produce controllable cell dense structures, a collagen-alginate-fibrin bio-ink and an in-
house developed bioprinting technique (ReJI) were optimised and used to develop high 
and low cell density cell-laden hydrogels. This has clearly shown the importance of cell 
density on microtissue formation. 
To achieve what is written above, the following objectives are stated: 
1. Establishment of a single cell coating system to avoid cell agglomeration in bio-
inks; 
2. Evaluation of the effect of the coating system on cell function before and after 
inkjet bioprinting; 
3. To study inkjet bioprinting reliability with and without cell coating as part of the 
bio-ink formulation; 
4. Optimisation of the methodology for the biofabrication of high cell density 
collagen-alginate-fibrin hydrogels through ReJI; 
5. Characterisation of the mechanical and biological properties of the produced cell-
laden hydrogels. 
 
1.2 Thesis structure 
To accomplish the research objectives defined above, this thesis is divided in nine 
chapters. 
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The current Chapter 1 provides an overall introduction to the theme, defining the aim 
and objectives to be obtained during this work. Additionally, it also highlights how the 
thesis is organised. 
Chapter 2 reviews the literature behind the concepts that support the work developed in 
this thesis. It gives a general overview about tissue engineering and regenerative medicine 
and a brief insight on encapsulation systems, including cellular coatings. Finally, an in-
depth cover of the different main bioprinting techniques, focusing on the processes, its 
bio-inks, limitations and applications, is also reviewed. 
Chapter 3 reports the general methodology as well as original methods developed during 
this research. The coating technique, inkjet and reactive jet impingement bioprinting, 
hydrogel development and respective characterisation of the processes in terms of 
biological, functional and mechanical properties are described here. 
The main results obtained during the experimental work are reported in Chapters 4 and 
5. Chapter 4 describes the performance of the developed single cell coating process. It 
also focuses on the application of the process to allow reliable and viable inkjet cell 
printing. Finally, Chapter 5 presents the data acquired during the development of a new 
cell-laden hydrogel through an in-house printing technique for microtissue development. 
In each of these chapters, an interin discussion is included. 
An overall discussion about the main findings is found in Chapter 6. Here, the novelty of 
this investigation is also examined. Finally, Chapter 7 outlines the global conclusions of 
the research, including the limitations found and potential future improvements. 
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Chapter 2. Literature Review 
2.1 Tissue Engineering 
Autografts and allografts are common treatments when diseases or injuries heavily 
damage the human body. Although these strategies are often life-savers, they are also 
expensive and painful, being associated to infection or tissue rejection due to the host’s 
immune system. Additionally, the recovery process is slow, being able to take several 
months, and are limited by donor availability (Khan et al., 2008; O’Brien, 2011). 
Xenografts have also been used, however using animals as tissue and organ donors 
possesses several rejection challenges (hyperacute, acute vascular, cellular and chronic) 
with higher rejection level than allografts (Cascalho and Platt, 2008). 
Tissue Engineering (TE) is a recent field that aims to i) avoid tissue replacement by 
developing innovative therapies to promote regeneration and create healthy and 
functional tissues and organs for grafting and transplantation and ii) to establish reliable 
in vitro models of tissues and diseases to foster therapeutic advancements (Ozbolat and 
Gudapati, 2016; Patra and Young, 2016). This scientific area brings together tools and 
knowledge of different scientific fields by combining cells, scaffolds and growth and 
differentiation factors (Figure. 2.1).  
 
Figure 2.1 – The Tissue Engineering triad – Biomaterials, cells and growth factors. 
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Earlier, TE used different physical and chemical approaches (such as, salt-leaching or 
phase separation) to produce biomimetic three-dimensional structures, followed by cell 
entrapment inside the fabricated scaffold. . These constructs could be used and designed 
in three different ways: as support systems, i.e. solely offering topographical cues to the 
cells; fostering cell and tissue growth through the addition of biological cues, such as 
growth factors; or as a carrier for cell delivery behaving as a protective shell to avoid host 
immune reaction (Howard et al., 2008; Garg et al., 2012). However, although these 
solutions were able to produce simple engineered structures, these presented several 
limitations (Ikada, 2006; Place, Evans and Stevens, 2009; Cui, Boland, et al., 2012; 
Nerem and Schutte, 2014; Vacanti and Vacanti, 2014): 
i) Tissues with complex structures, such as organs, are constituted by different 
cell types with precise locations and organisation. Cell seeding by pipetting 
does not allow to accurate placement of cells into scaffolds. 
ii) Scaffold production techniques offer little control over porosity, size or 
architecture, producing scaffolds with different properties in the same batch. 
iii) Cell seeding into scaffolds does not allow homogenous cell distribution due to 
deficient seeding techniques and/or to poor scaffold designs.  
iv) Uneven distribution of growth factors along scaffolds.  
v) Lack of vascularisation, necessary for thick tissue survival. 
These issues are responsible for the lack of complexity observed , but also for the reduced 
reliability and repeatability observed in these engineered systems.  
Although the limitations pointed above slowed down the initial improvements observed 
in early TE, additive manufacturing (AM) was able to offer new strategies to the Tissue 
Engineering field (Morouço, Lattanzi and Alves, 2017). Three-dimensional biological 
structures were able to be produced by AM, via layered fabrication of 3D structures using 
biological inks – 3D Bioprinting. As it will be possible to observe during this literature 
review, 3D Bioprinting is able to overcome most of the constraints stated above by 
efficiently producing cell-laden constructs with architectural complexity and custom 
designs (Bishop et al., 2017). 
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2.2 Bioprinting  
Bioprinting is a computer-assisted technology that aims to precisely fabricate biological 
three-dimensional structures in an organised and optimised manner on a layer-by-layer 
basis, by depositing small droplets or filaments into specific substrates (Malda, 2011; Lee 
and Yeong, 2016). This technique has lately gained large importance due to its accuracy, 
efficiency and possibility for scaling-up, posing as a revolutionary technique to current 
healthcare problems (Dababneh and Ozbolat, 2014). Since first reported, bioprinting field 
has been gaining more attention year by year, with a constant increase on the number of 
publications in this field (Figure 2.2) 
 
 
Figure 2.2 – Number of peer reviewed papers with the keyword “Bioprinting” listed at the  
ISI Web of Science. 
 
Bioprinting aims to create mature tissues and organs for human replacement in the future 
(Mironov et al., 2009). However, a myriad of challenges mean that it cannot achieve this 
yet. Organs present an accurately organised multi-cellular pattern, complex architecture 
and highly branched vascularisation networks that no technology is able to mimic 
nowadays (Miller, 2014; Murphy and Atala, 2014). Additionally, organs are constituted 
by cell densities not yet reproducible (Miller, 2014). Despite these limitations, bioprinting 
has been successfully applied to different areas: cancer research, drug screening, 
cardiovascular structures, cartilage, mini-organ assembly, and organ-on-chip, among 
others (Li et al., 2016; Peng et al., 2017; Yang, Lian and Xu, 2017; B. Zhang et al., 
2018). The possibility to reliably produce 3D models or tissues is already changing the 
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pharmaceutical industry by replacing the two-dimensional disease models, which are 
constantly reported by its poor capability on mimicking the human environment (Peng et 
al., 2017; Combellack, Jessop and Whitaker, 2018). 
Tissue engineering comprises three main strategies: 1) cell therapy; 2) scaffold-based 
approach; 3) cell-laden constructs. In the first, cells are delivered to the patient; in the 
scaffold-based approach, AM processes are used to produce 3D biocompatible and 
biodegradable porous scaffolds that will be seeded with cells; finally, AM processes are 
used to print bioinks – bioprinting – to produce cell-laden constructs (Pereira and Bartolo, 
2015). Four main bioprinting technologies are used: microvalve bioprinting, inkjet 
bioprinting, extrusion-based bioprinting and laser-assisted bioprinting (Figure 2.4) (Chua 
and Yeong, 2014; Murphy and Atala, 2014; Seol et al., 2014). Each technique presents 
unique characteristics that make them more suitable for certain applications than others 
(Table 2.1). 
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Figure 2.3 – a Microvalve bioprinting; b Inkjet bioprinting; c Extrusion-based 
bioprinting; d Laser-assisted bioprinting. Adapted from (Shu, 2013; Murphy and Atala, 
2014). 
 
Bioprinting highly relies on biomaterial(s) and cell(s) selection that will be dependent on 
the tissue engineering application. Once selected, these are normally mixed into one 
single solution, forming a bio-ink. Bio-inks must be tailored-specific to each bioprinting 
technique, as the working principles differ from each other, and must fulfil rigorous 
specifications to be used in bioprinting: rheology, gelling speed, printability, degradation 
kinetics and bi-products, among others (Dai et al., 2017; Ji and Guvendiren, 2017; 
Gungor-Ozkerim et al., 2018). This way, the number of materials possible to be used in 
bioprinting is highly limited. For example, viscosity significantly controls the shear stress 
suffered by cells when leaving the printing nozzle, which is determinant on cell viability 
(Ovsianikov, 2016). Printing cells impose strict requirements to minimise cell death, 
 10 
 
therefore, all the non-necessary stimulus, mechanical forces and crosslinking processes 
must be discarded. If extra manipulation is necessary, this must be carefully studied not 
only in terms of cell viability, but also cell behaviour may be affected, leading to 
unexpected outcomes. 
 
Table 2.1 – Comparison between advantages and disadvantages of different bioprinting 
technologies. 
 
The following pages of this literature review aim to present the technologies, bio-inks and 
biomaterials used in the bioprinting field. 
 
2.2.1 Inkjet bioprinting 
Inkjet bioprinting is a bioprinting method that allows accurate deposition of cells and 
materials. This technique was originally developed by improvements on the widely used 
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2D inkjet printing, which is normally associated to a computer-based text printing method 
(Saunders and Derby, 2014). The 2D inkjet ink is substituted by a mixture of 
biomaterials, cells and cell factors (called bio-ink) and the paper by a computer-controlled 
moving stage that allows precise xyz movement. Inkjet bioprinters have been widely used 
to impinge different biological materials, such as cells, enzymes, DNA or proteins 
(Campbell and Weiss, 2007). 
Inkjet bioprinting is sub-divided in three methods: electro-hydrodynamic jet bioprinting, 
continuous inkjet bioprinting and drop-on-demand inkjet bioprinting (Gudapati, Dey and 
Ozbolat, 2016). Only drop-on-demand will be reviewed as the latter category is the most 
used technology among research groups. Drop-on-demand inkjet bioprinting includes 
thermal or piezoelectric inkjet bioprinting (Figure 2.5). 
 
Figure 2.4 – Drop-on-demand inkjet bioprinting: a thermal, b piezoelectric inkjet 
bioprinting. Adapted from (Gudapati, et al., 2016). 
 
The first comprises an electrical thermal actuator located in the printhead that once 
generating heat will form small air bubbles that produce pulses of pressure by collapsing. 
The bio-ink is then ejected from the fluid chamber through the nozzle by overcoming the 
surface tension at the orifice (Cui et al., 2012; Seol et al., 2014; Ozbolat and Hospodiuk, 
2016). The volume dispensed ranges from 10 to 150 pL (Cui et al., 2012; Saunders and 
Derby, 2014; Iwanaga et al., 2015). The thermal printheads heat during short periods, 
around 2 µs, ranging high temperatures from 200°C to 300°C (Cui et al., 2012; 
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Ovsianikov, 2016; Bishop et al., 2017). Although reaching extremely high temperatures 
the impact is normally described to be low as cells only feel an increase of 4°C−10°C, 
with cells retaining their functionality, phenotype or proliferation capacities, with high 
cell viability (Cui et al., 2012; Cui et al., 2012; Jose et al., 2016; Bishop et al., 2017). 
However, several research groups report that the thermal stress induced by the short 
heating is enough to negatively affect the cells, by originating damage or cell death (Xu et 
al., 2006, 2013). This way a careful study on apoptosis, cell membrane pore size or heat-
shock proteins expression is suggested to evaluate the potential damage (Derby, 2008; 
Cui et al., 2012; Saunders and Derby, 2014). Droplet size may vary not only due to the 
nozzle diameter, but also due to the pulse frequency, cell concentration, ink viscosity and 
temperature gradient (Cui et al., 2012; Derakhshanfar et al., 2018).  
In piezoelectric inkjet bioprinting, a piezoelectric actuator mediates the droplet formation. 
The electrical impulse generates a contraction and expansion of the actuator, causing a 
deformation in the fluid chamber and resulting in a pressure wave. This pressure change 
leads to uniform droplet ejection by overcoming the surface tension at the nozzle (Singh 
et al., 2009; Li et al., 2015). Contrary to the thermal technology, due to the lack of 
heating and by supplying alternating voltage at a chosen frequency, the piezoelectric 
system produces directional and equal size droplets (Nakamura et al., 2005; Saunders et 
al., 2008; Lee and Dai, 2015). Additionally, controlled cell numbers are able to be 
deposited in the substrate (Ribeiro et al., 2017). These allow to create accurate 
concentration gradients, representing an advantage on the use of this technology in in 
vitro studies, as well as, drug discovery and diagnostics (Miller et al., 2009; Jose et al., 
2016; Hong et al., 2017). Parameters of the piezoelectric inkjet bioprinting include the 
voltage pulse characteristics (amplitude, rise and fall times, dwell time, echo time, and 
frequency), nozzle diameter and bio-ink viscosity (Fauzia et al., 2010; Christensen et al., 
2014; Murphy and Atala, 2014; Ribeiro et al., 2017). Some studies report that the 
movement and vibration frequencies may cause cell membrane damage, leading to lysis 
(Borthwick et al., 2005). However, other teams show that viability is barely affected by 
inkjet process (Saunders et al., 2008; Martin, 2014; Smith, 2016). Additionally, lower 
voltage pulses with bigger dwell and rise/fall times are recommended in detriment of 
using high pulse amplitude and short dwell and rise/fall times, as the second increases the 
shear stress that cells suffer (Saunders and Derby, 2014). 
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Regarding the advantages, inkjet bioprinting present high versatility, being able to be 
easily modified, and are low cost, when comparing to the other bioprinting techniques. 
They are fast and present high resolution due to the high drop deposition rate (1-10000 
droplets per second) and to the low-volume droplet generation, ranging from 1 to 300 pL  
(Miller et al., 2009; Nair et al., 2009; Jones, 2012; Jana and Lerman, 2015; Li et al., 
2016). The possibility to tightly control the droplet position allows to create gradients, 
precise patterns and ejection of single cells (Roth et al., 2004; Liberski et al.,  2011; Park 
et al., 2017). In situ bioprinting poses as an interesting application for inkjet bioprinting 
as there is no need for immovable substrate and this does not need to be flat, being able to 
present any conformation (Binder et al., 2010; Skardal et al., 2012). Cells are reported to 
be printed with high viability, however, some studies identify thermal and mechanical 
stress as two inkjet bioprinting properties that may increase cell death (Cui et al., 2012; 
Blaeser et al., 2015; Jose et al., 2016). 
However, inkjet bioprinting is limited by the reduced number of compatible biomaterials 
for bio-ink composition. Inkjet printing bio-inks must be presented in the form of a liquid 
solution, with low viscosity, otherwise viscous solution will block the nozzle and cause 
high shear stress to cells (Dababneh and Ozbolat, 2014; Murphy and Atala, 2014; Wu et 
al., 2016; Bishop et al., 2017). Consequently, the printed droplets lack structure, rigidity 
or mechanical properties. Crosslinking techniques are commonly used after printing to 
confer the desired properties (Ovsianikov, 2016; Hong et al., 2017). Crosslinking can be 
chemical, photo, thermal and pH crosslinking (Saunders and Derby, 2014; Iwanaga et al., 
2015; Jose et al., 2016). The first is characterised by the combination of two or more 
substances that once mixed form a solid (Arora et al., 2017). Photocrosslinking uses a 
light source (UV, IR or visible) instead (Cui et al., 2012). Materials that change their 
properties with temperature use thermal crosslinking (Ji and Shi, 2013). Finally, pH 
crosslinking is used when changing the material pH (Yoon et al., 2016). However, the 
need for crosslinking constitutes an extra step, slowing down the bioprinting and due to 
the nature of the process, being able to modify natural extracellular matrix (ECM), 
changing their chemical and physical properties (X. Wang et al., 2017a). The crosslinking 
technique must be carefully chosen as some required conditions and materials are often 
toxic to cells, limiting their functionality and viability (Hennink and van Nostrum, 2002; 
Delgado et al., 2015). Crosslinking may occur before or after the printing process 
(Ovsianikov, 2016; Pereira et al., 2018). 
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Another drawback of inkjet bioprinting is cell sedimentation. This limits the cell density 
able to be used within this technology, as cell sedimentations leads to nozzle blockage 
(Dababneh and Ozbolat, 2014; Murphy and Atala, 2014; Mandrycky et al., 2016). Hence, 
physiological cell densities, which are desirable for tissue printing, are not possible to be 
processed. Nozzle blockage results in an unreliable process that causes deficient droplet 
formation and high shear stress, damaging cells. To overcome this issue, some groups 
have added surfactants and other materials to neutralise the bio-ink buoyancy (Cheung, 
2010; Chahal et al. 2012; Ferris et al., 2013). However, this addition may cause negative 
effects in cells due to the potential toxicity of these compounds (Jose et al., 2016). 
Disadvantages also include the fast droplet drying due to the low volume (Iwanaga et al., 
2015). This way, fast crosslinking after printing or droplet deposit in aqueous media are 
required to avoid cell damage. However, using aqueous solutions, all the resolution will 
be lost as drops will get mixed with the watery medium (Nishiyama, 2010). 
In terms of applications, Xui and colleagues modified an office thermal inkjet printer to 
fabricate cartilage tissue in situ.  Using a poly(ethylene glycol) dimethacrylate 
(PEGDMA) with human chondrocytes solution, defects in osteochondral plugs were 
successfully repaired. High glycosaminoglycan production and conserved cell phenotype 
were observed after printing and respective crosslinking. Printed cells originated 
cartilaginous tissue with high host tissue integration. This group also observed the 
importance of growth factors on bioprinted constructs. The treatment with fibroblast 
growth factor-2/transforming growth factor β1 (FGF-2/TGF-β1) promoted cell 
proliferation and ECM production increasing the regeneration speed (Cui et al., 2012). 
Boland and his team fabricated a small vascular network using thermal inkjet printing. 
Here, the researchers modified a commercial inkjet printer and using a fibrin hydrogel, 
cells were deposited successively. 3 weeks later, cells had fused to each other, creating 
small vessel-like structures (Cui and Boland, 2009). Using a modified thermal inkjet 
printer, Xu and colleagues developed a drug screening array. Different antibiotics were 
tested in bioprinted bacteria entrapped inside alginate hydrogels and compared to 
common micropipetting technique. Bioprinting produced similar results to the 
micropipetted bacteria, however it has shown to be a high-throughput technique being 
able to print 213 assays per second (Xu, 2012). Kim and researchers verified that 
importance of piezoelectric inkjet printing on accurate in vitro studies for cell-cell 
communication. Colony size, spacing distance, printing timing and patterns were 
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observed to be the most important governing factors on cell-cell communication (Choi et 
al., 2011). Atala et al used a commercial inkjet printer to fabricate a multi-cell construct 
encapsulated in a collagen-alginate hydrogel. Cells from different species were used - 
human amniotic fluid-derived stem cells (hAFSCs), canine smooth muscle cells (dSMCs), 
and bovine aortic endothelial cells (bECs). Cells were viable, proliferative and conserved 
phenotype. Normal electrophysiological behaviour was observed in dSMCs and 
vasodilation was noted on bECs. hAFSCs were able to osteogenic differentiate and 
vasculature was obtained after in vivo implantation (Figure 2.6a) (Xu et al., 2013). 
Akashi and colleagues developed a high-throughput array of 3D human tissues for 
screening. Using a layer-by-layer (LbL) approach, layers of cells were separated by 
fibronectin-gelatin films to recreate native ECM. High viability and hepatocellular 
functions were observed, as well as cell-cell interaction (Figure 2.6b) (Matsusaki et al., 
2012). Markwald and colleagues used a piezoelectric inkjet printer to produce zigzag 
tubes through an overhanging strategy. Using a sodium alginate (NaAlg) cell-loaded bio-
ink, droplets were printed into a calcium chloride (CaCl2) bath for instant crosslinking 
forming a tube with a complex shape. This group concluded that cells survived to this 
process and the developed strategy may constitute an advancement for complex 
microvasculature printing (Figure 2.6c) (Xu et al., 2012). Similarly, Huang and 
colleagues, have developed branched and hollow vascular-like structures using inkjet 
bioprinting. High cell viability was confirmed after printing the complex structures 
(Christensen et al., 2014).  
 
 
 16 
 
 
Figure 2.5 – a Vascularisation of the printed cell construct; b 3D bioprinted human tissue 
array; c methodology used to obtain zigzag hollow vasculature tubes. Adapted from 
(Matsusaki et al., 2012; Xu et al., 2012, 2013). 
 17 
 
2.2.2 Microvalve bioprinting 
Microvalve bioprinters are composed by a computer-controlled stage and a certain 
number of microvalve printheads (Lee et al., 2009). Each microvalve is individually 
connected to a (positive) pneumatic pressure system and to a power supply, both 
responsible for droplet ejection (Ng et al., 2017). Once voltage is applied (Figure 2.7), a 
magnetic field is induced in the solenoid coil, pulling the plunger up and opening the 
nozzle orifice, controlling the time the orifice is opened and closed (Figure 2.8) (Gudapati 
et al., 2016; Ng et al., 2016; Ng et al., 2017). A reservoir contains the bio-ink that flows 
to the microvalve when the pneumatic pressure is able to overcome the fluid surface 
tension. By carefully controlling the valve opening time and the pneumatic system, 
microvalve bioprinting can generate droplets by two modes: continuous jetting or droplet-
on-demand (Gudapati et al., 2016; Suntornnond et al., 2016). 
 
Figure 2.6 – Microvalve typical electrical waveform. Adapted from (Ng et al., 2017). 
 
The bio-ink deposition is dependent on the rheological properties of the fluid, the nozzle 
size, the pneumatic pressure, cell concentration and the applied voltage pulse (Shu, 2013). 
These parameters must be optimised for each specific bio-ink. The deposition of viscous 
solutions is possible by increasing the valve opening and closing time and increasing 
pneumatic pressure (Sun et al., 2009). However, droplet generation will stop when the 
printability range is exceeded. Additionally, increased valve opening and closing periods 
will induce satellite droplet formation (Sun et al., 2009). On the other hand, if pressure is 
below the minimum necessary for droplet ejection, a considerable droplet will be formed 
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on the nozzle orifice. This happens when the pneumatic pressure is not able to overcome 
the fluid surface tension (Ng et al., 2017).  
 
Figure 2.7 – Microvalve composition and working principle. From (Gudapati, Dey and 
Ozbolat, 2016). 
 
Although producing droplets with higher diameters (50–300 µm) when compared to other 
bioprinting techniques, such as inkjet or laser-assisted bioprinting, accuracy and high-
throughput are evidenced when using microvalves (Gudapati et al.,  2016; Ng et al., 
2017). The concept behind this technique and the increased nozzle diameter allows 
materials with higher viscosities (∼1 to 200 mPa/s) and reduced nozzle blockage when 
compared to inkjet printing. However, despite reduced, cell sedimentation is still a 
problem noted when using microvalves (Lee et al., 2009, 2013). Nozzle size is an easy 
way to control the droplet diameter, however prior studies have noted that smaller 
diameters have narrower opening and closing times, which will have an implication on 
the number of materials able to be jetted using small diameter nozzles (Ng et al., 2017). 
Microvalve bioprinting grants high cell viability due to the gentle fluid releasing system 
(Shu, 2013; Horváth et al., 2015). Also, prior studies evidenced that microvalve 
bioprinting did not affect cell functionality, genotype or phenotype, as well as 
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differentiation capacity (Shu, 2013). Moreover, the lack of complexity makes this 
technology user-friendly. 
Microvalve bioprinting has been widely applied in tissue engineering. In 2015, Shu and 
colleagues reported the first microvalve bioprinting using human induced pluripotent cells 
cells (hiPSC), showing that this technology did not affect these cells not only in terms of 
viability, but also regarding their pluripotency capability. The latter was observed by 
comparing control hiPSC with bioprinted iPSC for different biomarkers. Additionally, 
human embryonic stem cells (hESC) and hiPSc were differentiated into hepatocytes and 
the fabricated cell-laden alginate hydrogels showed to allow cells to retain their hepatic 
function (Shu, 2015). Skardal and his group demonstrated growth of skin tissue from a 
culture made using an in-situ microvalve bioprinter (Figure 2.9a). A cell-laden collagen 
and fibrinogen solution were deposited alternately with thrombin solution to form a 
hydrogel to cover the wound in the back of murines. Two different cell types were studied 
in order to compare its regenerative properties – amniotic fluid-derived stem cells 
(AFSCs) and mesenchymal stem cells (MSCs). Both cell types were comparable and 
accelerated the healing process, resulting in wound contraction, re-epithelisation and 
neovascularisation. Ng’s team also worked in skin by fabricating 3D human pigmented 
skin constructs from keratinocytes, melanocytes and fibroblasts. High similarity between 
the obtained constructs and native skin was observed by the different characterisation 
techniques. This highlights how useful this kind of system can be for drug testing and 
other in vitro assays (Skardal et al., 2012).  
The reliability and consistency of microvalve printing has been shown by Okubo and 
colleagues. When comparing with manual pipetting, bioprinting with an agitator showed 
highly reduced coefficient of variance, from 23.9 – 34.7 to 8.3 – 9. Additionally, viability 
was observed to remain high. This study clearly shows the importance of microvalve 
bioprinting for in vitro assays (Okubo et al., 2016). Cartilage has been fabricated by 
Gurkan’s team by printing hMSCs in a gelatin methacrylamide (GelMA) and growth 
factors solution. To improve the mechanical strength and give structure, ultraviolet (UV) 
crosslinking was carried after printing. Cell organisation showed to mimic native 
fibrocartilage with hMSCs showing simultaneous upregulation of osteogenic and 
chondrogenic genes (Gurkan et al., 2014). Rothen-Rutishauser and colleagues have 
engineered 3D air-blood tissue barrier to mimic lung tissue (Figure 2.9b). By adapting a 
layer-by-layer approach using three distinct layers, two cell layers using alveolar 
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epithelial type II cells and endothelial cells and a middle one composed by matrigel. The 
group observed that the microvalve bioprinted model resembled the structure and 
functionality of the native tissue. Additionally, manual co-cultures were compared to the 
bioprinting ones, showing poor structure and, therefore, deficient cell-cell interaction. 
Microvalve bioprinting was also used to produce neural tissue models (Horváth et al., 
2015). Yoo (2010) and his colleagues produced a layered construct made of collagen, 
fibrin and murine neural stem cells to study neuronal migration (Figure 2.9c). After 
printing each gel-precursor (collagen precursor and fibrinogen) was crosslinked. The 
neural stem cells were stimulated by the addition of vascular endothelial growth factor 
(VEGF) in the fibrin hydrogel promoting cell migration and proliferation successfully 
(Lee et al., 2010).  
 
Figure 2.8 – a Deficient re‐epithelialization without bioprinting (1) and well-defined 
epithelium after using cell printing (2 and 3); b Bioprinted structures presented a 
microenvironment similar to the native one, while manually seeded cells resulted in thick 
layers of cells; c VEGF supported cells migration towards fibrin gels when encapsulated 
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in a collagen construct. Adapted from (Lee et al., 2010; Skardal et al., 2012; Horváth et 
al., 2015). 
 
2.2.3 Extrusion-based bioprinting 
Extrusion-based bioprinting (EBB) was originally developed as an AM technique for 
industrial applications, such as shape-specific fabrication of plastic (Ozbolat and 
Hospodiuk, 2016). The introduction of this AM technology into the TE field allowed to 
fabricate tailor-made scaffolds to study cell behaviour in specific 3D constructs 
(Hutmacher et al., 2001; Zein et al., 2002; Hollister, 2005). The use of this AM technique 
combined with hydrogels and cells (bio-inks) brought promising results, contributing to 
the fast dissemination of the extrusion technology and attracting research groups that lead 
to advances in the bioprinting field. 
This bioprinting technology is the most widely used bioprinting technique. Here, a 
computer-controlled dispensing system allows precise cell-laden filaments to be 
deposited in 3D custom-shaped constructs onto a mobile or immobile stage (Murphy and 
Atala, 2014; Seol et al., 2014; Ozbolat and Hospodiuk, 2016). Furthermore, apart the 
components mentioned above, some systems also include a photoinitiator, such as an UV 
source, to aid on the material gelation (Murphy and Atala, 2014). To form 3D structures, 
a layer-by-layer approach is followed, i.e. after the solidification of the first layer, a new 
one is deposited on the top of it (Li et al., 2016; Ning and Chen, 2017). 
Extrusion-based technology uses pneumatic or mechanical (piston or screw-based) 
systems to extrude the material filaments (Figure 2.10) (Chang et al., 2011; Malda, 2013; 
Bertassoni et al., 2014; Skardal et al., 2015; Liu et al., 2017). Each technique uses a 
different driving force: pneumatic systems use air pressure, while vertical and rotation 
mechanical forces are responsible for pulling the material through the nozzle on piston 
and screw-based bioprinting, respectively (Derakhshanfar et al., 2018). Comparing the 
systems, it is reported that pneumatic-based bioprinting provides tighter control over the 
material extrusion by defining the pulse frequency, i.e. the valve opening time, and the air 
pressure provided by the pneumatic system (Ozbolat and Hospodiuk, 2016). Additionally, 
the delay of the compressed air volume demonstrates to better control the material flow 
(Murphy and Atala, 2014; Ovsianikov, 2016; Hong et al., 2017). Regarding the 
mechanical-based extrusion bioprinters, the piston and screw-based extrusion provides 
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more spatial control, since their parts can be managed electronically, and higher 
deposition forces allow highly viscous solutions to be easily printed (Malda et al., 2013; 
Murphy and Atala, 2014; Hong et al., 2017). However, the latter may produce pressure 
drops along the nozzle or needle that results in a shear stress increase and potential harm 
to the cells and is more susceptible to malfunctions due to its complex parts (Dababneh 
and Ozbolat, 2014). The printing process is controlled by several parameters, such as the 
bio-ink viscosity and flow rate, the applied pressure and the nozzle shape and size 
(Ozbolat and Hospodiuk, 2016; Jungst, 2017; Webb and Doyle, 2017). By carefully 
optimising these specifications it is possible to control the amount of deposited bio-ink. 
 
Figure 2.9 – Extrusion-based bioprinting. a Pneumatic and b mechanical extrusion-based 
bioprinting. Adapted from (Ozbolat and Hospodiuk, 2016). 
 
Different printing strategies are possible to be adopted when using this bioprinting 
technology. The first is based on the extrusion of a highly viscous cell-laden solutions 
that manage to directly form 3D constructs due to the rheological properties (Seol et al., 
2014; Thayer et al., 2018). However, this procedure is responsible for low cell survival as 
high shear and extensional stress is produced during the extrusion of the bio-ink (Chang 
et al.,  2008; Nair et al., 2009). To reduce the cell damage, less viscous cell-laden 
solutions are used and combined with gelation methods to provide shape fidelity and 
mechanical integrity to the 3D construct (Ahn et al., 2015; Skardal and Atala, 2015; 
Derakhshanfar et al., 2018). Different gelation mechanisms are normally used, such as 
physical (e.g., temperature), chemical (e.g. ionic) or photo-crosslinking (e.g. UV source) 
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(Axpe and Oyen, 2016; Liu et al., 2017; Suntornnond et al., 2017; X. Wang et al., 2017b; 
Li et al., 2018). Extrusion-based bioprinting also allows cell agglomerates to be printed 
successively in a certain pattern. These are able to fuse over time and form complex 
structures (Norotte et al., 2009; Yurie et al., 2017; Q. Zhang et al., 2018).  
Extrusion-based bioprinting is the most versatile bioprinting technique allowing to print a 
high range of viscosities (30 mPa/s to 6×107 mPa/s) and, this way, different types of 
materials can be used, from hydrogels to copolymers, micro-carriers or cell spheroids 
(Khalil and Sun, 2009; Mironov et al., 2009; Mateos-Timoneda, 2014). High cell 
densities are also managed to be printed, contributing to a faster formation of neotissues 
(Murphy and Atala, 2014; Suntornnond et al.,  2016). The emergence of a number of 
companies, such as CELLINK or Allevi, turned screw and piston-based systems portable, 
affordable and user-friendly, without needing an air compressor unit or other accessories 
(Choudhury et al.,  2018). On the other hand, pneumatic-based technologies allow to 
achieve higher accuracy and precision than the latter, despite increasing the equipment 
cost (Ozbolat and Hospodiuk, 2016). 
However, the number of different challenges and limitations are a downside on extrusion-
based bioprinting. The most challenging parameter is related to the bio-ink viscosity as it 
not only affects the process itself as it has capital importance on cell survival (Murphy 
and Atala, 2014; Ozbolat and Hospodiuk, 2016). The bio-ink must have sufficient 
viscosity in a way that overcomes the surface-tension-driven droplet formation. 
Otherwise, straight filament printing will not be possible. High viscosity is also related to 
nozzle blockage (Ozbolat and Hospodiuk, 2016). Bio-ink solidification inside the nozzle, 
as well as cell agglomerate formation are responsible for not allowing the cell-laden 
material to correctly flow through the nozzle. Viscosity is also bounded to the stress that 
cells are subjected during printing (shear stress and extensional stress) that affect not only 
their viability, but also their functions (Gupta et al., 2006; Yourek et al., 2010; Wolfe and 
Ahsan, 2013). During the printing process, the cell-laden bio-ink is forced to flow through 
the nozzle or needle. This movement deforms the cells until a limit that membrane 
disruption may happen and cause cell death. Even if the latter does not happen, cells may 
not be able to recover from the deformation suffered, causing non-expected behaviours 
(Fletcher and Mullins, 2010). More viscous solutions demand higher driving forces that 
increase the stress that, consequently, will cause more damage to the cells (Chang et al., 
2008; Murphy and Atala, 2014). Billiet and colleagues have observed that cell damage is 
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increased when subjecting to lower stress during increased amounts of time, when 
compared to when exposed to considerable stresses during short periods of time (Billiet et 
al., 2014). Extensional stress is also an issue on extrusion bioprinting. This happens when 
there is a sudden change in the nozzle geometry as the bio-ink is flowing through it (Ning 
and Chen, 2017). Studies have shown that extensional stress causes higher cell death than 
shear stress. To reduce the impact of stress in cells, the nozzle shape must be carefully 
designed to minimize the extensional stress. The nozzle material must also be precisely 
selected due to the friction coefficient, which regulates the shear stress caused by the bio-
ink flow (Ozbolat and Hospodiuk, 2016). Moreover, low viscosity and shear thinning bio-
inks should be used instead of viscous materials as they allow to lower the dispensing 
pressure, reducing the stress caused to cells (Guvendiren et al.,  2012; Ovsianikov, 2016). 
Increasing the nozzle orifice diameter is also a measure to attenuate the issues reported.  
For the reasons above, different studies report low cell survival using this technology, 
ranging from 40% to 80%, with viability decreasing with increasing pressure (Chang et 
al.,  2008; Atala, 2015). However, others refer that extrusion-based bioprinting causes 
little cell harm, when compared to other techniques (Gao et al., 2018). Additionally, 
extrusion-based bioprinting has generally low resolution, with a minimum reported to be 
over 100 µm (Murphy and Atala, 2014). Despite extrusion-based bioprinting allow more 
materials than the other bioprinting techniques, still the number of materials that can be 
applied is also a concern as fast gelation kinetics are required for cell encapsulation and 
stack successive layers (Derakhshanfar et al., 2018). 
Other disadvantages are related to hardware issues (Ozbolat and Hospodiuk, 2016). The 
air used in the pneumatic microextrusion bioprinting must be sterile to prevent 
contaminations. To minimise this issue, filters are normally used. On mechanical-based 
technologies, it is possible to autoclave several nozzle component parts, keeping the 
printing environment sterile. Mechanically driven extrusion bioprinters must have their 
extrusion parts carefully checked before printing, otherwise malfunctions may cause 
additional friction forces or leakage of bio-ink, for example.   
Extrusion-based bioprinting has been widely used in different scientific works. Kang and 
colleagues developed a dual bioprinter that combined the fused deposition modelling and 
extrusion bioprinting in one machine (Figure 2.11a). The first technique offers a support 
structure to the construct, working like a skeleton, being then filled by the hydrogels and 
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sacrificial inks extruded from the second technique. By developing sophisticated nozzles, 
using fast-crosslinking materials and using sacrificial materials to create microchannels 
for nutrient and oxygen diffusion, human-scale mandible bone, ear-shaped cartilage and 
organized skeletal muscle were obtained. Additionally, a calvarial bone defect was 
reconstructed. Clinical image data was used to obtain relevant human structures. The 
different engineered tissues presented high cell viability, as well as the desired 
functionality. These authors developed an equipment that is able to fabricate human 
complex structures with mechanical integrity. The in vivo application of the designed 
structures showed to mimic the native functionality of the tissues, as it is represented by 
the tissue maturation observed in the application to the calvarial defect filling and by the 
formation of highly orientated myofiber bundles on the muscle tissue application (Kang et 
al., 2016). Similarly to Kang and colleagues, Pati et al developed a decellularised 
extracellular matrix cell-laden constructs supported by a PCL framework (Figure 2.11b). 
By decellularizing cartilage and adipocyte tissue, the three-dimensional structures 
revealed high cell viability and functionality, as well as ECM production. The 
decellularized tissue used in the bio-ink was reported to commit cell differentiation into 
adipogenic and chondrogenic lineage, if adipogenic or chondrogenic decellularized ECM 
(dECM) bio-ink was used respectively. This technique is particularly interesting in terms 
of recapitulating native tissue microenvironment (Pati et al., 2014). Similarly, Cho’s 
group printed a multi-cellular ear shape structure using an in-house developed system that 
allowed to deposit six different biomaterials independently, at the same time structural 
support was given by a printed polycaprolactone (PCL) framework. Adipogenic tissue 
formation was shown on the earlobe, at the same time the auricular cartilage was 
regenerated. It was observed that the structure had mechanical properties similar to native 
ear (Cho, 2014). Woodfield and colleagues fabricated complex hierarchical chondrogenic 
structures that granted high cell viability and deposition of cartilage-specific ECM, at the 
same allowed to microtissue to fuse to each other in order to form highly complex 
structures. The developed system has potential to be applied to in vitro microtissue 
applications, such as drug screening or cancer research (Woodfield, 2018).   
Differently, Tan and co-workers developed a cell-laden microsphere bio-ink for 
extrusion-based bioprinting. This strategy allowed to print increased cell numbers with 
high viability, at the same time the cells were protected from the stress and strain 
produced during extrusion. The authors advance that this technique would be highly 
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suitable for freeform fabrication (Tan et al., 2016). Yue’s group have developed a 
portable extrusion-based “bio-pen” for osteochondral defects. The aim of this technology 
is to be used at the theatre to aid on healing the wounds developed by late osteoarthritis 
stages. The pen was able to extrude a gelMA/hyaluronic acid–methacrylate hydrogel that 
was crosslinked after printing by an UV source. Similarly to other extrusion processes, 
the pressure demonstrated to affect the resolution achieve by the device. The viability of 
adipose stem cells was exhibited to be similar to control samples.  
Nowadays, some systems allow multiple reservoirs to deposit multi-material filaments in 
a continuous manner being able to keep printing without stopping in-between reservoir 
switching (Figure 2.11c). Gradient structures were developed with cells retaining cell 
viability and function. This technique may open new avenues in the bioprinting area by 
being able print highly complex and multi-cellular structures (W. Liu et al., 2016). Apart 
from human application, extrusion bioprinting is also being applied to plants by Lode’s 
group. Here, a callus-derived bio-ink was used to encapsulate basil cells that showed the 
expected viability and functionality after printing. This group advances the importance of 
this application to study cell responses to environment changes (Lode, 2017). 
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Figure 2.10 – Dual extrusion bioprinting has been used to fabricate different structures 
such as a ears or b dECM cell-laden hydrogels. These combine a PCL framework to give 
structure, a cell-laden hydrogel and, sometimes, sacrificial inks. c Printing of different 
cell lineages using a continuous extrusion printing technique. Cell viability remains high 
and proliferation is verified. Adapted from (Pati et al., 2014; Kang et al., 2016; W. Liu et 
al., 2016). 
 
2.2.4 Laser-assisted bioprinting 
Laser-Assisted Bioprinting (LAB) most popular technique is  Laser Induced Forward 
Transfer (LIFT) (Dababneh and Ozbolat, 2014). The latter was initially used to pattern 
metals in industries (e.g. chip fabrication), however, Odde and colleagues introduced 
laser patterning of biological scaffolds after equipment modifications (Odde and Renn, 
1999). Afterwards, printing of biological materials, such as DNA, enzymes or cells, 
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became possible (Li et al., 2016; Sorkio et al., 2018). Five main components can be 
identified in common LAB equipment: a pulsed laser source, a focusing system, a ribbon, 
a biomaterial layer (such as cells and/or hydrogels) and a receiving substrate (Figure 2.12) 
(Hong et al., 2017; Keriquel et al., 2017). The ribbon is composed by a support material 
(e.g. glass) that is covered with a thin absorbing layer of metal (titanium or gold, for 
example) and a bio-ink layer below. The absorbing layer can transfer the energy to the 
ribbon and then to the material layer.  
 
 
Figure 2.11 – Laser-assisted bioprinting main components. From (Gruene, Unger, et al., 
2011).  
 
The LAB working principle relies on high-pressure bubbles induced by the energetic laser 
pulse (Guillotin et al., 2010; Skardal and Atala, 2015; Pati, et al., 2016). Short duration 
laser pulses (in the order of nanoseconds) with UV or near-UV wavelengths are used. The 
laser beam causes evaporation of the material, originating pressurised bubbles that create 
shock waves when collapsing. This way material-containing droplets are propelled 
towards the substrate. By moving the substrate or the laser focus in the ribbon, different 
patterns are acquired. Similarly to inkjet and microvalve bioprinting, substrates may be 
chosen accordingly to the user’s desire as any configuration may be adopted (Catros et 
al., 2015; Keriquel et al., 2017).  
Precise and small bio-ink volumes are dispensed using LAB with high accuracy and 
resolution (10-100 µm), with single cell printing being achievable (Guillotin et al., 2010). 
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However, the sensitivity to its control parameters makes LAB difficult to apply. Laser 
energy and frequency, material’s rheological properties, thickness of the absorbing and 
bio-ink layers, distance between the ribbon and the substrate or printing speed are some 
of the parameters that have impact on the resolution of the printed material (Guillotin et 
al., 2010; Murphy and Atala, 2014; Gudapati et al., 2016). LAB is a nozzle free 
technique; therefore, cell agglomeration and nozzle blockage are avoided, contrary to 
what happens in other bioprinting techniques. This specification avoids shear stress 
caused when cells and materials pass through nozzles and needles. Additionally, the bio-
ink layer may include materials with high viscosities (1–300 mPa/s) and high cell 
densities (up to 108 cells/mL) (Murphy and Atala, 2014). Multiple cell types can be 
printed due to the laser accuracy with frequencies as high a 5 kHz and speeds up to 1,600 
mm/s (Guillotin et al., 2010).  
However, the disadvantages of LAB outweigh the advantages. The small printing volume 
and high resolution demand the use of materials with fast gelation kinetics, as well as, fast 
moving stage (Skardal and Atala, 2015). This is essential to achieve not only shape 
fidelity, but also cell viability preservation, as demonstrated by Gudapati and colleagues 
(Chrisey, 2014). Also, the lack of photocurable materials is an issue. LAB is not indicated 
for high-throughput applications as the preparation of the ribbon, especially when it 
includes biological materials, is time-consuming (Skardal and Atala, 2015). Additionally, 
to fabricate structures with considerable size, preparation of multiple ribbons may be 
needed and, therefore, reloading is indispensable. On the other hand, the printing process 
itself is fast. Also, metallic residues were found to contaminate the bioprinted constructs 
because of the vaporization of the metallic laser-absorbing layer during printing (Murphy 
and Atala, 2014). However, non-metallic absorbing layers may be adopted. Although 
LAB may use materials with a considerable range of viscosities, accurate targeting and 
precise cell deposition may be difficult when using bio-inks with lower viscosities 
(Murphy and Atala, 2014). The biological effect of LAB is the most discussed 
disadvantage. Some groups state that little or no cell damage is caused by the printing 
process, however, others note that the heat and UV exposure may affect cells. 
Additionally, Hopp (2012) and colleagues verified that femtosecond pulse laser caused 
less thermal damage when compared to nanosecond laser irradiation. However, this group 
found that cell viability was below 85% (Hopp et al., 2012). Finally, the high cost of LAB 
is also a disadvantage, which limits the number of studies available. 
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In terms of applications, Koch (2017) and colleagues used LAB to print fibroblasts and 
keratinocytes (skin cell lines) and hMSCs. Here this group observed the impact of the 
printing technology on cell viability, proliferation or phenotype. It was demonstrated that 
cells kept the ability to proliferate with viability. No cell exhibited increased apoptosis 
and phenotypes were conserved (Koch et al., 2017). Guillotin (2010) and his team 
showed that LAB can accurately deposit cells with high resolution, fabricating 
miniaturized tissues. Using a thrombin and CaCl2 cell-laden solution, cells were printed 
onto a fibrinogen “biopaper”. Cells showed high viability, even when using high cell 
densities (6x107 cells/mL) and speeds up to 200 mm/s. The best resolution was acquired 
for printing at 5 kHz. LAB has been also used for cardiac regeneration (Guillotin et al., 
2010). Gaebel (2011) and his team seeded human umbilical vein endothelial cells and 
hMSCs into polyester urethane cardiac patches both manually and using LAB. These 
were evaluated by in vivo implantation after infarction. It was noted that LAB cell 
seeding influenced the cell behaviour generating increased vessel formation. 
Additionally, infarcted hearts were more functional with LAB cardiac patches than with 
the manually seeded ones (Gaebel et al., 2011). Skin substitutes were engineered by 
Michael (2013) and colleagues (Figure 2.13a). Keratinocytes and fibroblasts were 
precisely placed onto a Matriderm layer. After maturation, these constructs were tested in 
vivo by covering a skin wound in nude mice. The engineered skin showed to completely 
attach to the skin surrounds after 11 days. Cells proliferated the skin stratum corneum and 
basal layer and were able to form multi-layered epidermis. Blood vessel formation was 
also demonstrated in the wound area (Michael et al., 2013). Catros (2010) and colleagues 
used LAB to print nano-hydroxyapatite into in vivo mouse calvaria defect (Figure 2.13b). 
Three month later, mature bone tissue was observed (Catros, 2010). 
 31 
 
 
Figure 2.12 – a Skin regeneration 11days after implantation of LAB engineered skin 
tissue; b In situ strategy used by Keriquel and co-workers to print nano-hydroxyapatite to 
a calvaria defect. Adapted from (Catros, 2010; Michael et al., 2013). 
 
2.3 Bio-inks  
Bio-inks are the most important component on bioprinting. These are constituted by soft 
materials, cells and growth factors that, once processed by a bioprinting technique may 
originate 3D cell-laden structures (Stanton, et al, 2015; Hospodiuk et al., 2017). As 
observed before, depending on the bioprinting modality, i.e. extrusion-based, microvalve, 
inkjet or laser-assisted bioprinting, bio-inks must consider different properties in order to 
release not only the full potential of the process, but also allowing cells and materials to 
behave has expected (Guillotin et al., 2010; Pati et al., 2014; Ribeiro et al., 2017). 
Material ejection or extrusion is obtained by manipulating external pressure, electrical 
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inputs, nozzle sizes and designs, as well as, shear stress and the material nature (Murphy 
and Atala, 2014; Gudapati, et al, 2016; Ozbolat and Hospodiuk, 2016). 
The number of complex requirements makes bio-ink design extremely challenging (Table 
2.3). Bio-inks must: i) be bioprintable (Dababneh and Ozbolat, 2014; Murphy and Atala, 
2014; Jose et al., 2016; Bishop et al., 2017; Hospodiuk et al., 2017); ii) allow the 
production of 3D structures with mechanical integrity, stability and shape fidelity 
(Murphy and Atala, 2014; Jose et al., 2016; Bishop et al., 2017; Hospodiuk et al., 2017); 
iii) work as a biomimetic microenvironment to support not only cell maintenance during 
all bioprinting stages, but also cell attachment, proliferation or differentiation (Murphy 
and Atala, 2014; Jose et al., 2016; Bishop et al., 2017; Hospodiuk et al., 2017); iv) be 
biocompatible, not causing any inflammatory reaction (Murphy and Atala, 2014; Jose et 
al., 2016; Bishop et al., 2017; Hospodiuk et al., 2017); and v) be biodegradable, not 
producing toxic by-products and with controllable degradation kinetics (Murphy and 
Atala, 2014; Jose et al., 2016; Bishop et al., 2017; Hospodiuk et al., 2017). Additionally, 
to build complex biological systems, cell-cell and cell-ECM interactions must naturally 
occur and angiogenesis must be promoted (Murphy and Atala, 2014; Jose et al., 2016; 
Hospodiuk et al., 2017). However, the lack of materials that can be processed via 
bioprinting modalities and, at the same time, conserve the properties mentioned above, is 
very low (Murphy and Atala, 2014; Hospodiuk et al., 2017). 
Currently, bio-inks are composed by individual cells or cell aggregates suspended in 
liquid solutions, such as cellular medium or other cell-friendly solutions, or more 
frequently by cells mixed with hydrogel precursors or hydrogels (Mironov et al., 2009; 
Malda, 2013; Mateos-Timoneda, 2014; Lee and Yeong, 2016; Ribeiro et al., 2017; X. 
Wang et al., 2017a). Hydrogels are normally made of natural or synthetic components 
(Nicodemus and Bryant, 2008; Zhu and Marchant, 2011). Natural components, such as 
gelatin, collagen, alginate, among others, specifically mimic natural ECM, granting 
biomimetic properties, which are essential on cell microenvironment (Hospodiuk et al., 
2017). This biomimicry is of importance as it will also potentiate cell migration, which is 
crucial when obtaining microtissues (Murphy and Atala, 2014; Reig et al., 2014; Bishop 
et al., 2017; Hospodiuk et al., 2017). They also possess inherent bioactivity. Furthermore, 
natural materials are degraded by enzymatic processes and replaced by cell-produced 
ECM and promote cell viability and functionality (Murphy and Atala, 2014; Hospodiuk et 
al., 2017). However, these are normally soft, which causes mechanically weak constructs 
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with poor shape fidelity and printing resolution (Ashby et al., 1995; Murphy and Atala, 
2014; Ozbolat and Hospodiuk, 2016). Synthetic materials, such as polyethylene glycol 
(PEG) or GelMA, can have their physical properties carefully designed to facilitate the 
bioprinting process and control cell characteristics (Langer and Tirrell, 2004; Lutolf and 
Hubbell, 2005; Saha et al., 2007; Murphy and Atala, 2014; Hospodiuk et al., 2017). 
Similarly to natural materials, synthetic materials used in bioprinting are also degradable, 
but via hydrolytic mechanisms. However, challenges including poor ECM mimicking and 
biocompatibility, as well as toxic by-products, represent drawbacks for using these 
materials (Murphy and Atala, 2014; Hospodiuk et al., 2017). Some research groups have 
been studying the use of hybrid materials to gather the properties of natural materials to 
the synthetic ones. In this sub-chapter hydrogels and the most common bio-ink used 
materials are reviewed. 
Table 2.2 - Bio-ink characteristics for each bioprinting methodology. 
Bio-ink property Inkjet bioprinting 
Microvalve 
bioprinting 
Extrusion-based 
bioprinting 
Laser-based 
bioprinting 
Printability 
Low viscosity, 
non-fibrous 
characteristics 
and low cell 
density. 
Low viscosity, 
non-fibrous 
characteristics 
and low cell 
density. 
Shear thinning 
and thixotropic 
fluids. 
Transfer 
thermal energy 
to kinetic 
energy; 
Adhesion and 
low surface 
tension 
properties 
Biocompatibility 
Should support cell maintenance during printing process, as well as 
promote cell survival, proliferation and differentiation. Should not cause 
adverse immune reaction if implanted. 
Biodegradability 
Should be able to control the degradation kinetics, at the same time no 
toxic by-products are produced. 
Mechanical 
integrity 
Very weak -
Crosslinking 
needed 
Usually weak - 
Crosslinking 
often needed 
Good - 
Crosslinking 
often needed 
Usually weak - 
Crosslinking 
needed 
Materials used Liquid solutions 
Liquid 
solutions/soft 
hydrogels/cell 
aggregates 
Hydrogels and 
cell aggregates 
Hydrogels 
 
2.3.1     Hydrogels 
Hydrogels were first reported in 1960 by Wichterle and Lim in their work where poly-2-
hydroxyethylmethacrylate (PHEMA) was used for contact lens applications (Wichterle 
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and Lim, 1960). Hydrogels are constituted by three-dimensional meshes made of 
hydrophilic polymers that are crosslinked after the reaction of one or more monomers 
with other substances, crosslinker and/or initiator, or stimulus, such as temperature or UV 
irradiation. (Nicodemus and Bryant, 2008; Slaughter et al., 2009; Caló and 
Khutoryanskiy, 2015; Buwalda et al., 2017). These are able to swell through the 
absorption of water or other biological fluids up to a thousand times, but are water 
insoluble, may turn into any desired physical forms and possess tissue-like elasticity, 
behaving similarly to normal ECM (Nicodemus and Bryant, 2008; Zhu and Marchant, 
2011). Furthermore, hydrogels are able to be tuned in terms of porosity and density of 
cross-links. However, hydrogel synthesis may pose some concerns, such as low solubility 
and degradability, poor mechanical properties or the use of harmful crosslinkers (Ullah et 
al., 2015). To overcome these issues, natural and synthetic polymers are combined to 
maximise the properties of the desired hydrogel (Ahmed, 2015; Freudenberg et al., 2016; 
Buwalda et al., 2017). Synthetic materials have been widely used due to its tunable 
characteristics: degradation rate, mechanical properties or water absorption capability 
(Zhu and Marchant, 2011; Ahmed, 2015; Trimaille et al., 2016). On the other hand, 
natural materials add high biocompatibility and tissue-like ECM (Hinderer et al., 2016).  
After mixing cells with the liquid precursors, crosslinking is normally needed to give the 
desired structure and mechanical properties to the hydrogel. Depending on the molecular 
arrangement of the crosslinked material, hydrogels can be defined as reversible (physical) 
or permanent (chemical) (Caló and Khutoryanskiy, 2015; Akhtar et al., 2016). They are 
physical if the hydrogel network is formed via hydrophobic or ionic forces or hydrogen 
bonds (Hennink and van Nostrum, 2002). As the classification suggests, these are 
reversible by dissolution through different processes, such as temperature or pH. 
Contrarily, chemical hydrogels are irreversible due the covalently bonded, i.e. by sharing 
electron pairs, network of macromolecular chains (Hennink and van Nostrum, 2002). 
Crosslinking processes must be carefully controlled as high crosslinking degrees will 
confer brittle structures and swelling limitations to the hydrogel (Place et al., 2009). On 
the other hand, low crosslinking degrees produce materials with poor mechanical 
properties. Additionally, crosslinking constitutes a major challenge, as these techniques 
are able to affect cell viability and functionality (Nicodemus and Bryant, 2008; Gasperini, 
et al., 2014). To minimize the impact, recently, hydrogels have been developed in order 
to be crosslinkable using natural and non-harming processes, such as visible light (Hu et 
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al., 2012). Optimisation of the crosslink procedure is needed to obtain a hydrogel with the 
desired characteristics. 
 
2.3.2     Natural materials 
Natural materials are normally derived from animal tissues or plants. These materials are 
normally highly biocompatible and support cell viability, proliferation and differentiation. 
Additionally, these materials possess biomimetic characteristics that allow cells to behave 
similarly as to when in the human environment. However, natural materials normally lack 
structural integrity and form very soft gels. This issue affects bioprinting negatively by 
decreasing the shape fidelity and printing resolution. To solve this common problem, 
natural materials are normally combined with other natural or synthetic materials. The 
material hybridization not only is able to maintain the advantages, but also eliminates the 
concerns reported above. In the following pages, some of the most commonly bioprinted 
natural materials are reviewed. 
 
2.3.2.1 Fibrin 
Fibrin is a natural hydrogel that is produced from the enzymatically reaction between 
fibrinogen and thrombin (Smith, 1980; Weisel, 2005). This naturally occurs in the human 
body having primary importance in wound healing, hemostasis, fibrinolysis and tumour 
growth (Gurtner et al., 2008; Lee et al., 2010; Kołodziejczyk and Ponczek, 2013; 
Litvinov and Weisel, 2016). Fibrin is formed “via thrombin-catalysed cleavage of two 
pairs of fibrinopeptides that exposes binding sites in the central nodule complementary to 
sites constitutively available at the ends of the molecule” (Figure 2.14) (Litvinov and 
Weisel, 2016). 
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Figure 2.13 – Fibrin formation via reaction between fibrinogen and thrombin. From 
(Litvinov and Weisel, 2016). 
 
Fibrin has gained a lot of attention, not only for its high biocompatibility, but also for its 
mechanical properties (Jung et al., 2009; Litvinov and Weisel, 2016). This property 
prevents damage when encapsulating cells inside a fibrin hydrogel. Additionally, as an 
important ECM component, it mimics the human microenvironment by having an 
important role in cell-ECM interactions (Tibbitt and Anseth, 2009; Geckil et al., 2010; 
Kim et al., 2016). Fibrin is easily functionalised, promotes angiogenesis and supports cell 
viability and proliferation (Brown and Barker, 2014; Y. Li et al., 2015). However, disease 
transmission or immune reaction is a disadvantage in the use of heterologous proteins. To 
avoid sample contamination, the production of fibrinogen and thrombin via 
recombination technology and virus and bacteria inactivation is essential (Hennis et al., 
1992; Chen and Jain, 2010; Hirashima et al., 2016). Another limitation is how dependent 
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the crosslinking speed is on the thrombin concentration (Weisel, 2005). This may result in 
slow or poor crosslinking when using low thrombin concentrations. Consequently, shape 
fidelity and early mechanical properties will be low (Gruene et al., 2011).  
Fibrin forms fibrils that easily cause nozzle blockage. Also, it has been reported that only 
very low concentrations (<2 mg/mL) of fibrinogen are able to be used with inkjet 
bioprinting with these producing hydrogels with very weak mechanical properties 
(Hospodiuk et al., 2017). On the other hand, thrombin solutions present low viscosity, not 
constituting a problem for inkjet bioprinting. Hence, the most common strategy is to print 
thrombin solution into a fibrinogen substrate, as reported by Cui and Boland (Cui and 
Boland, 2009). Within this approach, human-like microvasculature was fabricated. On the 
other hand, Atala and colleagues use the “alternating ink” strategy to produce fibrin-
collagen hydrogels (Figure 2.15) (Atala, 2013). This group demonstrated ejecting hybrid 
cell-laden fibrinogen-collagen solution onto an electrospun PCL layer. The hydrogel was 
then crosslinked by printing a thrombin solution layer after each gel precursor layer. The 
fabricated 3D construct allowed the formation of in vitro and in vivo cartilage-like tissues. 
The nozzle clogging limitation makes microvalve systems a preferable drop-on-demand 
system to be used with fibrin hydrogels. Lee and colleagues avoided the possibility of 
clog formation by printing fibrinogen and thrombin from two different reservoirs (Lee et 
al., 2010). This group used microvalves to produce a cell-laden fibrin hydrogel containing 
VEGF to study the influence of this growth factor on neural stem cells. Hybrid fibrin-
based materials can be processed in extrusion-based bioprinting, as it allows higher 
viscosities. However, fibrin is not regularly used due to its fast and irreversible 
crosslinking, which make this natural material difficult to extrude (Hospodiuk et al., 
2017). Despite this problem, Soker and colleagues fabricated a hybrid fibrin/collagen 
hydrogel for skin wounds (Skardal et al., 2012). By encapsulating AFSCs to modulate the 
inflammatory response, in vivo skin wound has showed to close and angiogenesis was 
promoted. Laser-assisted bioprinting also presents concerns for printing fibrin as the 
material sensitive structures may be affected by laser pulses. 
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Figure 2.14 – Alternating-ink strategy to produce in situ hydrogels. Adapted from (C. Li 
et al., 2015). 
 
2.3.2.2 Agarose 
Agarose is a polysaccharide molecule that is extracted from certain seaweeds (Hospodiuk 
et al., 2017; Tarassoli et al., 2018). It is widely used in electrophoresis to separate 
molecules, such as deoxyribonucleic acid (DNA) (Lee et al., 2012). Different types of 
agarose solidify and melt at different temperatures, a propriety called thermal hysteresis 
(Indovina et al., 1979). These temperatures depend on the type and agarose solution 
concentration, however it thermally crosslinks at low temperatures, depending on the 
hydroxyethylation, and presents a liquid conformation between 20 and 70°C (Ozbolat and 
Hospodiuk, 2016). Non-covalent hydrogen bonds connect agarose fibres to each other, 
forming a mesh of helical fibre bundles that hold to each other, granting a solid structure 
by lowering the temperature (Stellwagen, 2009). Once solidified, agarose forms brittle 
structures with shape fidelity. Like any other hydrogel, agarose must be hydrated, 
otherwise drying will quickly happen. Cell viability and functionality may be affected by 
lack of cell attachment to the agarose hydrogels (Livoti and Morgan, 2010). However, 
agarose is used in combination with other materials to provide stability and thermally 
induced crosslinking (Duarte Campos et al., 2014). Agarose hydrogels are also adapted 
for cell aggregate bioprinting, working as support structures (Ozbolat, 2015). Although 
not highly viscous, agarose rheological properties are prohibitive for inkjet bioprinting. 
Although sharing the same concerns, microvalve printing allows agarose printing 
 39 
 
(Hospodiuk et al., 2017). However, a temperature controlling nozzle and reservoir are 
needed to avoid agarose solidification. Tan and colleagues bioprinted an agarose-collagen 
hybrid hydrogel as vehicle for poly(lactic-co-glycolic acid) (PLGA) encapsulated cells 
(Figure 2.16a) (Tan et al., 2016). The hydrogel and encapsulation protected cells during 
extrusion, which resulted in high viability and proliferation rates. A hybrid agarose-
matrigel loaded with intestinal epithelial cells was extruded by Fan et al.(2016). This 
group verified that nutrient and oxygen diffusion was diminished, which lead to low 
viabilities after 10 days. In laser-assisted bioprinting, agarose has been used as a coating 
on the substrate due to its viscoelasticity and fast crosslinking mechanism (Koch et al., 
2009). 
 
2.3.2.3 Gelatin 
Gelatin is a hydrolised form of collagen that is extracted from animal tissue: skin, bones, 
tendons, etc (Gómez-Guillén et al., 2002; Olsen et al., 2003). It is biocompatible and 
biodegradable, being able to be synthesised at a very low cost (Rose et al., 2014). These 
properties make gelatin one of the most used materials in pharmaceutical and medical 
fields (G. Yang et al., 2018). Gelatin gels at low temperatures by inducing gelatin strands 
self-organisation into helical conformations (Guo et al., 2003; Bode et al., 2013). By 
heating, this organisation is, once again, replaced by random coil arrangement. 
Liquification can be obtained at 37°C. Gelatin behaviour is related to different factors, 
such as pH, concentration or temperature (Osorio et al., 2007). Normal cell adhesion and 
behaviour, as well as migration have been observed using gelatin hydrogels (Yang et al., 
2016). However, gelatin is highly degradable, which makes difficult for gelatin constructs 
to retain mechanical integrity and shape fidelity: gelatin is normally combined with other 
materials to avoid dissolution (Ng et al., 2016; Hospodiuk et al., 2017; Li et al., 2018). 
Another strategy is use chemical or enzymatic crosslinking to increase the hybrid gelatin 
construct mechanical properties (Hospodiuk et al., 2017).  
Gelatin has been mixed with alginate and collagen to fabricate cell-laden hydrogel with 
controllable degradation. Wu et al showed high cell viability and proliferation rates and 
specific markers expression after hydrogel extrusion (Wu et al., 2016). Xu and colleagues 
reported cell differentiation and self-organisation by extruding a hybrid cell-laden 
hydrogel, containing gelatin, alginate and fibrinogen (Xu et al., 2010). Additionally, this 
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system was useful as an in vitro model for metabolic syndrome study. Wang et al (2006) 
printed cell-laden gelatin hydrogels via extrusion-based bioprinting. These authors 
demonstrated high hepatocyte viability during more than 2 months. Contrary to the 
increased number of works published in extrusion-based bioprinting, not many are 
available in either inkjet and microvalve bioprinting. However, Boland and colleagues 
used an alginate/gelatin blend to produce 3D constructs (Boland et al., 2007). Here, CaCl2 
was accurately inkjet printed onto the hybrid solution bath (Figure 2.16b). Cells were 
culture on the top of the fabricated hydrogels showing attachment. Gelatin has been also 
adapted for laser-based bioprinting. Huang and colleagues tested gelatin as absorbing 
layer coating material and verified that post printing cell survival and DNA double-strand 
breaks were reduced by 10 and 50%, respectively (Huang, 2017). Additionally, droplet 
size and jet velocity were also reduced. 
  
 
Figure 2. 15 – a Agarose-collagen hydrogel; b Alginate-gelatin hydrogel. Adapted from 
(Tan et al., 2016; Boland et al., 2007). 
 
2.3.2.4 Collagen 
Collagen is a fundamental component of the ECM of various tissues. It is highly abundant 
in the human body, constituting between one quarter and one third of the total body 
protein tissue (Shoulders and Raines, 2009; Ferreira et al., 2012). Collagen has been 
widely used for its abundancy, easy processing, biocompatibility or hydrophilicity 
(Skardal and Atala, 2015; Gudapati et al., 2016). Additionally, it presents low 
antigenicity as collagen is conserved between species, which causes minimal immune 
 41 
 
responses (Hospodiuk et al., 2017). Cell attachment and proliferation are highly 
supported by the collagen matrix (Murphy et al.,  2010). However, crosslinking is 
difficult to control as it remains liquid at low temperatures and forms fibrils at 
temperatures higher than 37°C or at neutral pH. Collagen is rarely used in bioprinting on 
its own, otherwise, cell distribution would be controlled by gravity until effective 
crosslinking (Hospodiuk et al., 2017). To overcome this issue and the lack of mechanical 
properties, collagen is widely combined with other materials, such as gelatin, fibrinogen, 
alginate, among others, to form hybrid materials with superior characteristics (Wu et al., 
2016; He et al., 2018; Holder et al., 2018; X. Yang et al., 2018). 
The fibrous micro-architecture of collagen does not allow it to be processed by inkjet 
bioprinting, otherwise, nozzle blockage would occur (Hospodiuk et al., 2017). Yanez et al 
used cell-laden coated substrate and an inkjet bioprinted cell-laden fibrin layer to obtain a 
stratified skin tissue using collagen as dermal layer (Yanez et al., 2015). In another study, 
Lee and colleagues used microvalve bioprinting to fabricate skin tissue (Figure 2.17a) 
(Lee et al., 2014). Keratinocytes and fibroblasts were printed on the top of a printed 
collagen solution. Quick collagen gelation was obtained by nebulized sodium 
bicarbonate. Histology and microscopy results revealed that the model obtained was 
similar to the native in vivo tissue. Using extrusion-based bioprinting, as reported before, 
a fibrinogen-collagen cell-laden hydrogel was produced to form in vitro and in vivo 
cartilage-like tissue (Atala, 2013). Similarly, collagen has been successfully used in laser-
assisted bioprinting. Michael and colleagues developed a collagen cell-laden bio-ink to 
produce skin constructs to implant in a in vivo model (Michael et al., 2013). This 
technique allowed the formation of stratified skin with highly viable cells. This system 
also actively promoted angiogenesis. 
 
2.3.2.5 Alginate 
Alginate is a naturally derived polysaccharide that is obtained from algae or seaweed 
(Tønnesen and Karlsen, 2002; Gudapati, Dey and Ozbolat, 2016). It is made of 
alternating and covalently linked blocks of (1-4)-linked β-D-mannuronate (M) and its C-5 
epimer α-L-guluronate (G) (Axpe and Oyen, 2016; Gelinsky, 2018). The most common 
crosslinking method involves ionic gelation with CaCl2 or calcium sulfate (CaSO4) – the 
attraction of carboxylic groups from two alginate chains forms a bridge between the 
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divalent calcium ions (Axpe and Oyen, 2016; Lai et al., 2016). Other crosslinking 
techniques are also used, such as physical or covalent crosslinking (Lee and Mooney, 
2012). Alginate is one of the most used materials in tissue engineering research, and is 
widely used in bioprinting, due to the low price and ease of use and combination with 
other materials to fabricate 3D constructs (Hospodiuk et al., 2017; Zanoletti et al., 2018). 
Additionally, it presents high biocompatibility and supports cell differentiation (Bozza et 
al., 2014; Laronda et al., 2014; Chen et al., 2015). Chemical modifications are widely 
used to improve alginate mechanical properties and to promote higher cell survival and 
desired cell functions (Hospodiuk et al., 2017).  
Alginate bio-inks are widely used in extrusion-based bioprinting. Due to its viscosity, 
alginate is able to be extruded as gel precursor solution or pre-crosslinked. Giuseppe and 
his team produced different cell-laden alginate/gelatin hydrogels by extrusion-based 
bioprinting to test several proprieties, such as printing accuracy, compressive behaviour 
and cell viability (Giuseppe et al., 2018). Aortic valve conduits were successfully printed 
by Duan and colleagues through the use of a cell-laden alginate/gelatin bio-ink (Figure 
2.17b) (Duan et al., 2012). High viability and expression of alpha-smooth muscle actin 
were demonstrated. However, for drop-on-demand applications, alginate rheological 
characteristics are normally a concern. It has been reported that only alginate 
concentrations lower than 2% are able to be inkjet bioprinted (Hospodiuk et al., 2017). To 
overcome this limitation, Atala and his team produced a cell-laden CaCl2 solution that 
was once deposited inside a sodium-alginate/collagen bath (Xu et al., 2013). The fast 
crosslinking allowed rapid cell attachment. Additionally, cells presented normal cell 
behaviour and phenotypic expression. Once implanted in vivo the bioprinted tissues were 
able to mature and angiogenesis was noted. Alginate has been successfully adapted to 
laser-assisted bioprinting. Guillemot and his research team used a cell-laden alginate bio-
ink to fabricate tissue-like constructs that presented highly viable cells (Guillotin et al., 
2010). 
 
2.3.2.6 Decellularised extracellular matrix  
The demand for truly biomimetic bioprinting has led some groups to process 
decellularized tissues to produce custom bio-inks. The concept is generally slow, difficult 
and costly. Generally, tissues are subjected to chemical, physical and enzymatic processes 
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that actively remove all the cellular content and only preserve the extracellular matrix 
(Crapo et al., 2011; Brancato et al., 2016; Ji and Guvendiren, 2017). After DNA 
quantification, which must represent less than 2% from the original content, the 
decellularized tissue is crushed and then dissolved in buffers to form a gel-like bio-ink, 
the dECM bio-ink (Hospodiuk et al., 2017; Ji and Guvendiren, 2017). This technique not 
only provides an unlimited source for bio-inks, but also closely mimics specific native 
cell microenvironment, positively influencing cell-cell and cell-ECM interactions (Zhang 
et al., 2016). To improve the bio-inks characteristics such as rheology or crosslinking 
properties, hydrogels and other materials are normally mixed with the dECM (Pati et al., 
2014; Toprakhisar et al., 2018). Apart from being slow and laborious, sample 
contaminations must be considered due to the chemical manipulation (Hospodiuk et al., 
2017).  
dECM heart, cartilage and adipose tissue derived bio-inks were produced by Pati and 
colleagues (Figure 2.17c) (Pati et al., 2014). This group fabricated cell-laden dECM 
hydrogels supported by a PCL structure for tissue formation. High levels of cell viability, 
ECM formation and differentiation commitment were obtained. Additionally, different 
tissue formation was observed to be guided by cell-cell interactions. In another work, the 
same Cho’s group used a similar strategy to produce adipose dECM cell-laden hydrogels 
supported by PCL constructs (Pati et al., 2015). Before in vivo experiments, it was 
observed that cells overexpress adipogenic genes without any adipogenic 
supplementation. This clearly shows the level of influence of specific dECMs bio-ink in 
cells. Once implanted, the construct showed to aid tissue remodelling and adipose tissue 
formation was detected. Moreover, no immune reaction was reported. Dong-Woo Cho 
group also used the strategy above to produce a cardiac patch for in vivo applications 
(Jang et al., 2017). Tissue formation, vascularisation and enhancement of cardiac function 
were reported. 
 44 
 
 
Figure 2.16 – a Collagen-based bioprinted skin on day 0 and 7; b Alginate/gelatin aortic 
valve conduit; c dECM-based tissue construct. Adapted from (Lee et al., 2014; Duan et 
al., 2012; Pati et al., 2014). 
 
2.3.2.7 Methacrylated Gelatin  
Methacrylated gelatin is a denatured form of collagen that consists of methacrylate groups 
conjugated to its amine side groups (Gudapati et al., 2016). GelMA is normally 
synthesised by a direct reaction of gelatin with methacrylic anhydride (MA) in phosphate 
buffer at 50 °C (Yue et al., 2015; Shirahama et al., 2016). In this reaction, methacryloyl 
substitution groups are introduced on the reactive amine and hydroxyl groups of the 
amino acid residues. Due to its controllable mechanical characteristics and 
biocompatibility it has been widely used in tissue engineering (Wang et al., 2014; Yue et 
al., 2015; Zhao et al., 2016). Additionally, GelMA is a biomimetic material that can be 
degraded enzymatically (Benton et al., 2009; Arya et al., 2016), at the same time it 
produces high cell survival and proliferation rates (Nichol et al., 2010; Klotz et al., 2016). 
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Photoinitiators are generally used to allow photocrosslinking by exposing the material to 
UV light (Benton et al., 2009; Xiao et al., 2011). This forms covalently crosslinked 
hydrogels. GelMA concentration has been reported to influence cell migration, with 10% 
and 15% of movement inhbition inside the gel (Hospodiuk et al., 2017). 
GelMA is widely used in bioprinting due to its ability to be manipulated. Bertassoni and 
colleagues demonstrated that mechanical properties and printability are dependent on the 
GelMA concentration used on the cell-laden bio-inks (Figure 2.18a) (Bertassoni et al., 
2014).  In another work, by combining gelatin with GelMA bio-inks Yin and colleagues 
improved the crosslinking mechanism of GelMA (Yin et al., 2018). This feature allowed 
to improve the bio-ink rheology and consequently increase the shape fidelity after 
printing. Bone marrow stem cells showed high viability on the optimised bio-ink 
concentration. Hoch and colleagues showed to be able to inkjet print GelMA through 
chemical modifications (Hoch et al., 2013). A second acetylation reaction was able to 
modulate the physical and rheological properties of the solution and, consequently, 
allowing to be use in piezoelectric inkjet printers. High cell viability was obtained after 
printing. The fibrocartilage microenvironment was mimicked by using microvalves to 
print a cell-laden GelMA bio-ink that incorporated bone morphogenetic protein 2 and 
transforming growth factor beta 1 (Gurkan et al., 2014). Gurkan and his group showed 
that with this tailored bio-ink hMSCs were able to differentiate into chondrocytes and 
osteoblasts. Also, Stratesteffen and colleagues printed a cell-laden GelMA/collagen blend 
using a microvalve bioprinter (Stratesteffen et al., 2017). Capillary-like structures were 
obtained with cell viability shown to be directly linked to the UV light exposure 
necessary for crosslinking. GelMA was observed to increase the mechanical properties of 
the construct, while collagen contributed to enhance cell spreading. The benefits of 
combining natural to synthetic materials by mixing GelMA to polyethylene glycol 
diacrylate (PEGDA) were shown by Wang and colleagues (Z. Wang et al., 2015). The 
hybrid material showed improved characteristics, such as visible light crosslinkable, high 
biocompatibility and printability or increased mechanical properties. 
 
2.3.3     Synthetic materials 
Contrarily to natural materials, synthetic materials can be tailored in terms of physical and 
chemical properties (Bishop et al., 2017; Abelardo, 2018). Through careful design, a 
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desired material can be obtained to target a specific tissue. Mechanical properties, type of 
crosslinking, gelation speed or molecular weight are some of the tunable properties 
(Bishop et al., 2017; Hospodiuk et al., 2017; Gungor-Ozkerim et al., 2018). However, 
synthetic materials lack biomimetic properties and natural cell attachment sites (Skardal 
and Atala, 2015). These properties may not only affect cell behaviour, but also cell 
survival. Polyethylene glycol (PEG) is one of the most used synthetic materials (Skardal 
et al.,  2010; Schuurman et al., 2013; Gao et al., 2015; Jose et al., 2016; McBeth et al., 
2017). 
 
2.3.3.1 Polyethylene glycol 
Polyethylene glycol is a polyether-based material that has been widely used for medical 
and pharmaceutical applications (Thomas et al., 2014; Hospodiuk et al., 2017). It is a 
hydrophilic substance and must be combined with other materials, such as polymers, to 
gain adhesion capability to cells and proteins (Ji and Guvendiren, 2017). Nevertheless, 
some cells can survive inside PEG capsules without using any additive (Hospodiuk et al., 
2017). PEG gives a higher strength than natural materials, but the strength remains low. 
To overcome this limitation, PEG is generally functionalised with diacrylate (DA) or 
methacrylate (MA) (Gudapati et al., 2016; Ozbolat and Hospodiuk, 2016). This 
functionalization process introduces C=C bonds into the polymer backbone, therefore 
exposure to UV is necessary to photocrosslink the materials.  
Due to the water solubility of PEG, drop-on-demand printing techniques are able to use 
this material as bio-ink. Cui and colleagues used a modified inkjet printer for in situ repair 
of osteochondral plugs using a chondrocyte-laden PEGDMA bio-ink (Cui et al., 2012). 
The mechanical properties matched the native articular cartilage and high viability was 
obtained. This group verified that simultaneous photocrosslinking increased viability, 
when compared with photopolymerisation after printing. Printed chondrocytes infiltrated 
the native tissue, producing high proteoglycan deposition at the interface between printed 
and native cartilage. In another work, Cui and his team used thermal inkjet printing to 
produce chondrocyte-laden PEGMA hydrogels (Figure 2.18b) (Cui et al., 2012). Using 
growth factors (TGF-β1 and FGF-2), as well as an insulin-transferrin-selenium based 
medium, high cell proliferation and chondrogenic ECM deposition was observed. 
Ultimately, this lead to the formation of new cartilaginous tissue. Using extrusion-based 
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bioprinting side, Kaplan and his team combined PEG with silk to form a cell-laden bio-
ink (Zheng et al., 2018). The EBB printed structures showed high shape fidelity and 
resolution, at same time cells presented high survival and proliferation rates. In vivo 
implantation demonstrated that the fabricated hydrogels are able to conserve encapsulated 
cell survival for 6 weeks. Hockaday et al fabricated aortic valve constructs using extruded 
cell-laden PEGDA hydrogels (Butcher, 2012). High shape fidelity and good mechanical 
properties were obtained. Porcine aortic valve interstitial cells were shown to remain 
viable and functional during 21 days of culture. PEGDA has been also used in laser-based 
bioprinting, being first demonstrated by Boland and his team (Dhariwala et al, 2004). The 
authors demonstrated that cell survival was determined by photoinitiator concentration. 
 
 
Figure 2.17 – a Cross-section and array of cell-laden GelMA-based hydrogels; b – Cell-
laden PEG construct for cartilage regeneration. Adapted from (Bertassoni et al., 2014;  
Cui, et al., 2012). 
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2.3.4 Cell carrier techniques 
In the research presented in this thesis, a polycationic cell coating is used as part of a bio-
ink formulation. In this sub-chapter, cell carrier techniques are briefly reviewed to offer 
the reader an insight on these techniques that are widely used in cell and drug delivery. 
Cells and molecules have been reported to have the ability to heal different diseases, from 
aggressive cancers to endocrinological chronic conditions, such as diabetes (Orive, 
Hernández, et al., 2003; Orive et al., 2015). However, long-term cell transplantation is 
not successful without the following of a rigorous immunosuppressive protocol, 
necessary to avoid graft rejection (Ryan et al., 2002; Duncan and Wilkes, 2005; Zarrinpar 
et al., 2016). As an alternative, immune-isolating cell carriers have been widely 
investigated in the last few decades. These avoid the high costs and low quality of life of 
chronic administration of immunosuppressants, responsible by the development of 
opportunistic infections and other worse conditions, at the same time it increases outcome 
of cell therapies (Su et al., 2010; Krishnan et al., 2014). Cell immuno-isolation can be 
defined as the immobilization of cells inside a perm-selective capsule, i.e. a semi-
permeable membrane that allows influx of oxygen and nutrients, at same time it grants 
outflux of cellular waste, avoids immune-mediated reactions, and offers protection from 
mechanical stress (Uludag et al., 2000; Nafea et al.,  2011; Orive et al., 2015). The perm-
selective membrane must have the desired degradation kinetics, biocompatibility, 
physical, chemical and mechanical properties and well-defined permeability to avoid cell 
escape and possible formation of teratomas (Murua et al., 2008; Kirk et al., 2014). This 
technology is highly-versatile allowing cell delivery via intravascular, oral or 
subcutaneous routes, among others, depending on the cell carrier design (Murua et al., 
2008; De Vos et al., 2010). Additionally, cell immobilisation may consider the 
transplantation of non-human cells, which would help on the shortage of donor tissue, and 
the immune-isolation of genetically engineered cells to express any required substance 
without affecting the host’s genome (Lathuilière et al., 2014; Wang et al., 2015). The 
therapy performance may be increased through the addition of molecules and virus to the 
system (Martinez-Quintanilla et al., 2015).  
The concept of cell carrier is offered by different cell encapsulation strategies: 
macroencapsulation, microencapsulation and single cell encapsulation (Figure 2.19) 
(Orive, Gascón, et al., 2003; Park et al., 2014; Steele et al., 2014).  
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Figure 2.18 – Cell delivery techniques. a) Macroencapsulation; b) Microencapsulation; c) 
Single cell encapsulation. 
 
Briefly, macroencapsulation comprises the use of implantable flat-sheet devices or 
hollow-fiber membranes that imprison a large number of cells (millions) that are released 
in a controlled-manner (Orive et al., 2003). Microencapsulation involves the use of small 
sized capsules, in range from 100 μm to 750 μm, or conformally coated tissues, that 
encapsulate hundreds to thousands of cells, allowing the maximization of oxygen and 
nutrients influx due to a large surface/volume ratio (Murua et al., 2008; Song and Roy, 
2016). Finally, single cell encapsulation requires the use of thin conformal coatings that 
encapsulate cells at a unity level (Fakhrullin et al., 2012; Song and Roy, 2016). 
 
2.3.4.1 Macroencapsulation 
Macroencapsulation systems are normally equipped with semi-permeable membranes on 
its boundaries to allow adequate diffusion of oxygen and nutrients and outflux of waste, 
necessary to maintain cell survival and renewal, at the same time it protects the 
encapsulated cells from the host immune response (Uludag et al.,  2000; Desai and Shea, 
2017). Additionally, macroencapsulation systems must support neovascularization of its 
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surroundings in order to maximize nutrient and oxygen delivery (Wang et al., 2016). 
Good oxygen diffusion is essential in macrodevices to avoid cell core necrosis, and 
respective failure of the implant (K. Wang et al., 2015). Device design, size and thickness 
are important properties as the system geometry is able to affect the way cells are 
delivered, conditioning cell survival (Veiseh et al., 2015; Desai and Shea, 2017). 
Physicochemical and mechanical properties of the macroencapsulation apparatus must be 
well controlled to provoke minimal innate immune response, which may originate the 
formation of a fibrotic capsule around the system and affecting its performance (K. Wang 
et al., 2015; Desai and Shea, 2017). 
Nowadays, macroencapsulation devices are mainly researched for cell and molecule 
delivery, however, when they first appeared in the middle of last century, they were used 
to study tumour development and tissue rejection through the maintenance of mouse 
homografts in extravascular diffusion chambers (Algire, 1943; Gray, 2006). During these 
experiments, Algire and colleagues (1943) found the importance of having the 
encapsulated tissue/cells apart from the host tissue, which granted cell survival. 
Nonetheless, xenografts were rapidly rejected due to the passage of smaller proteins and 
molecules, such as antibodies, which highlighted the importance of the perm-selective 
property of the membrane. The first macroencapsulation device was commercialized by 
the Millipore Corporation in the 70’s applying the knowledge obtained from Algire and 
colleagues (Scharp and Marchetti, 2014). This was first applied to diabetes through islet 
entrapment for insulin delivery. Still today, diabetes affects millions in the world, which 
presents an incredible commercial potential that lead to the appearance of various 
biotechnological companies. The search for a solution to this problem has developed 
macroencapsulation devices in terms of reliability and performance (Scharp and 
Marchetti, 2014; Desai and Shea, 2017; Skrzypek et al., 2017). The improvement and 
creation of new designs and use of coatings and new biomaterials on the device 
manufacture opened avenues to new clinical applications. 
Macroencapsulation systems include majorly two main types: flat sheet devices and 
hollow fibers (Figure 2.20a,b) (Uludag et al., 2000; Lathuilière, et al., 2014; Lathuilière et 
al., 2015; Skrzypek et al., 2017). In flat sheet devices cells are immobilized inside an 
isolated compartment formed by two porous membranes attached to opposite sides. An 
outer pre-vascularised or vascularisation supporting layer holds the whole system and a 
cell loading port are also essential parts of this system. For hollow fibers, cells are 
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entrapped inside the lumen of a selective permeable membrane being the ends of the fibre 
closed to prevent undesired cell escape. Depending on the engraftment type, 
macroencapsulation apparatus can be intravascular or extravascular, if the device is 
engrafted to the host’s vasculature or supports neovascularization on its surroundings, 
respectively (Vaithilingam and Tuch, 2011; Song and Roy, 2016). 
 
 
Figure 2.19 – Macroencapsulation systems. a) Flat sheet; b) hollow fibre; c) cell-laden 
microfibers. Adapted from (Lathuilière et al., 2014; Schwenter et al., 2011; Onoe et al., 
2013). 
 
More recently, a new macroencapsulation system has been developed by microfluidic 
spinning – cell laden microfibers (Figure 2.20c) (Onoe et al., 2013). Using a double-
coaxial laminar flow consisting on a pre-gel solution containing cells (core), a second pre-
gel solution (shell) and a crosslinking agent (sheath), cells are able to be continuously 
encapsulated inside a solid and porous hydrogel fibre. This technique does not limit the 
fibre size, the diameter and length are easily tuned up by the flow rate, being able to reach 
nanometres to hundreds of micrometers in diameter and meters in size, and presents high 
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reproducibility and does not rely on voltages or temperatures. Additionally, patterns were 
obtained, allowing single fibre production and insignificant damage is caused to the cells. 
However, this process is time-consuming and relatively slow. 
 
2.3.4.2 Microencapsulation 
The first cell microencapsulation system was reported by Chang and colleagues in 1964 
(Chang, 1964), and in 1980, microcapsules were firstly applied to diabetes treatment by 
Lim and Sum (Lim and Sun, 1980). Due to the reduced size, 100-750 µm, 
microencapsulation attracted attention due to the ability to deliver and implant cells and 
other therapeutics via small diameter catheters, avoiding any major surgery (Rabanel et 
al., 2009; Al Kindi et al., 2011; Perán et al., 2012). Microencapsulation systems are 
mostly constituted by polymeric or polyelectrolyte capsules, coatings or hydrogels. 
Simple and gentle methodologies are vital to grant normal cell behaviour after the 
encapsulation or coating process (Fakhrullin et al., 2012; Drachuk et al., 2013; Song and 
Roy, 2016). Most of the procedures use aqueous conditions, such as cell medium, which 
is beneficial for cells. Slow processes and harsh reagents may compromise cell viability 
but develop a capsule with better mechanical properties (Uludag et al., 2000). 
Similarly to macroencapsulation devices, microencapsulation systems are constituted by a 
thin and semipermeable membrane to allow influx of oxygen and nutrients and outflux of 
cell by-products (Orive et al., 2004; De Vos et al., 2012). Lack of nutrient and oxygen 
diffusion will lead to hypoxia and, ultimately, necrosis (Ma et al., 2013). The perm-
selectivity capacity of the membrane allows to exclude the entrance of high molecular 
weight cells and molecules, such as macrophages or antigens, which can originate 
foreign-body reaction (FBR) and respective fibrotic tissue deposition (Tomeit et al., 
2015). However, macrophages and other cells produced cytokines and low molecular 
weight proteins may cross the barrier and affect cell. It has been reported that 50-150 kDa 
represents the ideal molecular weight cut-off for microencapsulation systems (Tomeit et 
al., 2015). Additionally, the surrounding membrane immune-isolates the encapsulated 
cells from the external environment, at the same time it confers the mechanical integrity 
and resilience necessary to avoid capsule disruption or cell stress (Orive et al., 2003; 
Drachuk et al., 2013). The capsule or coating enable a controlled release of cells and/or 
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therapeutic products, avoiding any toxic effect to the surrounding tissues as consequence 
of a potential rapid release (Orive et al., 2004).  
Microencapsulation systems must be designed carefully, attending to three main 
properties: composition, transplantation site and geometry (Figure 2.21) (Olabisi, 2015; 
Tomeit et al., 2015). These characteristics affect the system performance, both in vitro 
and in vivo, and ultimately, result in inflammatory reactions and graft failure. Spherical 
structures are commonly adopted to better mimic the morphology and physiology of cells 
in living tissues and to provide an ideal surface-to-volume ratio for nutrient diffusion 
(Orlando et al., 2014; Tomeit et al., 2015). These two proprieties allow cells to maintain 
their viability and functions when comparing to other geometries. Additionally, a 
spherical shape avoids sharp surfaces that worsen inflammatory responses. Nowadays, 
most the capsules and coatings are “conformal”, where the material or materials cover the 
cell, right on the cell membrane, which constitutes an important step to reduce the internal 
mass transfer resistance (Uludag, De Vos et al., 2000; Drachuk et al., 2013). 
Biocompatibility is connected to material properties, such as chemical composition and 
surface charge, as well as to physical properties, such as surface roughness, shape and 
size (Drachuk et al., 2013; Bhujbal et al., 2014; Tomeit et al., 2015). Biomaterials must 
support normal cell behaviour, such as proliferation, migration and differentiation.  
 
Figure 2.20 – Microencapsulation key parameters for capsule design. From Tomeit et al., 
2015). 
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Cell microencapsulation has been also widely used in bioprocessing techniques. Due to 
the increased demand on cell therapies, scaling-up is necessary to shift from small studies 
in laboratories to industrialised batches. Nowadays, suspension bioreactors are the main 
tools used in industrial bioprocessing (Wilson et al., 2013; Allazetta and Lutolf, 2015). 
Here, cells are held in suspension and rotated within the suspending solution, suffering 
hydrodynamic shear stress, which end up affecting cell viability and phenotype (Serra et 
al., 2011; Fernandes et al., 2013; Wilson and Mcdevitt, 2013; Wilson et al., 2014). This 
technique is not recommended, especially when using stem cells, since these are 
extremely sensitive to external stimuli, changing its properties in adverse conditions 
(Fernandes et al., 2013; Wilson and Mcdevitt, 2013; Wilson et al., 2014). Another major 
issue of the use of suspension bioreactors is the low volumetric productivity obtained 
(Westman et al., 2012). To minimise the effect of external cues and control the cell 
microenvironment and, at the same time, increase the productivity, cells have been 
immobilised recurring to different 3D suspension culture methods: self-aggregated 
spheroids, cell immobilization on microcarriers or cell microencapsulation (Fan et al., 
2015). 
3D aggregate spheroids are widely used in stem cell science. These structures allow the 
re-establishment of cell-cell contacts, mimicking cell microenvironment and, therefore, 
enhancing cell behaviour and promoting stem cell differentiation (Achilli et al., 2012; Xie 
et al., 2017). 3D cell aggregates are presented as an interesting and easy strategy for 
translation to industrial bioprocessing, since these can be cultured in suspension and used 
in suspension bioreactors (Serra et al., 2011). 
In microcarrier-based cultures, small beads are suspended in medium and used as 
substrate for cell proliferation (Schop et al., 2008; Dias et al., 2017). The microcarrier 
must be chosen according to the cell characteristics and desired application, however 
some cells require an extra microcarrier functionalisation in order to not compromise cell 
characteristics (Alves et al., 2012). The flexibility of this technology is represented by the 
ease of scaling up, since increasing the substrate area, directly increase the cell seeding 
area (Badenes et al., 2016). This reduces the volume of any consumables needed, 
decreasing the total cost of cell bioprocessing.  
Although 3D aggregate spheroids and microcarriers present interesting advantages for 
bioprocessing applications, some problems compromise their use. For both strategies cells 
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suffer different mechanical forces due to the stirring in bioreactors, which end up 
affecting cell characteristics, namely cell differentiation, morphology and metabolism 
(Fan et al., 2015). Additionally, both systems are able to form uncontrolled aggregate 
sizes and microcarrier clumping, which lead to necrotic centers and/or 
promotion/inhibition of cell differentiation (Alves et al., 2012). In terms of 
cryopreservation, an essential process for scaling up, cell viability is compromised after 
thawing, when using both systems (Serra et al., 2011). 
Cell microencapsulation has shown to overcome the bioprocessing problems stated 
above. The capsule is able to protect the cell from the hydrodynamic shear stress and 
avoid the clumping of aggregates and microcarriers in culture through the prevention of 
excessive cell agglomeration (Serra et al., 2011). This matrix works as a semi-permeable 
membrane that allow influx of nutrients, oxygen, and growth factors, and outflux of waste 
products (Wilson and Mcdevitt, 2013). As reported earlier, the capsule is able to be 
designed in terms of materials, porosity and thickness, in order to best mimic the 
microenvironment, modulating the cell phenotype and controlling its differentiation. 
However, it must be noted that biomaterials must be carefully chosen. When in stirred 
bioreactors, scaffolds suffer hydrodynamic forces, which are not present in static cultures, 
and that may change not only the scaffold properties and structural integrity, but also the 
cell properties (Rathore et al., 2013; Fan et al., 2015). It was observed that 
microencapsulated cells improve cell post-thaw functions for different cell types due to 
the maintenance of cell-cell contacts and protection from ice crystal damage (Fernandes 
et al., 2013). This is an important characteristic for bioprocessing in order to turn into a 
high-throughput process in terms of cell preservation for storage and transportation of cell 
products.  
 
2.3.4.2.1     Microcapsules 
As reported earlier, microcapsules are widely used in tissue engineering and 
bioprocessing research, due to the beneficial properties. In both applications, high-
throughput is essential to produce the high cell number needed for implantation or 
therapeutic production. The most used encapsulation methods include extrusion 
technologies and emulsion techniques (Mazzitelli et al., 2011; Selimović et al., 2012; 
Sánchez et al., 2013; Rakszewska et al., 2014; Oliveira et al., 2015). The latter is based 
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on combining a cell-laden aqueous solution with an immiscible organic phase, such as oil.  
When well dispersed, the capsule is formed by adding a crosslinker. On the other hand, in 
extrusion techniques, capsule formation is based on the extrusion of a cell-laden gel 
precursor, droplet formation and respective crosslinking. Different extrusion technologies 
have been used to fabricate microencapsulated cells (Figure 2.22): Simple dripping, 
electrostatic extrusion, coaxial flow, vibrating nozzle, jet cutting and spinning disk 
atomization (Sánchez et al., 2013; J.-Z. Wang et al., 2017; Némethová et al., 2017). Each 
technology has its own pros and cons (Table 2.4), however these do not allow to produce 
capsules with sizes smaller than 200-300 µm.  
 
Figure 2.21 – Different microcapsule production methodologies. a Simple dripping, b 
electrostatic extrusion, c coaxial flow, d vibrating nozzle, e jet cutting, and f spinning disk 
atomization. From (Mishra, 2015). 
 
Simple dripping or gravitational dripping is based on the extrusion of cell-laden gel 
precursor through a small needle (Zhang and Ma, 2016). As the constant pressure is 
applied, droplets will start to form until they break from the needle and fall due to the 
gravity into a hardening bath. This bath is filled with a crosslinker solution that will gel 
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the hydrogel precursor. In electrostatic extrusion, an electric potential is applied between 
the needle and the hardening bath (Manojlovic et al., 2006; Zhang and Ma, 2016). 
Droplets are formed due to the electrostatic force, surface tension and gravity. Coaxial 
flow is a similar method to the simple dripping (Andersen et al., 1980; Oliveira et al., 
2015; Némethová et al., 2017). However, instead of recurring to the gravity force to form 
and break down the gel precursor droplet, this technique applies compressed gas to force 
the droplet breakage and consequently fall into the hardening bath. Vibrating nozzle uses 
vibration to break down a continuous jet of gel precursor into droplets (Zhang and Ma, 
2016; Némethová et al., 2017). These are then crosslinked when falling into the 
hardening bath. Jet Cutter technology is based on a continuous stream of cell-laden gel 
precursor that is cut by a rotating cutting wires (Sánchez et al., 2013; Paulo et al., 2017). 
This way, droplets are formed and fall to the hardening bath. The spinning disk extrusion 
method used a spinning disk to cut the continuous stream of cell-laden gel precursor 
(Senuma et al., 2000; Teunou and Poncelet, 2005). The droplets are then formed and fall 
to the hardening bath to produce a resilient capsule. Detailed reviews on extrusion 
methodologies can be found elsewhere (Mishra, 2015; J.-Z. Wang et al., 2017; 
Némethová et al., 2017). Comparing the different extrusion techniques, vibrating nozzle 
shows to enable the repeatable and standardised production of homogenous 
microcapsules, in a sterile and operator-friendly environment (Némethová et al., 2017). 
Additionally, this technique presents low variability between batches, at the same time it 
may be used for high throughput production of microcapsules. 
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Table 2.3 - Characterisation of the different microencapsulation extrusion methodologies. 
Adapted from (Némethová et al., 2017). 
 
 
2.3.4.2.2     Conformal coatings 
Conformal coatings are characterised by a thin, protective and semi-permeable layer 
attached to the cell membrane. These can be fabricated with different materials: 
polyelectrolytes, biomolecules, metal nanoparticles or oxides (Fakhrullin et al., 2012; Dai 
et al., 2018). Just like microcapsules, these layers protect cells from external cells and 
stimulus, at the same time they grant nutrient, oxygen and waste transport to and from the 
coated cell. Contrarily to microcapsule fabrication, which produces capsules much larger 
than cells, resulting in inefficient mass transport, these coatings present reduced 
thickness, ability to coat single cells and tightly fit the cell membrane (Uludag et al., 
2000). The thickness of the protective layer can be ultrathin, reaching nanometers in size 
(2–100 nm). Conformal coatings are normally produced via emulsion, covalent or non-
covalent techniques (Kellam et al., 2003; Wilson et al., 2009; Drachuk et al., 2013). 
Covalent techniques rely on ionic and hydrophobic interactions between the cellular 
 59 
 
membrane and the material (Kellam et al., 2003). On the other hand, non-covalent 
methodologies comprise the introduction of new physical and chemical characteristics 
onto the cellular membrane through the adsorption of biomolecules and by 
electromagnetic interactions (Kellam et al., 2003; Prescher and Bertozzi, 2005; Rabuka et 
al., 2008). Conformal coatings via emulsion techniques use similar strategy to what is 
described in microcapsules sub-chapter.  
Non-covalent cell surface modification offers the advantage over covalent techniques of 
minimal perturbation of the cell physiology, thereby preventing interference with 
important cellular functions governed by cell surface molecules (Kellam et al., 2003; 
Prescher and Bertozzi, 2005; Rabuka et al., 2008). Also, reversibility is possible due to 
weak bounds between the cell membrane and material (Thibault et al., 2003; Di 
Crescenzo et al., 2014). On the other hand, covalent techniques are generally irreversible 
and may interfere with cellular functions after gelation mechanisms (Nicodemus and 
Bryant, 2008; Khetan et al., 2013). However, this procedure presents better mechanical 
properties than non-covalent surface modification (Wipff et al., 2009). Nowadays, LbL 
methods are presented as the most advanced conformal coating strategy for cell delivery, 
allowing single cell coating with a fully controlled environment as number of layers, 
porosity, mechanical properties, thickness and composition are able to be tuned (Johnston 
et al., 2006; Guzmán et al., 2017). This technique is achieved through the deposition of 
successive layers of negatively and positively charged materials on a cell surface. LbL 
successfully avoids membrane disruption caused by electrostatic coating, a consequence 
of the lack of polysaccharides on mammal cell membrane (Menger et al., 2003; 
Fakhrullin et al., 2012; Matsusaki et al., 2012; Vaidyanathan et al., 2015). However, it 
can be a laborious and time-consuming process, as it requires multiple 10–15-min 
sequential depositions of oppositely charged monolayers onto the cell surface with 
intermediate washes, with up to a 2-h interval between layers to guarantee good viability 
and typically four to six bilayers (Menger et al., 2003; Fakhrullin et al., 2012; W. Li et 
al., 2015).  Different polyelectrolytes have been used with LbL technique – Poly-L-
Lysine (PLL), poly(allylamine hydrochloride) (PAH), poly(styrene sulfonate) (PSS) or 
polyethylenimine (PEI). Nanoparticles and nanotubes can be also applied by using 
polyelectrolyte layers as templates (Fakhrullin et al., 2012).  
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2.3.4.2.3     Hydrogels as Cell Carriers 
The use of hydrogels in bio-inks (effectively a special case of cell carrying) has 
previously been described in section 2.3.1. The control over degradability and molecule 
release on hydrogels has also attracted interest for drug delivery applications (Van 
Vlierberghe et al., 2011; Caló and Khutoryanskiy, 2015; Xue et al., 2015). Natural and 
synthetic hydrogels are also widely in tissue engineering research, for cell delivery, space 
filling agents or as cell scaffolding, due to their beneficial properties. Decellularised 
meniscus ECM hydrogels were used as cell carrier for hMSCs for meniscus defects. Yuan 
and colleagues observed the upregulation of fibrochondrogenic marks, at the same time 
the hydrogels successfully delivered the cells to wound area (Yuan et al., 2017). Tissue 
regeneration was demonstrated, and hydrogels offered protection against the development 
of pathologies, such as osteoarthritis. Ballios et al used a hybrid hydrogel made of 
hyaluronan and methylcellulose to encapsulate retinal stem-progenitor cells (Ballios et 
al., 2010). It was exhibited that, once applied in the sub-retinal space, the hydrogel 
remained intact for 7 days. This technique showed to be a promising cell carrier as the 
cell distribution in the sub-retinal space was more homogenously than when using 
recurring saline solutions. In another study, hydrogels were found to be extremely useful 
to understand how the microenvironment influenced cells. Benoit and colleagues used 
distinct functionalised PEG hydrogels that showed that differentiation pathways were 
affected by the functionalisation type (Benoit et al., 2008). Additionally, Khetan and 
colleagues reported that hMSC behaviour is also regulated by the mechanical properties 
offered by the hydrogel (Khetan et al., 2013). Kerscher and her team developed a PEG-
fibrinogen encapsulation system to provide a specific microenvironment to differentiation 
human pluripotent stem cells in to heart tissues (Kerscher et al., 2016). This system 
allowed correct heart tissue development and maturation. To avoid the crosslinking 
negative effects, Foo and colleagues developed a cell encapsulation system using 
hydrogels that combined WW and proline-rich domains (Wong Po Foo et al., 2009). This 
two-component hydrogel was used to encapsulate neural stem cells that retained their 
normal behaviour, including differentiation and self-renewal (Figure 2.23a). More 
recently, hydrogels were also used to encapsulate living organisms for long-term 
microscopy periods due to its high hydration that stabilised the nematode Caenorhabditis 
elegans (Figure 2.23b) (Burnett et al., 2018).  
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Figure 2.22 – a Hydrogel encapsulated differentiated neurons showing neuronal marker 
MAP2 (green), glial marker (red), progenitor marker nestin (yellow) and nuclei (blue); b 
Methodology used for long-term microscopy of C. Elegans. It is observed normal worm 
function even after 12 hours. Adapted from (Wong Po Foo et al., 2009) and (Burnett et 
al., 2018). 
 
2.4 Summary  
The literature review has showed that: 
- Tissue Engineering aims i) to promote regeneration and create healthy and functional 
tissues and organs for grafting and transplantation and ii) to establish reliable in vitro 
models of tissues and diseases to foster therapeutic advancements. 
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- There are 4 main bioprinting technologies: inkjet, microvalve, extrusion-based and 
laser-assisted bioprinting. Each technique provides different advantages and 
disadvantages and its selection must be based on the desired application.  
- Bio-inks are composed by biomaterials, cells and differentiation and growth factors that, 
once processed by a bioprinting technique may originate 3D cell-laden structures. 
Currently, hydrogels and hydrogel precursors are the most used type of materials on bio-
inks. However, cell aggregates and single cells in suspension may be also adopted for bio-
ink formulation. 
- Bio-inks can be composed by natural (alginate, collagen, among others) and/or synthetic 
(PEG, etc). Materials must be carefully chosen depending on the desired properties and 
bioprinting technique. 
From the literature review above, it is possible to conclude that bioprinting is allowing a 
more controllable and biomimetic 3D cell culture systems. Each bioprinting technique 
presents different specifications (Table 2.1), which make each of them ideal for certain 
applications. However, limitations are inherent to each technology. 
In the following chapters, two novel bio-inks are developed to overcome limitations on 
inkjet bioprinting and production of high cell dense cell-laden hydrogels. The first bio-ink 
introduces positive electrical charges on the cell membrane which results on the inhibition 
of natural cell aggregation. This way, nozzle blockage on inkjet bioprinting is avoided, 
allowing printing for at least 60 minutes, at the same time it increases the technology’s 
reliability. Secondly, a collagen-alginate-fibrin hydrogel bio-ink was formulated and used 
with a proprietary drop-on-demand bioprinting technology to develop high cell dense 
cell-laden hydrogels. Here, cell densities of 40 x 106 cells/mL were possible to be 
impinged, without nozzle blockage or low cell viability. The same does not happen when 
using other bioprinting techniques, such as inkjet, microvalve and extrusion-based 
bioprinting. In the first two, nozzle blockage conditions the cell density used, which 
normally allow bio-inks with a maximum of 5 x 106 cells/mL. On the other hand, 
although high cell dense bio-inks can be applied in extrusion-based bioprinting, cell 
viability is normally reduced due to the shear stress. 
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Table 2.4 – Comparison between the four main bioprinting methodologies. 
 
Inkjet 
bioprinting 
Single 
microvalve 
bioprinting 
Extrusion 
bioprinting 
Laser-
assisted 
bioprinting 
Ref. 
Viscosity of 
Material 
Deposited 
on the 
Substrate 
3–30 
mPa/s 
1–70 mPa/s 
30 mPa/s 
to >6x107 
mPa/s 
 
1–300 mPa/s 
 
(Murphy and Atala, 2014; 
Donderwinkel, van Hest and 
Cameron, 2017; Ng et al., 
2017) 
Printing 
Speed 
1 – 10 000 
droplets/s 
6 500 
droplets/s 
10 µm/s – 
700 mm/s. 
100 – 5000 
droplets/s 
(Guillotin et al., 2010; 
Murphy and Atala, 2014; 
Bakhshinejad and D’souza, 
2015; Gudapati, Dey and 
Ozbolat, 2016; Lee and 
Yeong, 2016; Ovsianikov, 
2016; Ozbolat and 
Hospodiuk, 2016; 
Donderwinkel, van Hest and 
Cameron, 2017; Gao et al., 
2017; Ozbolat, 2017) 
Volume 
deposition 
rate 
160 µL/s 40 µL/s 3-15 µL/s 
175 - 1800 
nL/s 
(Guillotin et al., 2010; 
Gudapati, Dey and Ozbolat, 
2016; Graham et al., 2017; 
Koch et al., 2017; Zhang, 
2018) 
Resolution 
pL 
droplets 
pL to nL 
droplets 
5 µm to 
mm size 
deposited 
track 
<pL 
droplets 
(Murphy and Atala, 2014; 
Ozbolat, 2017) 
Cell 
viability 
>85% >90% 40-80% >95% 
(Murphy and Atala, 2014; 
Ozbolat, 2017) 
Crosslinking 
Process 
Post-
printing 
Post-
printing 
Pre-, post- 
printing 
Post-
printing 
(Murphy and Atala, 2014; 
Lee and Yeong, 2016) 
Cell density 
Low, 
<5x106 
cells/mL 
High, 
107/mL 
High, cell 
spheroids 
High, 108 
cells/mL 
(Murphy and Atala, 2014; 
Donderwinkel, van Hest and 
Cameron, 2017; Ozbolat, 
2017) 
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Chapter 3. Materials and methods 
3.1 General methods 
In this sub-chapter, the general assays used in this research will be described. Unless 
otherwise stated, all the reagents were obtained from Sigma-Aldrich, USA. 
 
3.1.1 Cell Culture 
Tissue culture was carried out in aseptic conditions using a class II laminar flow hood, 
previously decontaminated using a 70% ethanol solution. Different cell types were used 
during this study, osteosarcoma (U2OS, ATCC® HTB-96™), Ewing’s sarcoma (TC-71, 
kindly donated by Dr. Britta Vormoor, Newcastle University (Vormoor et al., 2014), 
Neo-Natal Human Dermal Fibroblasts (Neo-NHDF, Lonza, Switzerland), and 
immortalized human bone marrow stem cells using human telomerase reverse 
transcriptase (BMSC-hTERT) - Y2O1 cells - (kindly donated by Professor Paul Genever, 
York University (James et al., 2015). Primary MSCs were kindly donated by Dr. Deepali 
Pal. U2OS, TC-71 and Neo-NHDF were cultured using high-glucose Dulbecco's 
Modified Eagle Medium (DMEM, Life Technologies) supplemented with 10% Fetal 
Bovine Serum (FBS) and 5000 U/mL penicillin/streptomycin at 37 °C and 5% CO2. 
Y2O1 cells were culture in the same previous medium but also supplemented with 
pyruvate at 110 mg/L. For osteogenic differentiation, the Y2O1 basal medium was 
supplemented with L-Ascorbic acid 2-phosphate sesquimagnesium salt, ß-
Glycerophosphate, and Dexamethasone, at a final concentration of 50 µg/mL, 5 mM, and 
10 nM, respectively. Trilineage differentiation was carried by Dr. Deepali Pal, where 
primary MSCs were firstly incubated during 16 days in low glucose DMEM 
supplemented with 20% FBS and 1% penicillin/streptomycin, followed by a 14-day 
incubation using osteogenesis differentiation kit (Thermo Fisher Scientific, USA), 
chondrogenesis differentiation kit (Thermo Fisher Scientific, USA) and adipogenesis 
differentiation kit (Thermo Fisher Scientific, USA) for osteogenic, chondrogenic and 
adipogenic differentiation, respectively. All cell lines used in this study were obtained 
from the indicated suppliers and were tested for mycoplasma contamination.  
Cells were passaged when reached to 70-80% of confluency. Cells were washed with pre-
warmed DPBS (Dulbecco's phosphate-buffered saline) without calcium and magnesium 
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and detached using trypsin/ Ethylenediamine tetraacetic acid (EDTA) or 0.5% 
EDTA/DPBS, following 5-10 min incubation at 37 °C and 5% CO2. After cell 
detachment have been visually confirmed using a microscope, trypsin was neutralised 
using pre-warmed cell medium and the cell suspension centrifuged at 1200 rpm during 5 
min. The supernatant medium was aspirated, and the cell pellet diluted in fresh and pre-
warmed supplemented medium in an appropriate volume to subculture the cells at a ratio 
of 1 to 3 (one flask to three flasks). 
 
3.1.2  Cytotoxicity and Metabolic Assays 
Cytotoxic and metabolic assays are tools that quantify the cell response to these external 
factors in terms of viability or metabolism. In this research, the effect of different PLL 
concentrations on cell viability was measured recurring to Live/Dead and caspase-3 
activity detection and membrane permeability assays and cell metabolism studied through 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Additionally, 
Live/Dead was also used to characterise the cell-loaded collagen-alginate-fibrinogen 
(CAF) hydrogels. 
Live/Dead assay (Molecular Probes by Life Technologies, USA) was used to distinguish 
live from dead cells based on intracellular esterase activity and integrity of plasma 
membrane. Calcein acetoxymethyl (calcein AM) is a green fluorescent dye that stains live 
cells in presence of esterase activity. On the other hand, when plasma integrity is 
compromised, ethidium homodimer-1 (EthD-1) binds to nucleic acids staining dead cells 
with a bright red. This is a versatile assay that may be used to both quantitative and 
qualitatively examine cell viability, however, during this study Live/Dead assay was 
merely used as qualitatively assay through staining analysis using a fluorescence 
microscopy. 
The reagent stock solutions were removed from the freezer and warmed to room 
temperature and were mixed using the manufacturer’s recommendations to obtain a 4 μM 
ethidium homodimer and 2 μM calcein AM solution. For microscope slides, after a HBSS 
(Hanks' Balanced Salt Solution) wash, approximately 5 × 104 cells were cultured, 
followed by the addition of 100 μL of Live/Dead working solution and a 40-minute 
incubation at room temperature. For six-well plates, after a HBSS wash, approximately 2 
× 105 cells were cultured, followed by the addition of 500 μL of Live/Dead working 
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solution, and a 40-minute incubation at room temperature. For CAF hydrogels, after a 
HBSS wash, Live/Dead solution was used to completely cover each hydrogel during one-
hour incubation at room temperature. Slides and well plates were imaged with a 
fluorescence microscope (Leica DM IL LED, Leica Microsystems) using the suggested 
filters: fluorescein filter for calcein (live cells) and Texas red filter for ethidium 
homodimer (dead cells). Images were captured using SPOT Advanced software (SPOT 
Imaging Solutions). CAF hydrogels were imaged using a Nikon A1R (Nikon, Japan). 
Caspase-3 activity detection and membrane permeability assay was used to quantify the 
cell viability, being able to distinguish the cell death pathway between apoptosis and 
necrosis. NucView™ 488 Caspase-3 Substrate (Cambridge Bioscience) was used to 
detect caspase-3 activity in cells and to identify apoptotic cells. The NucView 488 DNA 
dye is attached to a caspase-3 substrate peptide sequence DEVD, which makes the dye 
unable to couple to DNA and be fluorescent. Once crossing the cell membrane, in 
presence of caspase-3 due to cell apoptosis, the substrate is cleaved, and the probe 
migrates to the nucleus staining it with green fluorescence (Figure 3.1a). The cell 
membrane permeability was studied using propidium iodide (PI, BD Biosciences), a 
membrane impermeant dye that binds to DNA staining the cell in red when cell 
membrane is compromised, a common characteristic of necrotic cells (Figure 3.1b). 
The caspase-3 activity detection and membrane permeability assay were adapted from the 
manufacturer instructions (Cambridge Bioscience, UK). After the coating procedure, 0.2 
mL of cells at a density of 1 × 106 cells/mL in DPBS was collected, and 1 μL of 0.2 mM 
NucView 488 substrate stock solution and 2.5 μL of PI stock solution (BD Biosciences, 
USA) were added. After the solutions had been mixed, the cells were incubated at 37 °C 
and 5% CO2 for 15–30 min, protected from light. Before cell analysis on an ImageStream 
X Mark II Imaging Flow Cytometer (Merck Millipore, Germany) - nearly 9500 events for 
each concentration - 200 μL of DPBS was added to each sample. Samples were analysed 
using IDEAS software (Merck Millipore). 
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Figure 3.1 - a Diagram showing intracellular caspase-3 detection using NucView 488 
Caspase-3 Substrate. The DNA dye is not fluorescent until cleavage by caspase-3 and 
DNA binding. b Schematic showing the principle behind the cell membrane permeability 
assay with PI. PI is only able to penetrate a disrupted cell membrane, staining the nucleus. 
 
The MTT assay is a frequently used colorimetric assay for cell metabolism study. When 
introduced into cell culture, the yellow coloured MTT is converted into water-insoluble 
purple formazan by the succinate dehydrogenase enzyme produced by the active 
mitochondria (Figure 3.2).  
Cells at a density of ∼1 × 105/mL were seeded in 24-well plates and incubated at 37 °C 
and 5% CO2 for 4, 24, 72, and 168 h. Following the incubation period, supplemented 
DMEM was replaced by serum-free DMEM and MTT solution (5 mg/mL in PBS), 
reaching a final concentration of 0.5 mg/mL. After a 4-h incubation period at 37 °C and 
5% CO2, serum-free DMEM was replaced by 200 μL of isopropanol (Fisher Scientific, 
USA) under gentle agitation for 20–30 min and protected from light. Afterward, 100 μL 
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of dissolved formazan was transferred to a 96-well plate, and the absorbance was 
measured with a spectrophotometer (Sunrise, Tecan, Switzerland) at 570 nm. 
 
Figure 3.2 - MTT assay concept representation. The mitochondrial produced succinate 
dehydrogenase reduces the MTT forming formazan. 
 
3.1.3  Cell Fixation and Probe Staining for Confocal Microscopy 
Cellular staining is essential in microscopy to reliable detect cell constituents (from cell 
membrane to nucleus and organelles) allowing a precise study on cell behaviour upon the 
introduction of an external factor. During this work, two different cell staining have been 
used: Phalloidin–Tetramethylrhodamine B isothiocyanate (phalloidin) and (4',6-
diamidino-2-phenylindole) (DAPI, Vector Laboratories, USA). The first uses a toxin 
derived from the mushroom Amanita phalloides that strongly binds to polymeric F actin, 
creating highly stabilized actin filaments and, due to rhodamine, staining the cell with a 
red fluorescence. DAPI is a commonly used nuclear staining that binds to the Adenine-
Thymine bonds in the DNA, emitting a blue fluorescence. A green coloured fluorescein 
isothiocyanate labelled PLL was also used along this work. 
Coated cells were fixed immediately after the coating process or 1h, 2h, 3h, 4h, or 1 day 
later once attached and proliferating using 4% paraformaldehyde for 15 min at room 
temperature. Cells were washed three times using 0.1% DPBS/Tween 20 (Sigma Life 
Science) and phalloidin (1 mg/mL) added during a 20-min light-protected incubation 
period at room temperature. After further washing, DAPI (1:2500 solution) was added, 
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and the solution was subjected to a 15-min light-protected incubation period at room 
temperature. Cells were washed and resuspended in 500 μL of 0.1% DPBS/Tween 20 
solution. CAF hydrogels followed the same protocol, however, phalloidin and DAPI 
incubation periods were increased to 60 and 40 min, respectively. Fixed cells and 
hydrogels were stored protected from light at 4 °C. Cells coated with PLL-Fluorescein 
isothiocyanate (PLL-FITC) were visualized using a Leica TCS SP2 UV AOBS MP 
(Upright) point scanning confocal microscope (Leica Microsystems) at 20× 
magnification. Cell loaded hydrogels were studied using a Nikon A1R point scanning 
confocal microscope (Nikon, Japan) at 10× magnification. 
 
3.1.4 Polymer Uptake Detection by Transmission Electron Microscopy 
Transmission Electron Microscopy (TEM) is an ultrastructural microscopy technique that 
uses an electron beam to pass through an ultrathin nanometric resin covered section of a 
pre-treated cell or tissue sample. Once the electron beam is passing through the sample, it 
will be absorbed or scattered, being then collected by a detector and forming a 2D black 
and white image. Due to the ultra-resolution (≈20 nm) of this technique it is possible to 
precisely study different cell organelles, viruses or bacteria. 
The polymer localization examination was performed using a Phillips CM 100 
Compustage (FEI) transmission electron microscope (Philips, Netherlands), and digital 
images were collected using an AMT CCD camera (Deben, UK). Coated cells were fixed 
using a solution of 2% glutaraldehyde (TAAB Laboratory Equipment, UK) in sodium 
cacodylate buffer at 4 °C, followed by a secondary fixation with 1% osmium tetroxide 
(Agar Scientific, UK). Cells were subjected to several dehydration steps, embedded in 
resin, and cut in ultrathin sections (approximately 70 nm) using a diamond knife on a 
Leica EM UC7 ultramicrotome (Leica Microsystems). The sections were stretched with 
chloroform to eliminate compression and mounted on Pioloform-filmed copper grids 
(Agar Scientific). 
 
3.1.5  Polymer Metabolisation by Flow-Activated Cell Sorting 
Flow cytometry is widely used biochemical method that allows a complete cell 
characterisation. It works on a single cell basis and uses a number of lasers to analyse cell 
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size and roundness as well as the expression of fluorescent cell surface and intracellular 
markers. This allows the identification of different cells from a heterogenous population 
being able to organise the cell in sub-population depending on its physical characteristics 
and expressed markers. During this work, Flow-Activated Cell Sorting (FACS) was used 
to measure the fluorescein isothiocyanate intensity during the PLL-FITC metabolisation 
by coated cells.  
PLL-FITC-coated cells were analysed 15 min, 24 h, and 48 h following coating. A cell 
density of ∼2 × 106/mL in HBSS without phenol red was prepared, and data were 
acquired on a FACSCalibur flow cytometer (BD Biosciences). Forward-scattered and 
sideways-scattered data were used to gate in intact cells and exclude cell debris. The 
obtained data were analysed using Flowing Software v2.5. 
 
3.1.6  G-Band Karyotyping 
G-band karyotyping is a conventional cytogenetic analysis that allow the observation of 
genetic aberrations in chromosomes. Cells are arrested in the metaphase, the cell cycle 
phase when the chromosomes are the second most-condensed and highly coiled, 
following processing to obtain a characteristic banding pattern that allow chromosome 
identification as well as their numerical and structural aberrancies.  
Cells were incubated with 0 or 10 μg/mL PLL until 50–80% confluency. On the day 
before the harvest, 10 μL/mL colcemid was added to each cell culture flask and incubated 
overnight. Cells were gently washed with DPBS, and trypsin was used to detach the cells. 
After a 7-min 400g centrifugation, 0.075 M potassium chloride was added to the pellet 
with vortexing to ensure mixing. Then, 5 mL of Fresh Carnoy’s Fixative was added 
dropwise, and another 5 mL of the same fixative added without mixing. Subsequently, the 
mixture was centrifuged at 400g, the supernatant was removed, and an additional 5 mL of 
fixative was added. To evaluate whether the slide provided good-quality information on 
the harvest, the following protocol was used: cells were centrifuged at 400g for 5 min, 
and the supernatant was removed until only 300 to 500 μL remained, after which the cells 
were gently resuspended. Drops of the cell suspension were pipetted onto a slide, and 
fresh Carnoy’s Fixative was added. Finally, for G-banding, the slides were aged at 60 °C 
overnight and immersed in 50 mL of PBS and 1 mL of 10× trypsin (0.5%), before being 
stained with Leishmann and Giemsa Staining Solution for 3 min. Slides were then 
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allowed to completely dry. DPX mountant was finally added, and the slides were 
observed using a light microscope at 1250× magnification. 
 
3.1.7  CAF hydrogel compression test 
Mechanical properties of scaffolds are of capital importance on 3D cell cultures. Cells 
sense shear stress, stiffness or hardness of materials, shaping their morphology, activity, 
and even fate [Harnessing Traction-Mediated Manipulation of the Cell-Matrix]. 
Therefore, it is essential to guarantee that the produced CAF hydrogels presented similar 
mechanical properties to natural soft tissue. Compression tests were performed using a 
tensile tester EZ-SX (Shimadzu, Japan) prepared with a 20 N load cell. Three samples 
were cut to a parallelepiped shape with a dimension average of 0.65x0.65x0.33 cm. The 
crosshead speed was set at 1 mm·min−1 and the test was carried at room temperature. The 
compressive modulus was calculated on the linear elastic regime (10-20%) following the 
equation below: 
𝐸𝑐 =
𝜎𝑐
𝜀𝑐
 
where Ec represents the compressive modulus (Pa), σc is stress in Pascal, and εc is the strain 
represented by the elastic portion of the stress-strain curve. 
 
3.1.8  Gel precursor viscosity 
The microvalves used during this work do not allow to jet materials with superior 
viscosities. Therefore, it was essential to understand the viscosities of the gel precursors 
used during this work to characterise the microvalve compatibility. The rheological 
measurements for viscosity were performed on a HR-2 Discovery Hybrid Rheometer (TA 
Instruments, USA), with a standard steel parallel plate geometry (40 mm) and 1 mm of 
gap. Each tested sample had a volume of 1.2 mL and all measurements were performed at 
25ᵒC. 
 
(3.1) 
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3.1.9  Hydrogel degradation assay 
The hydrogels produced in this work aim to be used as matrix for the development of 
microtissues, therefore slow degradation was necessary to assure for long incubation 
periods. CAF hydrogel degradation was obtained through gravimetric analysis. Once 
printed, each sample was wiped with filter paper and weighted before immersion in high-
glucose with pyruvate DMEM at 37ºC and 5% CO2 for 1, 3, 7, and 14 days. After the test 
end, samples were dried with filter paper to remove the excess of medium and 
reweighted. The degradation was calculated using the following equation:  
𝐷𝑒𝑔𝑟𝑎𝑑𝑎𝑡𝑖𝑜𝑛 (%) = 1 −
𝑊𝑓
𝑊𝑖
× 100 
where Wi represents the sample weight after printing (day 0) in grams, and Wf is the 
sample weight after 1,3, 7 or 14 days of immersion in DMEM in grams.  
 
3.1.10 Glucose uptake 
High-cell density hydrogels were produced during this research therefore, it was 
important to guarantee that nutrients were able to diffuse to the most inner site of the 
hydrogel. For this, a glucose analogue, 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-
2-Deoxyglucose (2-NBDG; Thermo Fisher Scientific, USA), was used to study the 
hydrogel capacity on solution uptake. A 0.06845 mg/mL 2-NBDG in DPBS without 
calcium or magnesium solution was prepared and protected from light. After washing the 
samples with DPBS without calcium or magnesium, 2 mL of 2-NBDG solution was 
added to each gel during different time-points. Once reached the time-point, gels were 
transferred to a new well-plate with DPBS without calcium or magnesium to release the 
absorbed 2-NBDG. The resultant was read at an excitation/emission of 465/540 nm using 
a LS-50B Luminescence Spectrometer (Perkin Elmer, USA).  
 
3.1.11  Scanning electron microscopy 
To assess the inner and outer morphology of CAF hydrogels, as well as to observe 
microtissue development and calcium deposition, a Tescan Vega LMU (Tescan, UK).  
scanning electron microscopy (SEM) was used. Before image acquisition, specimens 
(3.2) 
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without cells were freeze-dried and then mounted on carbon discs (TAAB Laboratory 
Equipment) and gold-coated using a Polaron E5000 SEM Coating unit (Quorum 
Technologies Ltd (Polaron Division), UK). For hydrogels with cells, samples were first 
fixed using a pre-warmed solution of 2% glutaraldehyde (TAAB Laboratory Equipment) 
in Sorensons buffer. The constructs were then stored at 4 °C overnight followed by 
dehydration steps using 25%, 50%, 75%, and 100% ethanol. Afterwards, specimens were 
stored at 4 °C in 100% ethanol until critical point dried using a BAL-TEC 030 Critical 
Point Dryer (Leica Geosystems Ltd, UK). Finally, cell-loaded hydrogels were also 
mounted on carbon discs and gold-coated. 
 
3.1.12  Picogreen and Alkaline Phosphatase (ALP) 
Cell proliferation and DNA content was assessed at day 0, 7 and 14 using PicoGreen 
DNA quantitation assay (Thermo Fisher Scientific, USA). Three samples from each 
specimen at different time-points were immersed in 1.5 mL of molecular grade sterile 
water following freezing at -20 ºC for later analysis. Standards were prepared following 
manufacturer’s recommendations. Briefly, serial dilutions (Table 3.1) using DNA 
working solution (DNA std stock 1:50 in 1X TE buffer) were used to obtain the DNA 
standard curve. 
Table 3.1 – DNA standard serial dilutions. 
Final [C] DNA 
(ng/mL) 
Volume of 1X 
TE (µL) 
Volume of 
working DNA 
(2µg/mL) (µL) 
Volume of 
PicoGreen in 1X 
TE (1:200) 
 
Final [C] DNA 
in PicoGreen 
[1:1] (ng/mL) 
 
0 (blank) 300 0 200 0 
10 298.5 1.5 200 5 
50 292.5 7.5 200 25 
100 285 15 200 50 
250 262.5 37.5 200 125 
500 225 75 200 250 
750 187.5 112.5 200 375 
1000 150 150 200 500 
2000 0 300 200 1000 
 
The same way serial cell dilutions were used to obtain a standard cell curve (Table 3.2). 
All the dilutions were prepared from a volume (1200 µL) of molecular grade sterile water 
with 4x106 cells.  
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Table 3.2 – Cell serial dilutions for PicoGreen. 
Volume of 
water with 
cells (µL) 
Number of 
cells 
Volume of 
1X TE 
(µL) 
Number of 
cells per 
100 µL 
Volume of 
PicoGreen 
(1:200) 
Final cell 
concentration in 
PicoGreen 
[1:1] cells/mL 
300 1 000 000 0 333 333 200 166 666 
150 500 000 150 166 666 200 83 333 
90 300 000 210 100 000 200 50 000 
30 100 000 270 33 333 200 16 666 
15 50 000 285 16 666 200 8 333 
7.5 25 000 292.5 8 433 200 4 216 
3 10 000 297 3 333 200 1 111 
0 0 300 0 200 0 
 
Before analysis, samples undergone three cycles of freezing and thawing, followed by 20 
min of immersion in an ultrasonic bath for cell lysis. 50 µL of the cell lysate were 
combined with 100 µL 1xTE and 150 µL PicoGreen dye in 1x TE (1:200) before loading 
a 96 opaque well plate in triplicate. After a 10-min room temperature incubation protected 
from light, samples were read (excitation/emission 485/530 nm) using a Spectramax 
Gemini XPS microplate reader (Molecular Devices, USA). The same cell lysate was used 
to measure the alkaline phosphatase (ALP) activity by combining it with 1-Step PNPP (p-
nitrophenyl phosphate) Substrate Solution (Thermo Fisher Scientific). The results were 
compared with the serial dilution of a p-nitrophenol standard solution. For each sample, 
in triplicate and in a transparent 96-well plate, 80 μL of the cell lysate was combined with 
120 μL of 1-Step PNPP Substrate Solution. After a 1-hour incubation at 37°C, the 
absorbance was read at 405 nm using a Biotek ELX800 (Biotek, Winooski, USA). 
 
3.1.13 Ribonucleic acid isolation and quantification 
Ribonucleic acid (RNA) isolation was performed in low and high-cell density samples at 
different time-points using RNeasy Mini kit (Qiagen, Germany) and following the 
manufacturer’s recommendations. Briefly, RLT buffer with β-mercaptoethanol (β-ME) 
was prepared by adding 10 µL of β-ME to 1 mL of RLT buffer. To start, 700 µL of RLT 
buffer with β-ME was added to each sample for cell disruption. The resulting was frozen 
at -20ºC until analysis. The starting solution was then homogenized by pipetting and 
vortexing during 1 min in a QIAshredder spin column. 1 volume of 70% of ethanol was 
added for further homogenization followed by pipetting. Afterwards, samples were 
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centrifuged for 30 s at 13 000 rpm (discarding the flow-through) and genomic DNA 
contamination was eliminated by using 80 µL of DNase I incubation mix (constituted by 
10 µL DNase I stock solution and 70 µL of RDD buffer), preceded by the addition of 350 
µL of RW1 buffer and further centrifugation for 30 s at 13 000 rpm (discarding the flow-
through). A new RW1 buffer wash was carried by adding 350 µL of this buffer, followed 
by new centrifugation for 30 s at 13 000 rpm, with flow-through discarded. Two washes 
using 500 µL of RPE buffer were then performed, the first for 30 s at 13 000 rpm and the 
second for 2 min at 13 000 rpm to remove all the residual ethanol. The RNeasy spin 
column was placed in a new collection tube and a centrifugation for 1 min at 13 000 rpm 
was carried. Finally, 30 µL of RNase-free water was added to the spin column membrane 
and a final centrifugation for 1 min at 13 000 rpm was performed for RNA elution. RNA 
concentration was quantified by using a nanodrop (ND-1000; Thermo Fisher Scientific, 
USA). 
 
3.1.14 Complementary DNA (cDNA) synthesis 
Complementary DNA was synthetized using the RT2 First Strand Kit (Qiagen) and 
following the recommended protocol. Briefly, after thawing, all the reagents were 
centrifuged for 30 s to assure good mixing. A genomic DNA elimination mix for each 
RNA sample was prepared by mixing 200 ng of RNA with 2 µL of GE buffer and RNase-
free water to perform a total volume of 10 µL per sample. This mixture was incubated for 
5 min at 42ºC and then placed on ice for at least 1 min. For each sample, the reverse 
transcription mix was prepared by adding 4 µL of 5x BC3 buffer, 1 µL of control P2, 2 
µL of Reverse Transcriptase mix RE3 and 3 µL of RNase-free water. The total 10 µL of 
the reverse transcription mix was combined by pipetting with the 10 µL of genomic DNA 
elimination mix. 91 µL of RNase-free water was added to each sample and mixed by 
pipetting. All samples were placed on ice before loading to the real-time polymerase 
chain reaction (RT-PCR) array plate. 
 
3.1.15 Gene expression using RT-PCR arrays 
Before loading the RT-PCR arrays, the PCR component mix per sample was obtained by 
mixing 650 µL of 2x SYBR Green Master Mix, 102 µL of cDNA synthesis reaction and 
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548 µL of RNase-free water. 10 µL of the PCR component mixture was loaded to each 
well of the RT-PCR array. Gene expression was analysed using a ViiA7384-well block 
(Applied Biosystems, USA). 
 
3.1.16 Statistical Analysis 
Data are expressed as mean ± standard deviation. Mean values and standard deviations 
were calculated from at least three independent experiments of triplicates per group. 
Comparisons were performed by one-way analysis of variance (ANOVA) in conjunction 
with Tukey’s multiple comparison test using levels of statistical significance of P < 0.05 
(*), P < 0.01 (**), P < 0.001 (***), and P < 0.0001 (****). 
 
3.2 Methods developed for this research 
During the research presented in this thesis, original methods have been developed. Here, 
these will be reported. Unless otherwise stated, all reagents used during this investigation 
were obtained from Sigma-Aldrich, USA. 
 
3.2.1 Single Cell Coating 
Cells were coated using a polycation – poly-l-lysine – to avoid natural cell agglomeration 
due to the presence of positively charged polymeric particles coupled to the cell 
membrane, which favours the electrical repulsion between cells. 
Before the coating process, poly-l-lysine hydrobromide (Molecular Weight (MW) = 15–
30 kDa) was dialyzed for 2 days and then dissolved in Dulbecco’s phosphate-buffered 
saline without calcium and magnesium until a concentration of 1 mg/mL had been 
reached. A 1 mg/mL solution of PLL-FITC (MW = 15–30 kDa) was also prepared using 
DPBS. Both polymeric solutions were dissolved in HBSS without phenol red at four 
different concentrations: 100, 50, 10, and 0 μg/mL (control). Following cell detachment, a 
cell suspension of 2 × 106 per 200 μL was prepared for each polymer concentration, and a 
volume of 1 mL was made up with HBSS without phenol red. The cells were incubated 
within the polymer for 15 min at 37 °C and 5% CO2 for coating. Afterward, coated cells 
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were washed twice with HBSS without phenol red, using centrifugation at 250g for 5 min 
to remove any polyelectrolyte excess. The process is illustrated in the Figure 3.3. 
 
Figure 3.3 - Illustration representing the poly(l-lysine) cell speckled coating procedure. 
 
3.2.2  Cell Aggregation Test and Aggregate Area Quantification 
Cell aggregation is a common problem in bioprocessing. To evaluate the effect of the 
single cell coating, 1 × 106 coated cells were suspended in 1 mL of high-glucose 
(DMEM) supplemented with 10% fetal bovine serum (FBS) and 5000 U/mL 
penicillin/streptomycin inside a 1 mL syringe. Ten drops were dispensed through a 21- 
gauge needle every hour up to 3 h (Figure 3.4). The drops were observed using a 
fluorescence microscope (Leica DM IL LED, Leica Microsystems, Germany). Between 
depositions, cells were incubated at 37 °C and 5% CO2. The images obtained were 
processed using ImageJ software (National Institutes of Health, USA). Each image from 
the triplicate biological experiment was processed using the Threshold function, and 20 
samples were selected at random through ROI manager and subjected to area 
measurement. 
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Figure 3.4 – Cell aggregation test diagram. Once coated, cells were mixed with 
supplemented cell medium and loaded into a syringe. Cell drops were dispensed every 
hour up to three hours and the size of cell clusters visualised under microscope.  
 
3.2.3  Cell Printing – general information 
A commercial Microfab Jetlab4 (Microfab Inc., USA) single orifice piezoelectric, 
droplet-on-demand, printer was used for all printing experiments in the present study 
(Figure 3.5a and Figure 3.5b). The printer has been customized by Dr. Matthew Benning 
to operate with versatility using both microvalve (Figure 3.6a) and inkjet printheads 
(Figure 3.6b). In the same way, an in-house reservoir coupled to an agitator was 
developed (Figure 3.6c and Figure 3.6d, respectively). During this work, INKX0514950A 
microvalves (The Lee Company, USA) and 60 µm MJ-AT-01 inkjets (Microfab Inc., 
USA) have been used. 
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Figure 3.5 – (A) Microfab Jetlab 4 apparatus. 1 – Computer; 2 – HEPA filter; 3 – 
Temperature controller; 4 – STOP button; 5 – ON/OFF button; 6 – Power supply for the 
agitator; (B) Microfab Jetlab4 apparatus (detail). 1 – LED stroboscope; 2 – Inkjet holder; 
3 – Microvalve holder; 4 – Pressure cables; 5 – xyz stage. 
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The Microfab Jetlab 4 printer comes with a dedicated software that is mainly organized in 
three distinct tabs (Figure 3.7). The first one, “Jet Setup” (Figure 3.7a), is responsible for 
the controlling of the electrical waveform that expands and contracts of the piezoelectric 
crystal for inkjet printheads, and that is also accountable for the opening and closing of 
the mechanical shutter for microvalves. The camera strobe delay and the jet trigger mode 
are also controllable from here. The second tab “Motion” (Figure 3.7b) is responsible for 
the xyz position of the printheads. Finally, an automatic air pressure controller is used to 
assist the printing process with a backpressure, essential to hold the solution inside the 
reservoir until the electrical impulse orders to do so. However, an analogic pneumatic 
controller CT-PT4 (Microfab Technologies, Inc.) (Figure 3.6e) has been used during this 
work. This way, the backpressure was set via knob rotation. The printer also allows the 
printing of black and white bitmap (.bmp) images and simple coded files, ideal for high-
throughput, that are loaded in the “Print Patterns” and “Print” tabs. 
 
 
Figure 3.6 – Components using on cell printing. (A) INKX0514950A microvalve; (B) 60 
µm Microfab inkjet printhead MJ-AT-01; (C) In-house developed motorised agitator; (D) 
In-house developed reservoir; (E) Analogic pneumatic controller CT-PT4. 
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3.2.4  Cell printing – Inkjet printing 
For inkjets, droplet ejection was achieved through the actuation of the piezoelectric 
material within the inkjet head, affected by the application of a voltage differential. The 
wave impulse was applied in a simple trapezoidal form with a rise time, dwell time, fall 
time, dwell voltage and droplet frequency of 3 µs, 25 µs, 3 µs, 22 V and 1 kHz, 
respectively. Droplet formation is achieved when the electrical impulse reaches the 
piezoelectric material making it expand and contract. Firstly, the expansion, combined 
with the backpressure, is responsible for the fluid to come out from equilibrium position 
(Figure 3.8a). Secondly, the piezoelectric material contraction controls the emersion of 
the fluid (Figure 3.8b and Figure 3.8c). Finally, the arrival of a new wave form that 
expands the piezoelectric system pulls back the fluid (Figure 3.8d and Figure 3.8e), 
leading it to break off (Figure 3.8f) and leave the orifice in the form of a droplet (Figure 
3.8g). Droplet formation was confirmed prior to printing using a LED stroboscope. 
Following single cell coating, encapsulated cells diluted in filtered fresh serum-free media 
(bio-ink) were placed in the printing reservoirs. The bio‐inks were printed using a 60 µm 
diameter inkjet printhead, onto a chosen substrate, using different scripts. 
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Figure 3.7  – Jetlab 4 dedicated software. (a) “Jet Setup” tab; (b) “Motion” tab; (c) 
Pressure control tab. 
 
 
Figure 3.8 – Sequence of events representing from equilibrium (a) to droplet ejection (g). 
Adapted from www.microfab.com. 
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To obtain the reliability of the bio-ink with coated cells, two 1 x 106 cell/mL bio-inks 
containing PLL coated or non‐coated cells were dispensed from a 60 μm diameter inkjet 
printhead using the apparatus described above, onto glass microscope slides. 10 
depositions of 50 droplets were printed in a 1x10 array at 7 time-points (0 to 60 minutes) 
in ten-minute increment. Each sample was analysed after deposition using an inverted 
microscope (Leica DM IL LED, Leica Microsystems, USA) and the number of cells 
recorded. 
 
3.2.5  Reactive Jet Impingement  
The ReJI system is an in-house printhead for bioprinting developed by Dr. Matthew 
Benning (Figure 3.9a) (Benning and Dalgarno, 2017). It is composed by one or more 
pairs of solenoid valves INKX0514950A located in opposite sides at 55º of inclination, 
connected to two spike and hold drivers (The Lee Company, USA) per pair to control the 
opening and closure of the valves (Figure 3.9b). The microvalves were also connected to 
the ink loading reservoirs (Figure 3.9c), which are attached to the pneumatics controller 
CT-PT4. Droplet ejection was obtained by applying an electrical impulse in the form of a 
rectangular waveform with a dwell time, amplitude and frequency of 800 µs, 5 V and 400 
Hz. By optimising the pressure and the waveform, simultaneous droplet printing can be 
achieved and allowing in-air droplet mixing, before falling onto the stage. A schematic 
may be observed in (Figure 3.9d). Differently to inkjets, microvalves rely on an actuating 
voltage (spike voltage) to open mechanical shutter and on a hold voltage to close the 
same shutter. The period that the shutter is open, i.e. spike duration, is regulated by a 
resistor and a capacitor built in the connected spike and hold driver. 
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Figure 3.9  – ReJI components and schematic. (a) The ReJI printhead detail with one pair 
of microvalves; (b) IECX0501350A A spike and hold drivers used with ReJI; (c) Ink 
loading reservoirs; (d) Schematic showing the main components of the ReJI system. 
 
3.2.6  Collagen/Alginate/Fibrin hydrogel components formulation 
CAF hydrogels were initially developed by Dr. Ana Ferreira-Duarte (Montalbano et al., 
2018), however its optimisation towards a bio-ink to be used on the ReJI system has been 
developed on the course of this work. Before obtaining the printed CAF hydrogels, the 
hydrogel precursors (pre-gel and crosslinking solutions) were formulated. Prior to the pre-
gel solution preparation, a 37.5 mg/mL fibrinogen solution was obtained by gently 
 85 
 
dissolving fibrinogen in DPBS without calcium and magnesium at 37 °C. A 2.5% NaAlg 
in DPBS without calcium and magnesium solution was also prepared. To achieve the pre-
gel solution, the two preceding mixtures were gently mixed with a 6 mg/mL collagen 
solution in hydrochloric acid  (Collagen Solutions, UK) to a ratio of 0.25;0.5;2 of 
collagen, alginate and fibrinogen, respectively. As crosslinking solution, a 500 U/mL of 
thrombin dissolved in high-glucose with pyruvate DMEM with 0.1% of CaCl2 was used. 
 
3.2.7  Fibrin hydrogel formulation 
As the higher percentage of CAF hydrogel is composed by fibrin, before jetting CAF 
hydrogel, different fibrin hydrogels were formulated in order to optimise its 
characteristics, namely the crosslinking time and hydrogel viscosity. Fibrin hydrogels 
were obtained by mixing different concentrations of fibrinogen and thrombin solutions. 
Firstly, fibrinogen from bovine plasma was gently dissolved in DPBS without calcium 
and magnesium at 37 °C to obtain the following concentrations: 100, 50 and 25 mg/mL. 
10 kU of thrombin from bovine plasma was dissolved in 20 mL of supplemented DMEM 
with pyruvate to obtain the concentration of 500, 250 and 100 U/mL. Both fibrinogen and 
thrombin solutions were mixed through manual pipetting at 1:1 and 2:1 ratio to make 
fibrin hydrogels as observed in Figure 3.10.  
 
 
Figure 3.10  – Fibrin hydrogels obtained using different fibrinogen and thrombin 
solutions at 1:1 and 2:1 ratio. 
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3.2.8  Cell-loaded CAF gels printing 
Two specific cell concentrations were used on the course of this work – 4 × 106 and 40 × 
106 cells/mL. The desired cell suspension was obtained by mixing 1 mL of 500 U/mL of 
thrombin solution with 0.1% of CaCl2 with the cell pellet. The pre-gel and cell-containing 
crosslinking solution were loaded at 37ºC into two separate reservoirs and the cell-filled 
hydrogels were fabricated by simultaneous droplet jetting from each precursor that, when 
mixed in air, formed a gel before reaching the stage (Figure 3.11). To jet the pre-gel and 
cell-containing crosslinking solution, the pressure system was in the range of 270–310 
mmHg and 450–550 mmHg, respectively. A specific pattern was achieved by coding and 
loading a script into the Jetlab4 software. After printing, the cell-laden constructs were 
incubated in osteogenic medium at 37 °C and 5% CO2. 
 
 
Figure 3.11  – Stroboscopic image of gel precursor and crosslinking solutions meeting in 
flight. 
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Chapter 4. Single cell coating using poly-L-lysine and reliable inkjet cell 
printing 
4.1 Introduction 
In this chapter, a simple and fast non-covalent cell surface modification using a positively 
charged polymer, PLL, has been applied in an attempt to reduce cell agglomerates 
without otherwise affecting cell behaviour. Afterwards, PLL coating was used as part of 
bio-ink formulation in order to increase inkjet cell bioprinting reliability. This chapter 
describes how different PLL concentrations affect the cells in terms of viability and 
metabolism, morphology and genetic information. Polymer ingestion and metabolisation, 
as well as PLL effect on agglomeration, are also characterised and discussed. Finally, 
tests on inkjet printing reliability are presented, including after-printing cell morphology 
and viability.  
 
4.2 Single cell coating concept 
The concept behind the PLL coating relies on the attraction between positively charged 
materials and the negatively charged cell membrane, similarly to other noncovalent cell 
surface modifications. Here, after immersing in the polycationic solution, cells get coated 
rather than imprisoned inside a complete capsule, as a result of the low polymeric 
concentrations used. Once attaching to a substrate, cells show to be able to ingest and 
metabolise the PLL coating depending on the polycation concentration used. The process 
reported is illustrated in Figure 4.1. 
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Figure 4.1 - Illustration of temporary cellular coating using poly(l-lysine) and further 
uptake of the biodegradable polycation.  
 
4.3 In Vitro Cell Viability Studies 
To evaluate the effect of the different PLL concentrations (100, 50, 10, and 0 µg/mL) on 
cell viability, four complementary assays were used. The first studied cell death as 
consequence of PLL damage on cell membrane – caspase-3 activity and cell permeability 
detection. Live/Dead assay reported cell viability by means of two fluorophores that 
attach to the cells depending on their condition, i.e. if they are alive or dead. The third 
relied on the cell metabolism by analysing the mitochondrial activity of the cells – MTT 
assay. Finally, cell karyotype was inspected to look for potential chromosomic 
aberrations caused by the PLL coating. 
As stated above, cell death as a cause of the coating process was studied through caspase-
3 activity and cell permeability detection on U2OS cells immediately after coating 
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(Figure 4.2). It was verified that, immediately after coating, only 62% of the 10 μg/mL 
coated cells were negative for both PI and NucView488, compared to 90% for untreated 
cells (Figure 4.2a). For the other two concentrations, 50 and 100 μg/mL, 34% and 10% of 
cells, respectively, were viable. Image flow cytometry reported that most of dead cells 
have suffered apoptosis, finding themselves at a late apoptotic stage, or necrosis, 
accounting over 5% for control samples, over 30% for 10 μg/mL specimens, 
approximately 65% for 50 μg/mL coated cells and almost 90% of the total cells for 100 
μg/mL (Figure 4.2b). On the other hand, although negligible, only control and 10 μg/mL 
samples presented cells in an early apoptotic stage. The reported cell survival is obtained 
by analysing not only the dye expression, but also through morphology observation 
(Figure 4.2c-f). Morphologically speaking, necrosis has been seen to increase with the 
PLL concentration, however, double positive populations for PI and Nucview488 were 
observed for the different conditions. 50 and 100 μg/mL coated cells presented, 
respectively, 34.72% and 65.19% double positive samples, and 31.20% and 24.86%, 
respectively for PI-only positive cells. The same did not happen for uncoated and 10 
μg/mL PLL coated cells, that presented less than 1% of double positives, but exhibiting 
5.13% and 35.38% PI positive cells, respectively. 
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Figure 4.2 - Caspase-3 activity and cell permeability detection for U2OS cells. (a) Cell 
death scores after analysis. (b) Total number of events for PI and PI and Nucview488 
positive cells. (c–f) ISx analysis samples: (c) control, (d) 10 μg/mL, (e) 50 μg/mL, (f) 100 
μg/mL. Scale bars, 10 μm. Double negative, apoptotic cells, necrotic cells, and double 
positive are represented by the numbers 1, 2, 3, and 4, respectively. 
 
Live/Dead assay was also used to qualitatively characterise the cells in terms of viability 
(Figure 4.3). Here, it is observable that the number of live cells (green) decreased by 
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increasing the PLL concentration, at the same time a raise on the number of dead cells 
(red) was accounted. 
 
Figure 4.3 – Live/Dead assay for (a) U2OS, (b) TC-71, and (c) Neo-NHDF cells. For 
each cell type, top pictures represent cells 4 hours after coating and bottom pictures show 
cells 24 hours after coating. Scale bars are 100 μm. 
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Cell metabolism after coating was characterised using MTT assay (Figure 4.4). U2OS 
cells coated using the 10 μg/mL PLL solution (Figure 4.4a) revealed a metabolic activity 
similar to that of the untreated cells (control) during the course of the experiment, 
reaching the same metabolic levels by day 7. Cell coating with the 50 μg/mL PLL 
solution reduced cell metabolic activity by more than 50% at day 0 compared to the 
control; however, a recovery was observed at later time points accounting absorbance 
values not far from control. Finally, the 100 μg/mL concentration showed to completely 
inhibit the mitochondrial activity as it is represented by the negligible absorbance values 
obtained. 
Ewing’s sarcoma cells response to the PLL concentrations was similar to that for the 
U2OS cells (Figure 4.4b). Cells coated using the 10 μg/mL concentration exhibited a 
metabolic behaviour identical to that of the control, however, by day 7, the 10 μg/mL 
coated cells ended up by overcoming control’s metabolic activity; the 50 μg/mL 
concentration initially decreased cell metabolic activity, but a sharp recovery was noted 
between days 3 and 7, showing cells metabolically more active when compared to the 
other PLL concentrations; to the 100 μg/mL concentration, a low metabolic response was 
observed, although a slightly slower cytotoxic response was found than for the U2OS 
cells at the end of the experiment. 
The Neo-NHDF (Figure 4.4c) cell behaviour was slightly different. These cells presented 
an initial lower metabolic activity compared to control for the 10 μg/mL concentration, 
although the activity recovered steadily over the first 3 days post-coating. The 50 μg/mL 
coated cells exhibited similar behaviour in terms of metabolic activity, but from a lower 
starting point and with a marked recovery at days 3 and 7. The 100 μg/mL coated cells 
barely presented any metabolic activity at day 0, improved slowly up to day 3, and then 
showed a significant recovery between days 3 and 7. 
Cell karyotyping was used to observe if the coating procedure could lead to any genetic 
mutation in the studied cells. Neo-NHDF 10 μg/mL coated cells presented unchanged 
karyotype after coating (Figure 4.5a,b), and TC-71 cells coated with the same PLL 
concentration conserved the translocation t(11;22)(q24;q12), an important hallmark of 
Ewing’s sarcoma (Figure 4.5c,d). 
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Figure 4.4 - MTT assay scores for days 0, 1, 3, and 7 for a) U2OS; b) TC-71; c) Neo-
NHDF. The data are shown as mean ± SD. Results are relative to control at the same time 
point. *, **, ***, and **** indicate a significant difference between groups at the levels p 
< 0.05, p < 0.01, p < 0.001, and p < 0.0001, respectively. Error bars represent the standard 
deviation (n = 3). 
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Figure 4.5 – Cell karyotype for Neo-NHDF (a – before coating; b – after coating) and TC-71 (c – before coating; d – after coating) cell lines. 
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4.4 Morphological analysis 
Cell and coating morphologies were investigated by confocal microscopy and 
transmission electron microscopy (TEM). Analysis of cell and coating morphologies 
showed cell integrity after the coating process and indicated that the polycation was 
tightly bound to the membrane for all three cell types (Figures 4.6, 4.7 and 4.8, U2OS, 
TC-71 and Neo-NHDF, respectively).  
 
Figure 4.6 - Cell and shell morphology after PLL coating for U2OS cells. A 
concentration-dependent capsule tightly fitting the cellular membrane immediately after 
coating is observed (d0). Shell release through internalisation processes and attachment 
and proliferation were observed one day after coating (d1). The nucleus is represented in 
blue (DAPI), f-actin in red (Phalloidin), and the PLL capsule in green (FITC). Scale bars, 
50 μm (day 0) and 150 μm (day 1). 
 
The PLL concentration used to coat the cells determined similar coating morphology for 
the different cellular lineages. For the 10 μg/mL concentration, cell membrane presented 
sparse PLL particles speckled around its surface. At higher concentrations, 50 and 100 
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μg/mL, it was observed an increase of polycation around the cell surface, which 
completely encapsulated the cell inside a PLL shell when using the 100 μg/mL PLL 
coating. One day after coating, the 10 μg/mL coated cells had ingested the majority of 
PLL and exhibited normal attachment and proliferation: U2OS cells presented a 
heterogeneous population showing attachment and spreading, TC-71 cells grew in 
clumps, and fibroblasts were flattened and elongated.  
 
Figure 4.7 - Cell and shell morphology after PLL coating for TC-71 cells. Staining similar 
to that in Figure 4.6. 
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Figure 4.8 - Cell and shell morphology after PLL coating for Neo-NHDF cells. Staining 
similar to that in Figure 4.6. 
 
At 50 and 100 μg/mL PLL concentrations, a reduced cell number at day 1, when 
compared to 10 μg/mL, was detected, which corroborates with the results obtained for the 
cell viability studies. Additionally, signs of increasing polymer ingestion and 
metabolisation by healthy cells could be observed at day one for all cell lines. The 
ingested PLL can clearly be seen inside the cell boundaries. 
Transmission electron microscopy directly explored the effects of PLL on cell 
ultrastructure (Figure 4.9). For both control and 10 μg/mL coated cells a little to no harm 
was demonstrated, having the cells maintaintheir boundaries and all organelles and 
nucleus seem to be stable. Contrarily, for 100 μg/mL coated cells, ruptures on the cell 
membrane are observable all over. Additionally, cell organelles are difficult to identify, 
and the chromatin was dispersed and lost around the cell. These characteristics are 
normally reported on necrotic cells. On 50 μg/mL PLL coated cells a mixed population of 
live and dead cells was noted. 
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Figure 4.9 – Cell death is dependent on polymer concentration. (a) Control cells. (b) Cells 
present normal morphology when coated in a 10 μg/mL coating. (c) Mixed cell 
population when coating cells with 50 μg/mL PLL (d) High polymer concentrations (100 
μg/mL) lead to cell death by necrosis. All cells fixed immediately after coating. Scale bar, 
5 μm (a, b, c) and 10 μm (d). 
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4.5 Polymer Uptake and Metabolisation 
PLL internalisation and respective metabolisation were examined through confocal 
microscopy, confirmed by transmission electron microscopy and quantified by flow 
cytometry.  
Through confocal microscopy, it was observed that cells coated using the 10 μg/mL PLL 
solution were able to attach within 1 h, after which the polymer was rapidly internalised 
by all cell lineages. However, each cell type showed different PLL metabolisation rates, 
with the fibroblasts metabolising most of the polymer in the first 4 h post-coating, with 
little PLL evident at this time point (Figure 4.10). On the other hand, the U2OS and TC-
71 cell lines metabolised the polymer at lower rates, with PLL still evident 4 hours after 
the coating procedure (Figure 4.11 and Figure 4.12, respectively). 
 
 
Figure 4.10 - PLL internalisation and metabolisation in the first 4 h after coating with 10 
μg/mL concentration allows normal Neo-NHDF cell attachment and proliferation. Neo-
NHDF cells attached within 1 h and metabolised almost all polymer within 4 h. Staining 
similar to that in Figure 4.6. Scale bars, 50 μm.  
 100 
 
 
Figure 4.11 - PLL internalisation and metabolisation in the first 4 h after coating with 10 
μg/mL concentration allows normal TC-71 cell attachment and proliferation. 
Osteosarcoma cells attached within 1 h, but slow polycation metabolisation was observed 
in the firsts 4 h. Staining similar to that in Figure 6. Scale bars, 50 μm. 
 
 
Figure 4.12 - PLL internalisation and metabolisation in the first 4 h after coating with 10 
μg/mL concentration allows normal TC-71 cell attachment and proliferation. TC-71 cells 
started attaching soon after the coating procedure, but polymer metabolisation was again 
slow. Staining similar to that in Figure 6. Scale bars, 50 μm.  
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TEM allowed to identify a range of endocytic pathways (Figure 4.13): caveolar-type 
endocytosis (Figure 4.13a), micropinocytosis (Figure 4.13b), phagocytosis (Figure 4.13c) 
and CLIC/GEEC-type endocytosis (Figure 4.13d);  
 
Figure 4.13 - PLL is actively internalised by coated cells using size-dependent endocytic 
pathways. (a–c) Three different endocytic pathways were observed for human fibroblasts 
once fixed immediately after coating: caveolar-type endocytosis, micropinocytosis, and 
phagocytosis. (d) CLIC/GEEC-type endocytosis noted on osteosarcoma cells. All 
micrographs represent day 0 cells coated using a 10 μg/mL PLL solution. Scale bars are 2 
μm and 200 nm for the zoom out (left) and zoom in (right) columns, respectively. 
 
To quantify the polycation metabolisation rate, the different PLL concentrations were 
analysed using Flow Cytometry during a period of two days (immediately after coating, 1 
and 2 days after coating). For the different cells lines, when coated with the 10 μg/mL 
concentration (Figure 4.14), a steep rose in fluorescence intensity with PLL-FITC-coated 
cells was noted, when compared to the control population, decreasing progressively over 
the two-day period. The intensity values approached the control values after 2 days, 
which reflected the polymer ingestion and metabolisation. Over this longer time period, it 
was observed that the rates at which the TC-71 (Figure 4.14b) and fibroblasts (Figure 
4.14c) cells metabolised the polymer were qualitatively higher than that for the U2OS 
cells (Figure 4.14a), as indicated by the relative overlaps between the control populations 
and the day 2 populations. Additionally, for all cells, a greater width was observed on the 
peaks that represent day 1.   
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Figure 4.14 - FACS gating and histograms for live (A) U2OS, (B) TC-71, and (C) Neo-
NHDF cells coated using a 10 μg/mL PLL solution. i is control (day 0), and ii, iii, and iv 
represent days 0, 1, and 2, respectively. 
 
On the other hand, 50 and 100 μg/mL PLL-FITC coated cells presented a high intensity 
of polymer during the two days of the test (Figure 4.15 and Figure 4.16). The polymer 
intensity peak showed to barely move for the U2OS cells at both concentrations, staying 
distant from control. For TC-71 cells it was possible to observe a diminishment on the 
PLL-FITC intensity on 50 and 100 μg/mL, however the peaks did not reach close the 
control values. It was also noted that the peak representing day 1 and 2 had an increase 
width when compared to the one representing day 0. A reduced number of counts was 
detected for this cell line when coated with the 100 μg/mL polycationic concentration. 
Neo-NHDF cells are observed to be the fastest cells to metabolise the polymer, even at 
high concentrations, which is represented by the closest peaks from the control by day 2 
and, additionally, presenting sharp peaks on that same day. However, the presence of two 
different cell populations were noted on day 0, which is expressed by the increased width 
of the peak and the existence of an extra peak. 
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Figure 4.15 - FACS gating and histograms for live (A) U2OS, (B) TC-71, and (C) Neo-
NHDF cells coated using a 50 μg/mL PLL solution. i is control (day 0), and ii, iii, and iv 
represent days 0, 1, and 2, respectively. 
 
 
Figure 4.16 - FACS gating and histograms for live (A) U2OS, (B) TC-71, and (C) Neo-
NHDF cells coated using a 100 μg/mL PLL solution. i is control (day 0), and ii, iii, and iv 
represent days 0, 1, and 2, respectively. 
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4.6 Cell agglomeration avoidance by polycationic coating  
To observe the potential effect of the polycationic coating on the avoidance of cell 
agglomeration, coated and noncoated U2OS cells were dispensed onto glass slides using a 
syringe and observed under a microscope (Figure 4.17), and the areas of aggregates were 
quantified (Figure 4.18 and Table 4.1). Untreated cells presented increased aggregate 
areas at time zero, when compared to treated cells at the same time-point. After 3 h of cell 
incubation inside the syringe, 10 μg/mL coated cells were largely free of natural cell 
agglomeration, remaining dispersed with a minimum formation of small aggregates 
(Figure 4.17a). Cell agglomeration was observed on noncoated cells after 2h of 
incubation, with sizable cell clusters observed after 3 h (Figure 4.17b). By viewing Figure 
4.18 and Table 4.1 it is possible to conclude that cells coated with 10 μg/mL PLL 
concentration did not create agglomerates as big as the uncoated cells. Additionally, 
coated cells formed agglomerates with more homogeneous sizes, when compared to the 
high size distribution observed on PLL-free cells. Finally, PLL coating determined that 
the agglomerate sizes of coated cells were approximately 2, 4, 5 and 10 times smaller by 
0, 1, 2 and 3 hours, respectively, when compared to the uncoated cells. 
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Figure 4.17 - PLL coating avoids cell aggregation and allows repeatable printing results. 
(a) U2OS cells coated with a 10 μg/mL coating present dispersion when deposited 
through a 21 G needle at different times after the coating procedure. (b) Uncoated U2OS 
cells present high degree of agglomeration (arrows) within the deposition times. Scale 
bars, 100 μm. 
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Figure 4.18 – U2OS cell agglomerate area distribution during 3-hour period. 
 
Table 4.1 – Cell aggregates area. 
Cell aggregation area (µm2) 
Time(h) Control 10 µg/mL 
0 335±169 162±106 
1 1151±1164 321±153 
2 2261±1677 547±448 
3 11036±12552 1177±789 
 
4.7 Inkjet cell printing reliability 
Bio-inks composed by cells suspended in cell medium have shown to create agglomerates 
and nozzle blockage, disrupting the inkjet printing process. Figure 4.19 reports the 
macroscopic views of the flow inside an inkjet nozzle by using different simple bio-inks – 
serum free medium (Figure 4.19a) and cells suspended in serum free medium (Figure 
4.19b) –, and, finally, nozzle blockage due to cell agglomeration (Figure 4.19c). 
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Figure 4.19 – Macroscopic view of the inkjet nozzle when using: a serum-free medium; b 
cells (white arrows) suspended in serum-free medium. c Nozzle blockage after 20 
minutes of printing using a simple bio-ink (U2OS cells suspended in serum-free 
medium). Scale bars represent 60 µm. 
 
Figure 4.20 shows the difference between using polycationic coated and non-coated cells 
on bio-inks for U2OS (Figure 4.20a), TC-71 (Figure 4.20b) and Neo-NHDF (Figure 
4.20c) cells. It was demonstrated that for a 60-min period the different bio-inks with PLL 
coated cells were able to maintain a stable number of cells without cell agglomeration. On 
the other hand, bio-inks without PLL coated cells exhibited to gradually decrease the 
number of printed cells until nozzle blockage. This issue happened 20 and 40 minutes 
after starting the experiment for U2OS and Neo-NHDF, and TC-71 cells, respectively.  
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Figure 4.20 – Reliability comparison between bio-inks with coated and non-coated cells. 
a U2OS cells; b TC-71 cells; c Neo-NHDF cells.   
 
4.8 Post-printing in vitro cell viability studies 
Live/Dead assay was used to obtain qualitatively information about the after-printing cell 
viability (Figure 4.21). Here, it is possible to note that the majority of the cells have 
survived to the coating manipulation and to the printing process. Only a small number of 
cells for the different cell types was observed to be dead. 
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Figure 4.21 - Live/Dead assay for printed PLL coated U2OS, TC-71, Neo-NHDF. For 
each cell type, pictures represent cells 4 hours after printing process. Scale bars are 100 
μm.   
 
4.9 Post-printing cell and coating morphologies 
Cell and coating morphologies were observed by confocal microscopy. Figure 4.22, 
Figure 4.23, and Figure 4.24 show the morphology of U2OS, TC-71 and Neo-NHDF, 
respectively, immediately after printing and 24 hours later. The morphologies obtained 
after printing were comparable to what was obtained and presented in chapter 4. 
Immediately after printing, the different cells presented round shape with PLL tightly 
bounded to their membrane. One day after printing, cells have attached and acquired their 
typical morphology: U2OS cells presented a heterogeneous population, TC-71 cells grew 
in clumps, and fibroblasts were flattened and elongated. Cells have retained the ability to 
ingest and metabolise the PLL as shown by U2OS and Neo-NHDF, which presented low 
amounts of PLL one day after printing. Contrarily, Ewing’s sarcoma cells showed higher 
magnitude of polycation at the same time point.  
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Figure 4.22 – Cell and PLL coating morphology after printing for U2OS cells. Staining 
similar to that in Figure 4.6. Scale bars represent 37.5 µm (left) and 150 µm (right). 
 
 
Figure 4.23 – Cell and PLL coating morphology after printing for TC-71 cells. Staining 
similar to that in Figure 4.6. Scale bars represent 30 µm. 
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Figure 4.24  – Cell and PLL coating morphology after printing for Neo-NHDF cells. 
Staining similar to that in Figure 4.6. Scale bars represent 30 µm (left) and 52 µm (right). 
 
4.10 Chapter discussion 
4.10.1 Cell viability and metabolic activity 
During this research a new, efficient and temporary single-cell PLL coating process has 
been developed. This procedure used a synthetic polycation that is considered cytotoxic 
by previous results (Menger et al., 2003), however results suggest that the cytotoxic 
response is dose dependent, and that cell viability and metabolic activity are acceptable 
when using low concentrations. Metabolically, cells presented different behaviours to the 
PLL coating, with one cell line reporting coated cells metabolic more active than the 
control samples. This clearly shows that the reaction to the PLL is different from cell to 
cell. 
For dead cells it was not possible to differentiate between late apoptosis and necrosis, 
perhaps as a result of caspase or other protease activity cleaving the probe in the dead 
cells. However, necrosis is considered as consequence of the coating process to be the 
most likely cause of cell death, and the cell morphologies in TEM support this view. This 
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is explained by the effect that PLL and other polycations cause on the cell membrane – 
the coupling between the negative cell membrane and the positive polymer disrupts the 
lipid bilayer by opening nanoholes on the cell membrane (Fischer et al., 2003; Menger et 
al., 2003; Hong et al., 2006; Vaidyanathan et al., 2015). This damage, when severe, 
destroys not only cell structures and organelles, but also its organisation, leading to cell 
necrosis.  
When damaged, cells are susceptible to mutate and carry chromosomic aberrations that 
would change its characteristics (Lodish et al., 2000). This way, it was observed that Neo-
NHDF and TC-71 retained their normal karyotype. Osteosarcoma was not analysed due 
to the nature of its karyotype – completely aberrant and random, with no consistent 
hallmark, such as Ewing’s sarcoma, which would not allow any conclusion (Morrow and 
Khanna, 2015). 
 
4.10.2 Cell morphology  
The coating protocol established in this research allows for the development of a high-
efficiency and tightly fitting coating. The PLL concentration was shown to be 
determinant on the morphology of the coating. Therefore, depending on the polycationic 
solution concentration, different amounts of PLL particles will be available to anchor the 
cell membrane, forming from simple speckled coating to full shells.  Through confocal 
microscopy it was also verified that cells ingest and metabolise the polycation, at the 
same time they attach and proliferate normally. This happened in each cell type, 
maintaining the characteristic phenotype during proliferation.  
 
4.10.3 Polymer uptake and metabolisation 
The polycation uptake and metabolisation has been confirmed by evaluating not only 
confocal microscopy and TEM images, but also quantified by flow cytometry. It was 
observed that the different cell types used during this investigation were able to attach 1 
hour after coating, however their behaviour has been shown to be distinct between them. 
Neo-NHDF confirmed higher metabolisation capacity, when compared to the other two 
cells, U2OS and TC-71, as 4 hours after the coating procedure barely no PLL was 
observable. U2OS and TC-71 cell demonstrated to not be able to process the polycation 
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as fast as the Neo-NHDF. However, all the different cells were able to show endocytic 
pathways to uptake the PLL particles. No preference for a certain endocytic pathway was 
observed, which is normally determined by the particle size (Zhang et al., 2009). This 
way, specific-pathway inhibitors must be used to clearly identify each pathway and its 
dependency on the size of the micro- or nanoparticles being ingested, as observed in 
previous studies (Vercauteren et al., 2010; Dutta and Donaldson, 2012). Flow cytometry 
has also reported that cells internalise and metabolise PLL differently, with Neo-NHDF 
showing better tolerance for the polycation, even at higher concentrations.  
Within this analysis it is possible to conclude that the developed PLL coating system may 
be used by different cells, however, depending on the application, it might need 
optimisation as the response to the same polycation concentrations will be distinct on the 
cell type. Each cell has its own characteristics that lead to certain phenotypes, 
proliferation rates or secreted cytokines, and, therefore, will naturally behave differently 
to materials and other foreign stimulus (Curtis and Wilkinson, 1999). 
 
4.10.4  Inhibition of agglomeration 
Agglomerates formed with non-coated cells presented an average area of approximately 
10 times higher than the average area for 10 μg/mL coated cells in the last time-point 
studied (3 hours). This way, the coating technique demonstrated to successfully attenuate 
cell agglomeration by keeping the cells apart due to the electrical repulsion between the 
positively charged polymer. 
 
4.10.5  Inkjet printing reliability and post-printing cell characteristics 
Bio-inks with polycationic coated cells showed to increase inkjet printing reliability, 
posing as an alternative to other strategies. However, similarly to in vitro assays, the bio-
ink behavior was distinct depending on the cell type. For U2OS and TC-71 cells, constant 
and repeatable results with low variability were obtained. On the other hand, bio-inks 
with coated Neo-NHDF presented high variability when compared to the other two. 
Additionally, it was noted that the number of cells per drop was different for each bio-ink, 
reaching approximately 1 cell per droplet for bio-inks with coated U2OS cells, when 
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compared to 0.2 to bio-inks with coated TC-71. Both issues are related to two 
characteristics – cell size and the interaction with the polymer. 
Ewing’s sarcoma present small round cells, being smaller than the other two. This 
characteristic is related to the cell mass, which make TC-71 cells potentially weight less 
than osteosarcoma cells and fibroblasts. Consequently, as the weight is lower, the gravity 
effect will be also reduced. Therefore, TC-71 cells will take more time to reach the inkjet 
nozzle and the number of cells per droplet will be decreased. Differently, Neo-NHDF 
cells show higher interaction with the PLL coating. As it was reported previously, faster 
internalization and metabolization of the polymer was demonstrated for these cells. 
Additionally, FACS showed lower FITC intensity when compared to the other two cell 
types. This way, the coating on these cells may be poorer, affecting the repulsion between 
Neo-NHDF. Both issues may grant lower and different repulsion magnitude between 
cells, leading to higher variability on printed cells. These results conclude that mechanical 
agitation and PLL concentration must be optimised for each bio-ink to obtain a reliable 
printing.  
Viability and cell morphology were observed to remain unchanged after printing. It is 
concluded that the shear stress from the agitation, but also from the printing process itself, 
did not have impact on cell viability nor PLL internalization and metabolisation.  
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Chapter 5. Reactive Jet Impingement for bone microtissue bioprinting 
5.1 Introduction 
In this chapter, a new printhead entitled Reactive Jet Impingement, that has been created 
by Dr. Matthew Benning and Prof. Kenny Dalgarno (Benning and Dalgarno, 2017), is 
characterised and used to print a collagen-alginate-fibrin hydrogel, originally developed 
by Dr. Ana Marina Ferreira (Montalbano et al., 2018), to allow bone microtissue 
development. Here, the functionality of this new printing technique using this hybrid 
hydrogel is analysed, showing how cell density influences several factors during 
microtissue formation, such as gene expression. Hydrogel properties, such as degradation 
or solution diffusion, cell proliferation and viability, morphology or differentiation ability 
are also studied during this chapter.  
 
5.2 Reactive jet impingement concept and characterisation 
To obtain cell-laden hydrogels without using an extrusion-based bioprinter, ReJI jets 
droplets from opposite sides that meet and mix in-air forming a hydrogel prior impact 
onto substrate. Simultaneous droplet jetting (Figure 5.1) is only possible after the 
optimisation of the electrical waveform and pressure. Specific printing patterns are 
possible to be obtained through a .txt script or transforming any image into a black and 
white bitmap file (Figure 5.2).  
 
Figure 5.1 - ReJI printing technique. Stroboscopic images of gel-precursor and 
crosslinking droplets meeting in air. 
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Figure 5.2  – From image to sample. a black and white bitmap and b respective printed 
pattern. Scale bar represents 6 mm. 
 
To test the concept, different solutions have been jetted using the ReJI printhead: water, 
NaAlg and CaCl2, fibrinogen, a collagen-alginate-fibrinogen mixture and thrombin 
combined with CaCl2. Table 5.1 shows the optimal parameters used to jet each solution. 
 
Table 5.1 – Optimal parameters for jetting different materials.  
 
 
The printing technique was observed to be reliable, printing gel droplets of similar sizes 
and at equidistant locations for the different materials, as seen in Figure 5.3a-c. Printed 
droplets are reported to be in a sub-millimetric range with (0.701±0.021) mm for water, 
(0.646±0.007) mm for NaAlg hydrogel and CAF gel loaded with 40 x 106 cells/mL 
presented (0.795±0.083 mm) of diameter. Additionally, it was found that channels are 
able to be obtained with 1 pixel of width, which corresponded approximately to 
(708.2±97.2) µm, when printing CAF hydrogel (Figure 5.3d). Viscosity gains of great 
importance when using microvalves as after a certain threshold, droplet jetting is not 
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possible. Pre-gel precursors are of a higher viscosity nature, when compared to the 
crosslinking solutions, that present “naked eye” viscosity close to water. Therefore, 
optimal concentrations for NaAlg and CAF, as presented on Table 5.1, exhibited 3.6x10-3 
Pa/s and 0.0249 Pa/s of viscosity, respectively.  
 
Figure 5.3 - a-c Water (0.701±0.021 mm), NaAlg gel (0.646±0.007 mm) and CAF gel 
loaded with 40 x 106 cells (0.795±0.083 mm) droplets spatially equidistant. d Channel 
with 1 pixel of size. Scale bars represent 1 mm, 2 mm, 200 µm, and 1 mm, respectively. 
 
5.3 CAF hydrogels characterisation 
5.3.1  Compression test 
The mechanical properties in compression of printed CAF hydrogels were measured. A 
stress-strain curve for freshly printed CAF hydrogels is reported in Figure 5.4. The 
compressed stress was calculated from the linear region of the stress-strain curve, in the 
10-20% strain interval. A similar compressive modulus was obtained for the three 
different samples, (1.125±0.042) kPa comparable to the modulus of similar gel 
formulations when prepared conventionally (0.9–1.3kPa). The conventionally formulated 
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CAF gels have showed similar mechanical properties to lower end of the range for soft 
tissues, such as pancreatic tissue (Montalbano et al, 2018). 
 
 
Figure 5.4 - Uniaxial compression of CAF gels. A compression modulus of (1.125±0,042) 
kPa was obtained for 10-20% strain interval. 
 
5.3.2  Degradation assay 
CAF hydrogels are composed of natural materials, including proteins, therefore, it was 
necessary to guarantee that no medium component would affect the printed hydrogel for 
long time-intervals, degrading it. This way, a degradation assay has been carried. It was 
observed that similar printed structures showed comparable degradation rates after 
different time-points, only losing around 30% of its total mass after any incubation time-
point inspected (Figure 5.5). 
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Figure 5.5 - CAF gel mass loss after incubation in medium during 1 to 14 days. Gels lost 
an average of 30% of its weight during the studied time-points. Not statistically 
significant. 
 
5.3.3  Diffusion assay 
As cells will be encapsulated inside the hydrogels, it is crucial that molecules are able to 
be delivered to the most inner site of it. Therefore, the CAF hydrogel absorbing and 
molecule permeation capabilities has been studied using 2-NBDG solution, a fluorescent 
glucose analogue (Figure 5.6). A fast increment on 2-NBDG uptake in the first 30 min 
was observed, reaching a close-to-maximum uptake plateau between 30 and 60 min. 
Between the last two time-points, 1 and 3 hours, the 2-NBDG uptake barely increase due 
to saturation. 
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Figure 5.6 - CAF hydrogel glucose uptake. A plateau on the uptake of 2-NBDG was 
reached 30 to 60 minutes (corresponding to 85-90% of maximum uptake) after putting the 
gel in contact with this solution. 
 
5.3.4  CAF hydrogel morphology 
The hydrogel microstructure was observed by scanning electron microscopy (Figure 5.7). 
A porous network was revealed by SEM images of samples at different time-points. It was 
observed that incubation in cell medium at 37 °C and 5% CO2 for 14 days did not change 
the hydrogel structure, presenting a similar morphology to the freshly printed samples. 
Outer and inner porosity can be seen with more detail in Figure 5.8. It is possible to note 
that the outside of the CAF hydrogel is filled with fibres, typical from fibrin, as well as 
small pores. Inside, the hydrogel exhibits interconnected pores similar to honeycombs.   
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Figure 5.7 - CAF gel morphology after freeze drying. The SEM images show a highly 
porous fibre-like structure. a and b show a gel fixed immediately after printing and c and 
d reveal a gel fixed after 14 days of incubation in medium. Scale bars represent 1 mm. 
Each assay was conducted in triplicate. 
 
 
Figure 5.8 - CAF hydrogel porosity. a Outer porosity. b Inner porosity. Scale bars 
represent 200 µm. 
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5.4 Biological assays 
5.4.1 Cell proliferation and viability  
To obtain the proliferation along the days, PicoGreen was used. This assay allowed to 
determine the number of cells and existent DNA amount in CAF hydrogels at three 
different time-points (days 0, 7, and 14). To obtain these parameters, a standard curve for 
cell number (Figure 5.9a) and for DNA amount (Figure 5.9b) were acquired. Linearity is 
observable with high value of R2. 
 
Figure 5.9 – Standard curves. a Cell number; b DNA amount. 
 
Cell proliferation along the days is shown in Figure 5.10a. An average of 
(0.611±0.036)x106 cells was obtained for low density cell hydrogels on day 0. On the 
same day, high density constructs presented (5.22±1.30)x106 cells per sample, which 
represents, approximately, 9-times more cells than what was obtained for the 4x106 
cells/mL specimens. By day 7 a cell reduction on the high-density hydrogels and a cell 
increment on the 4x106 cells/mL hydrogels, lead to similar cell numbers on both hydrogel 
types – roughly, 2.7x106 cells per gel. At day 14, both hydrogel constructs had their cell 
proliferation increased, however the 40x106 cells/mL samples presented higher 
proliferation rate, increasing its cell numbers to (5.44±1.88)x106 cells per gel. On the 
other hand, low cell density hydrogels presented a raise to (3.32±1.04)x106 cells per 
specimen. Using the two standard curves presented before (Figure 5.9), it was possible to 
calculate the DNA amount per sample, as observed in Figure 5.10b. By combining the 
information given by the two graphs, i.e. dividing the number cells per construct with the 
DNA amount for the same sample, the DNA amount per cell was determined - 5.6 
pg/cell. Cell amount has also reflected on the macroscopic aspect of the hydrogels, 
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presenting more opaque hydrogels for the high cell density ones and more transparent 
specimens for the low cell density samples (Figure 5.11). 
 
Figure 5.10 – a Cell number and b DNA amount present in CAF gels with 4x106 and 
40x106 cells/mL after incubation during 0, 7 and 14 days in osteogenic medium. *, **, 
***, and **** indicate significant difference between groups at the levels p < 0.05, p < 
0.01, p < 0.001, and p < 0.0001, respectively. Error bars represent the standard deviation 
(n = 3). 
 
 
Figure 5.11 – Macroscopic look for freshly printed CAF hydrogels – low cell density 
(left) and high cell density (right). Scale bar represents 2 mm. 
 
To qualitatively characterise the cells in terms of viability, Live/Dead assay was carried 
(Figure 5.12). A negligible number of dead cells (red) is possible to be observed in the 
low cell density hydrogels. Although exhibiting higher cell density, 40x106 cells/mL 
samples presented a low dead cell number, when directly compared to the high number of 
live cells (green) presented. 
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Figure 5.12 - Live/Dead assay. Cell viability of MSCs after printing, and 7 and 14 days of 
incubation in osteogenic medium (live cells are represented in green and dead in red). 
Scale bar represents 200 µm. 
 
5.4.2 Cell morphology  
Cell morphology and its organisation on hydrogels were studied using confocal 
microscopy and SEM. On day 0, random cell distribution was observed in Figure 5.13. 
Here, a relevant higher number of cells per unit of area is detected on the high cell density 
hydrogels, when compared to the 4x106 cells/mL samples. The same cells are possible to 
be observed in Figure 5.14, but now in a 2D image. It is possible to note that day 0 
present freshly printed cells for both low (Figure 5.14a) and high (Figure 5.14b) cell 
densities. Along the experiment, for the 4x106 cells/mL structures, it is evidenced that the 
random cell alignment gives way to a more organised morphology – cell alignment starts 
to be more notorious. This is easily detected on the high-density gels, where higher 
orientation and contact between cells is already observable on day 7, and the degree of 
this organization clearly increases by day 14, as it is represented by the development of 
clear tissue structures due to cell migration and interaction.  
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Figure 5.13 - Confocal microscopy volume stack showing cell distribution in CAF gels 
with different cell number. Scale bar represents 200 µm 
 
 
Figure 5.14 - Cell and tissue morphology after incubation during 0, 7 and 14 days in 
osteogenic medium by confocal microscopy. a shows 4x106 cells/mL loaded gels with an 
increase on cell organization along the incubation days. b For 40x106 cells/mL loaded 
gels, cell density seems to favour cell migration, organisation and highly-defined tissue 
formation (Red – F-Actin; Blue – Nucleus). Scale bars represent 100 µm. 
 
SEM data revealed information consistent with what was obtained previously (Figure 
5.15). For the low cell density hydrogels (Figure 5.15a), cellular organisation was noted 
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to increase along the days, culminating with high cell alignment by day 14. The 40x106 
cells/mL samples (Figure 5.15b) showed densely populated hydrogels by day 0, that 
allowed the formation of tissue structures with no hydrogel support by day 14. 
 
 
Figure 5.15  – Cell and tissue morphology by SEM. a Low cell density hydrogels. Scale 
bars represent 10, 20, and 50 µm, respectively.  b High cell density hydrogels. Scale bars 
represent 50, 20, and 50 µm, respectively. 
 
Additionally, this technique was used to explore the cell surface to understand how cell 
density influenced the calcium deposition. By observing Figure 5.16, it is noted that cells 
in low cell density hydrogels (Figure 5.16a) produce less calcium phosphates, when 
compared to the cells loaded in 40x106 cells/mL hydrogels (5.16b). This is evidenced by 
day 7, where almost no calcium deposition is detected on 4x106 cells/mL hydrogels. On the 
other hand, on the same day, cells loaded in high cell density samples already present a 
considerable amount of calcium deposition. On both cell densities, calcium deposition 
greatly increased by day 14, with particular incidence on the high cell density hydrogels 
that present cells trapped below high amounts of calcium phosphates.  
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Figure 5.16 - Calcium deposition after incubation during 7 and 14 days in osteogenic 
medium by scanning electron microscopy. a and b show the calcium deposition (blank 
arrows) on low and high cell density hydrogels, respectively. A faster and increased 
deposition is possible to be verified on 40x106 cells/mL hydrogels. Scale bars represent 
10 µm. 
 
Finally, SEM data also enlightened on MSC differentiation into osteoblasts (Figure 5.17). 
By day 7, low cell density hydrogels (Figure 5.17a) presented spread cells, a typical MSC 
morphology. However, in the same day, cuboidal cells, which are associated to osteoblasts, 
were already observed on 40x106 cells/mL hydrogels (Figure 5.17b). By day 14, both 
hydrogel types presented osteoblastic cells. 
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Figure 5.17 - Cell morphology changes after incubation during 7 and 14 days in 
osteogenic medium by scanning electron microscopy. a shows low cell density hydrogels 
and b exhibits high cell density hydrogels. Scale bars represent 20 µm (c and d). 
 
5.4.3 Cell differentiation  
Apart from the osteogenic route using hTERT MSCs, to test the hydrogel suitability on 
differentiation, trilineage differentiation of primary human MSCs was carried (Figure 5.18). 
After 30 days of incubation in basal MSC medium, MSCs presented to be widely spread 
and elongated following the same orientation (Figure 5.18a). Osteoblasts started forming 
nodular aggregations after 16 days in osteogenic differentiation (Figure 5.18b). After 16 
days in chondrogenic medium, cells presented typical chondrocyte elongation and a 
polygonal shape (Figure 5.18c). Finally, fat deposits are observed after 16 days of 
incubation in adipogenic medium, which is a clear sign of adipocyte differentiation (Figure 
5.18d). 
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Figure 5.18 – Trilineage differentiation of primary human MSCs after 30 days in CAF 
hydrogels. a MSCs, b osteoblasts, c chondrocytes and d adipocytes. The nucleus is 
represented in blue (DAPI) and f-actin exhibited in red (phalloidin). Scale bars represent 
100µm.  
 
5.4.4 Alkaline Phosphatase  
Alkaline Phosphatase was assessed to determine how cell density influenced its expression 
(Figure 5.19). ALP is an important marker on osteogenic differentiation, being crucial on 
the first steps of osteogenesis. The highest activity was observed by day 0, presenting no 
significant difference between the high and low cell density hydrogels. On the other time-
points, day 7 and day 14, it was verified that the ALP value has decreased two to three-fold, 
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achieving similar concentrations of PnPP per cell in both samples. However, further 
reduction from day 7 to day 14 was observed on high cell density hydrogels. 
 
Figure 5.19 - PnPP concentration per cell obtained from ALP assay after incubation 
during 0, 7 and 14 days in osteogenic medium. *, **, ***, and **** indicate significant 
difference between groups at the levels p < 0.05, p < 0.01, p < 0.001, and p < 0.0001, 
respectively. Error bars represent the standard deviation (n = 3). 
 
5.4.5 Gene expression  
To further characterise the effect of different cell density hydrogels in cell differentiation 
and tissue formation, samples were analysed using PCR arrays for osteogenic specific 
genes and compared some of the most important genes for osteogenic differentiation.  
Before PCR, the extracted RNA was quantified in table 5.2. 
Table 5.2 – RNA quantification after extraction. 
Day Sample RNA concentration (ng/µl) 
0 
4x106 cells/mL 35.6 
40x106 cells/mL 688.3 
14 
4x106 cells/mL 62.9 
40x106 cells/mL 93.8 
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Figure 5.20 exhibits the number of genes that were upregulated and down regulated when 
comparing low cell density hydrogels on day 14 with day 0 (Figure 5.20a), high cell 
density hydrogels on day 14 with day 0 (Figure 5.20b) and high cell density hydrogels 
with low density hydrogels by day 14. At day 14, lower cell density hydrogels presented 
encapsulated cells that overexpressed 48 genes (which 24 genes for skeletal development 
and 7 for bone mineral metabolism), double the number of downregulated genes (a total 
of 24, where 11 genes correspond to skeletal development and 2 for bone mineral 
metabolism), when comparing with day 0. In contrast, hydrogels containing high cell 
densities (40x106 cells/mL) evidenced an upregulation on 67 genes (with 36 genes for 
skeletal development and 11 for bone mineral metabolism), when compared to the under 
expression of 22 genes (which 9 genes for skeletal development and 2 for bone mineral 
metabolism) at day 14 to day 0 (Figure 5.20b). Comparing both cell densities on day 14, 
it was noted that high cell density hydrogels presented 39 overexpressed genes (with 19 
genes for skeletal development and 6 for bone mineral metabolism) and 29 down-
regulated genes (with 12 genes for skeletal development and 4 for bone mineral 
metabolism). 5 different growth factors were also overexpressed in 40x106 cells/mL 
hydrogels by day 14. 
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Figure 5.20 – Up and down regulated genes on different comparison between hydrogels. 
a represents the comparison between low cell density hydrogel on day 14 against day 0; b 
shows the comparison between high cell density hydrogel on day 14 against day 0; c 
exhibits the comparison between high cell density hydrogel at day 14 against low cell 
density hydrogel at day 14.  
 
Table 5.3 shows the expression of the different genes for the comparison between low 
cell density hydrogel on day 14 against day 0, the comparison between high cell density 
hydrogel on day 14 against day 0, and, finally, the comparison between high cell density 
hydrogel at day 14 against low cell density hydrogel at day 14, respectively. On the other 
hand, Figure 5.21 shows the expression of the most important osteogenic genes.  
Specifically: 
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- For the comparison between low cell density hydrogel on day 14 against day 0, 
most genes presented mild downregulation or overexpression. However, BMP2 
presented a 7.22-fold overexpression, COL14A1 exhibited a 5.74-fold 
upregulation, COL15A1 gene showed an underexpression of 6.77-fold, COL1A1 
demonstrated a downregulation of 5.17-fold, COMP exhibited a 12.21-fold 
overexpression, FGF1 was downregulated by 5.02-fold, MMP9 showed an 
upregulation of 10.97-fold and PHEX presented a 7.69-fold overexpression. For 
key osteogenic genes (Figure 5.21a), RUNX2 (more than 2-fold) or SP7 (1.5-fold 
exchange) were overexpressed, while certain genes such as BMP-2, 3, and 7 
remained the same. An underregulation was observed specifically on ALP (2.57-
fold) and SPP1 (3.52-fold). BGLAP presented similar expression in day 0 and day 
14. 
- High cell density hydrogel at day 14 presented several highly overexpressed genes 
when compared to the same hydrogel at day 0, such as, CSF2 (36.60-fold), CSF3 
(1382.25-fold), FLT1 (103.15-fold), MMP9 (2052.25-fold), MMP10 (1958.01) or 
NOG (38.82). On the other hand, some genes presented to be fairly 
downregulated, such as COL1A1 (12.54-fold), COL1A2 (8.13-fold), FGF1 (9.01-
fold) or SMAD3 (-8.67). For key osteogenic genes showed overexpression on 
RUNX2 (over 10-fold), SPP1 (higher than 7-fold) and different BMPs, with a 
particularly high overexpression of BMP-2 and -6 with over 300 and 250-fold, 
respectively (Fig. 6.21b). On the other hand, ALP (3.81-fold) was underexpressed. 
BGLAP and SP7 were observed to be similar between day 0 and 14. 
- By comparing high cell density to low cell density hydrogel at day 14, it was 
observed that gene expression was completely different, presenting highly 
overexpressed genes, such as, CSF2 (55.50-fold), CSF3 (2711.17-fold), FLT1 
(73.82-fold), MMP9 (131.99-fold) and MMP10 (1401.17-fold). For key 
osteogenic genes, it was noted that RUNX2 (over 2.5-fold), SPP1 (nearly 15-fold) 
and BMPs -2 (45-fold), -3 (2-fold), -6 (nearly 60-fold) and -7 (4-fold) were 
upregulated on the 40x106 cells/mL hydrogels (Fig. 7e). Contrarily, SP7 (1.49-
fold) and ALP (1.88-fold) presented underexpression. BGLAP expression 
exhibited to be similar in both conditions (1.08-fold). 
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Table 5.3 – Gene expression for osteogenic pathway PCR array. Black, red and blue represent, respectively, the comparison between low cell 
density hydrogel on day 14 against day 0, the comparison between high cell density hydrogel on day 14 against day 0, and, the comparison 
between high and low cell density hydrogel at day 14. 
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Figure 5.21 - Fold change of some of the most important osteogenic genes, comparing 
4M d14 to 4M d0, 40M d14 to 40M d0, and 40M d14 to 4M d14, respectively. At day 14, 
40x106 cells/mL loaded gels present gene expression that reflects mature osteoblast 
formation, contrarily to 4x106 cells/mL loaded gels that show pre-to-early osteoblast 
related gene expression. 
 
5.5 Discussion of the chapter 
The ReJI system is the first drop-on-demand bioprinting system that can deposit cell-laden 
hydrogels with a high cell density. The limitation of the ReJI process is that the system 
relies on rapid crosslinking to create gel droplets. However, this contrasts with other 
bioprinting processes, where crosslinking requires an additional process either before or 
after the deposition step (Gudapati et al., 2016; Ozbolat and Hospodiuk, 2016). Table 5.4 
compares the developed in-house technique to other common bioprinting techniques, to 
demonstrate that the system uniquely offers high cell density, with high cell viability, 
within a viscous gel, at high volume deposition rates. Additionally, ReJI does not present 
reliability and repeatability issues, which are commonly verified in inkjet bioprinting due 
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to cell agglomeration (Murphy and Atala, 2014; Bishop et al., 2017). Contrarily to inkjet 
bioprinting, with ReJI there is no the limitation in terms of mimicking natural environments 
or tissue complexity due to the instant crosslinking of biomimetic hydrogels and high-cell 
density bio-inks. Although allowing high cell densities, when comparing to extrusion-based 
and laser-assisted bioprinting, it is clearly that ReJI is faster, produces high cell survival 
and grants high volume rate. 
 
5.5.1 CAF hydrogel properties  
To obtain the developed microtissues, 14 days of incubation in osteogenic medium at 37°C 
and 5% CO2 was necessary. The 30% hydrogel mass loss may be connected to poorly 
crosslinked branches inside the CAF gel structure being washed off during the incubation 
period. The 3 mm thick CAF hydrogel was able to quickly absorb dissolved molecules with 
saturation in less than 1 hour. This guarantees stability of cells during their development. 
The porosity observed in the gel is essential for building up microtissues based on high cell 
densities, as cell migration will be necessary for tissue development (Yamada and 
Cukierman, 2007; Ma et al., 2010; Campbell et al., 2017). This porous network is preserved 
over a 14-day period, making this hydrogel ideal for tissue development applications. 
 
5.5.2 Cell viability and proliferation on bioprinted cell-laden hydrogels 
Cells survive the jetting and impingement processes. This is explained by the low viscosity 
of both cell carrier ink (crosslinking solution) and gel precursor (Derakhshanfar et al., 
2018). When leaving the microvalve nozzle, cells suffer little shear stress due to the low 
viscosity of each ink. Additionally, when mixing, the fast reaction instantly encapsulates 
the cells, giving them protection when droplet reaches the substrate, but also assuring 
elasticity (that fibrin enriched hydrogels are recognized to minimize stress on impact 
(Janmey et al., 2009; Piechocka et al., 2010)). One and two weeks after printing, cell 
viability is maintained, as fibrin and collagen are biocompatible natural materials that are 
widely used as scaffold materials due to their properties, including extracellular matrix 
promotion (Hong and Stegemann, 2008; Chan et al., 2016). Precise structures were printed 
using two different cell density inks, producing hydrogels with an average of 6x105 and 
5x106 cells on the low and high cell density hydrogels, respectively.  
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Cell detachment is considered as the main reason for cell number decrease on high cell 
density hydrogels on day 7. Contrarily, for the low cell density hydrogels, the 
underpopulation at day 0 resulted on a 5-fold cell number increase by day 7. Both hydrogels 
showed proliferation between days 7 and 14. High cell density hydrogels showed had a 
higher proliferation rate associated with cell migration and microtissue formation. The low 
cell density hydrogels did not increase to the same extent due to poorer cell-cell contact 
and, consequently, lower proliferation capability (Chan et al., 2016). Microtissue 
development is dependent on several factors, including cell density, mechanical forces and 
the presence of extracellular matrix (Nelson and Chen, 2002; Griffith and Swartz, 2006; 
Legant et al., 2009; A. S. Liu et al., 2016). Here, we reinforce past studies, with special 
focus on the importance of high cell densities in 3D structures to obtain fast and developed 
microtissues by direct differentiation (Shu, 2015; Bishop et al., 2017).  
 
5.5.3 Effect of cell density on differentiation process and microtissue formation  
Increased calcium deposition on the higher cell density hydrogels is assumed to be a result 
of a faster rate of MSC differentiation into osteoblasts. This was confirmed by the presence 
of cuboidal cells, a morphology which is associated with mature osteoblasts (Hwang et al., 
2008), already by day 7. ALP, an early osteogenic marker, supports this view. Increased 
ALP concentrations were produced at day 0, when compared to day 7 and 14, with the 
higher cell density hydrogels presenting the lowest concentration at day 14, as ALP levels 
are downregulated by the end of the osteogenesis (Liu et al., 1997; Golub and Boesze-
Battaglia, 2007).  
Gene expression was also influenced by cell density. Typical pre-osteoblastic behaviour 
was observed on low cell density hydrogels due to the increased expression of RUNX2 
and SP7 and reduced expression of BGLAP and SPP1 (Birmingham et al., 2012). BMPs, 
intrinsically connected to bone formation, also increased expression.  
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Table 5.4 – Comparison between ReJI and other bioprinting techniques. Numbers are based on what is achievable for one deposition unit. 
 
 
ReJI 
bioprinting 
Inkjet 
bioprinting 
Single 
microvalve 
bioprinting 
Extrusion 
bioprinting 
Laser-
assisted 
bioprinting 
Ref. 
Viscosity of 
Material 
Deposited 
on the 
Substrate 
1–70 
mPa/s 
3–30 
mPa/s 
1–70 mPa/s 
30 mPa/s 
to >6x107 
mPa/s 
 
1–300 mPa/s 
 
(Murphy and Atala, 2014; Donderwinkel et al., 2017; 
Ng et al., 2017) 
Printing 
Speed 
6 500 
droplets/s 
1 – 10 000 
droplets/s 
6 500 
droplets/s 
10 µm/s – 
700 mm/s. 
100 – 5000 
droplets/s 
(Guillotin et al., 2010; Murphy and Atala, 2014; 
Bakhshinejad and D’souza, 2015; Gudapati et al., 
2016; Lee and Yeong, 2016; Ovsianikov, 2016; 
Ozbolat and Hospodiuk, 2016; Donderwinkel et al., 
2017; Gao et al., 2017; Ozbolat, 2017) 
Volume 
deposition 
rate 
80 µL/s 160 µL/s 40 µL/s 3-15 µL/s 
175 - 1800 
nL/s 
(Guillotin et al., 2010; Gudapati et al., 2016; Graham 
et al., 2017; Koch et al., 2017; Zhang, 2018) 
Resolution 
100-300 
nL 
droplets 
pL 
droplets 
pL to nL 
droplets 
5 µm to 
mm size 
deposited 
track 
<pL 
droplets 
(Murphy and Atala, 2014; Ozbolat, 2017) 
Cell 
viability 
>90% >85% >90% 40-80% >95% (Murphy and Atala, 2014; Ozbolat, 2017) 
Crosslinking 
Process 
In process 
Post-
printing 
Post-
printing 
Pre-, post- 
printing 
Post-
printing 
(Murphy and Atala, 2014; Lee and Yeong, 2016) 
Cell density 
9x107 
cells/mL 
Low, 
<5x106 
cells/mL 
High, 
107/mL 
High, cell 
spheroids 
High, 108 
cells/mL 
(Murphy and Atala, 2014; Donderwinkel et al., 2017; 
Ozbolat, 2017) 
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This work has shown that cell density is crucial to the rate of functional bone microtissue 
formation. In cancer and in other diseases there is a clear commercial need for improved 
models for large scale screening, and microtissue models are considered to offer significant 
potential (Aubin and Triffitt, 2008; Xu, 2012). To date the scalability and reliability of 
microtissue models has been identified as limitations, with these issues closely related 
(Junaid et al., 2017; Peng et al., 2017). A lack of scalability means that limited replicates 
of any given experiment can be made, and a lack of replicates makes it difficult to 
understand variation in statistical terms.  By reliably depositing cells and materials at rates 
which allow for thousands of micro-tissue precursors to be generated per hour the ReJI 
technology has potential to address a key problem in terms of micro-tissue model 
development and exploitation. 
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Chapter 6. General discussion 
6.1 Summary   
Data presented in this thesis identified two new bio-ink strategies for bioprinting. The 
first methodology enabled the development of a bio-ink containing cells with a temporary 
single cell coating. This allowed increased inkjet printing reliability when printing viable 
single cells. This thesis also reported on the optimisation of a pre-designed hydrogel, 
CAF, and a new bioprinting system, ReJI. The combination of these two tools made 
possible the fabrication of high cell density cell-laden hydrogels. 
Chapter 4 describes the concept behind bio-inks that include single coated cells  and its 
validation. PLL, a synthetic polycation, was applied as cell coater and different 
concentrations were used to understand its effect on cells. Results demonstrated that the 
lowest concentration tested, 10 µg/mL, exhibited higher cell viability. At higher 
concentrations a raise on cell death rate was noted majorly due to necrosis. The coating 
was observed to be temporary, with cells having the ability to uptake and metabolise the 
PLL within two days. Cell aggregation was shown to be reduced due to the electrostatic 
repulsion granted by the PLL coating. This way, nozzle blockage, which is commonly 
responsible for the low reliability of inkjet bioprinting, was avoided during printing for 
one hour. This not only increased the reliability of the process, but also allowed stable 
printing for periods up to 60 minutes. Additionally, single cell printing of viable cells was 
obtained by using this strategy. 
Chapter 5 demonstrates the capabilities of an in-house developed printing strategy, ReJI. 
By adapting and optimising a collagen, alginate and fibrin hydrogel towards bio-ink, fast 
and repeatable hydrogels were fabricated. These presented porous networks and the 
ability to rapidly absorb solutions. Cell-laden hydrogels presented high viability and cell 
density was determinant on microtissue formation by influencing cell proliferation, 
migration and differentiation. High cell density hydrogels presented advanced osteogenic 
differentiation, showing osteoblastic behaviour, when compared to the pre-osteoblastic 
behaviour showed by low cell density hydrogels.  
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6.2 Novelty 
As introduced in the literature review, inkjet bioprinting presents limitations regarding the 
reliability of the process (Murphy and Atala, 2014; Gudapati et al., 2016; Bishop et al., 
2017). Bio-inks used within this technology must have low viscosity, generally in a liquid 
state, such as cell suspensions in medium. As consequence, cell sedimentation and 
aggregation cause blockages on the very small nozzles. Here, by using a polycationic 
speckled coating, electrical repulsion is able to significantly delay nozzle blockages. 
Additionally, the absence of nozzle blockage allows stable printing for periods up to 60 
minutes and allowing to achieve single cell printing. This represents a new strategy for 
inkjet bioprinting. Furthermore, the temporary coating itself represents also a novelty, 
constituting a new coating procedure that can be applied in other bioprocessing 
techniques.  
High cell density bio-inks are essential to produce microtissues. However, drop-on-
demand bioprinting techniques are limited by bio-inks loaded with a maximum of 2-
5x106 cells per mL, a value that does not represent the physiological cell densities of 
human tissues. The combination between ReJI and CAF bio-ink demonstrated to be a 
unique strategy to rapidly overcome this limitation. Additionally, this study reinforced the 
importance of cell density on microtissue development, showing that low cell density 
hydrogels had a much slower tissue maturation rate when compared to the high cell 
density hydrogels.  
 
6.3 Inkjet bioprinting, its limitations and dependence on bio-ink development 
The work presented in this study was performed using two different bioprinting 
techniques: inkjet bioprinting and an in-house microvalve-based bioprinting entitled ReJI. 
Although the technology behind these and other bioprinting strategies has been in 
constant development, there are still several limitations that do not allow further 
advances. 
Inkjet bioprinting was initially adapted from commercial home/office inkjet printers 
(Kolesky et al., 2014; Murphy and Atala, 2014). Despite having an auspicious beginning, 
the lack of development of the technology itself did not allow to obtain ground-breaking 
advances. The concept and process behind are still the same from 15 years ago, when 
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Boland and Wilson first reported the successful printing of viable cells (Wilson and 
Boland, 2003). The only evolution observed is related to the bioprinters parts, which 
became a little more specialised. However, the shear and thermal stress that cells suffer 
during printing, the nozzle blockage due to cell sedimentation and aggregation and the 
need for fast crosslinking to confer mechanical structure to the printed droplets are the 
same problems from 15 years ago. There is a need for the development of custom 
reservoirs that allow cells to be constantly, but gently, agitated (Gudapati et al., 2016). 
New jetting devices to minimise nozzle blockage are also essential. Most inkjet printers 
have tubbing that connect the reservoir to the inkjet printhead (Figure 6.1), which poses 
as recurrent cell aggregation area even with a slight bend. The use of anti-adherent 
materials or coatings would help on solutioning this issue.  
 
Figure 6.1 – Tubbing connection between reservoirs and inkjet nozzles. 
 
To obtain solid structures is also a concern. Crosslinking mechanisms must be applied 
almost simultaneously with printing, otherwise, there is a risk of fast droplet drying due to 
the very small volume (Murphy and Atala, 2014; Iwanaga et al., 2015). As reported 
before, another strategy would be to print directly into cellular medium or other cell-
friendly solution, however, accuracy and resolution would be lost in the process since 
cells would float. With ReJI, these problems were taken in account during the system 
design. Nozzle blockage was avoided by combining the microvalve working principle, a 
constant pneumatic pressure and cells in a very low viscous solution. Additionally, the 
ReJI design allowed gel precursor and crosslinking solution droplets to meet in air that, 
once combined, immediately start the crosslinking process. 
 143 
 
However, the inkjet bioprinting major dependence relies on bio-inks. These are the truly 
driving force of bioprinting, allowing or not, to release the full potential of the 
technology.  To avoid nozzle blockage, most of the inkjet bioprinting studies use very low 
cell density inks, with an average of 2 x 106 cells/mL (Murphy and Atala, 2014). This 
does not represent the physiological cell density, affecting any experiment that aims to 
study tissue development. Hence, inkjet bioprinting is normally applied to in vitro 
experiments, such as cell-cell interaction studies or lower scale vascularisation and 
disease models (Cui et al., 2012; Jang, 2017). Other strategy is to use very low viscous 
and shear thinning solutions, but these are very limited (Murphy and Atala, 2014; 
Gudapati et al., 2016). Optimising bio-inks with so many constraints have been slowing 
inkjet printing outputs. This way, the use of surfactants, such as Pluronic or Ficoll-
PM400, have been applied for some groups to originate neutrally buoyant cell 
suspensions (Chahal et al., 2012; Ferris et al., 2013). Although minimising cell 
aggregation and, consequently, resulting in reliable printing for longer periods, these 
additives are commonly toxic to cells (Jose et al., 2016). Also, turning bio-inks into more 
complex systems by adding more substances is not ideal. It is important to understand the 
effect of surfactants or other compounds not only in terms of cell viability and 
functionality, but also during and after crosslinking. 
The data reported in this thesis show that the use of the coated cells inhibit cell 
agglomeration and allow reliable cell printing for up to 60 minutes. Using minimal 
concentrations of a polycation, cells uptake and metabolise the polymer, resulting in few 
traces of PLL after 2 days. Additionally, cells start internalising the polymer immediately 
after cell attachment without causing any concern during this and other cell processes. 
However, even recurring to electrostatic repulsion, the use of this technique is still 
constraint to low cell densities (< 2x106 cells/mL), when using the optimised PLL 
concentration. Tests not reported in this thesis showed that only by increasing the PLL 
concentration up to 10-20 times more than the optimised concentration, the electrical 
repulsion would allow higher cell concentrations in the bio-ink – up to 30x106 cells/mL. 
Despite the effectivity of this increased PLL concentration on avoiding cell 
agglomeration, the impact on cell viability was highly significant, reducing cell viability 
to negligible values. The use of stronger but cell-friendly polycations would be important 
to understand if this kind of strategy could be improved. 
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6.4 Cell density and its relationship to microtissue development 
The main aim of chapter 5 was to obtain high cell density hydrogels, via the optimisation 
of an in-house developed bioprinting technique, ReJI, and by adapting a collagen-
alginate-fibrin hydrogel to the same bioprinting technology. The work developed showed 
that ReJI is the first drop-on-demand bioprinting system that can deposit cell-laden 
hydrogels with a high cell density. Cell density has been one of the major drawbacks of 
bioprinting, as it is essential on the development of tissues and, ultimately, organs 
(Murphy and Atala, 2014). The data generated in this chapter have clearly demonstrated 
that printed cell behaviour was distinct in hydrogels with a 10-fold difference in terms of 
cell concentration. Hydrogels printed with high cell densities showed a fast osteogenic 
differentiation, when compared to the low cell density ones. This resulted in an earlier 
and increased deposition of calcium, as well as, on the presence of cuboidal cell, typical 
osteoblastic phenotype. Additionally, the gene expression exhibited much higher 
overexpression of important osteogenic genes in the higher cell density hydrogels. This 
way, cells were shown to have clearly organised themselves in tissue structures.  
The work reported here clearly supports prior studies that highlight the importance of cell 
density on tissue development. Cell density allows cells to be spatially closer to each 
other, which increase the cell-cell interaction between them. Cell-cell interaction has been 
reported to modulate basic cell processes, such as adhesion, differentiation, proliferation 
or migration (Ratcliffe and Niklason, 2002; G Duclos et al., 2016). Groups have verified 
that high cell density cultures facilitated cell-cell interaction and this upregulated the 
proliferation rate and elastin expression of chondrocytes (Lee et al., 1994). Furthermore, 
osteogenic activity has been reported to be affected by early cell density (Luo et al., 
2013). On the other hand, contact inhibition has been reported to have significant 
consequences on tissue formation and growth (Cheng et al., 2006). In another spectrum, 
metastatic cancers are known for being “solitary” and able to grow with lack of cell-cell 
interaction (Sharif et al., 2015). However, research teams observed that the vascular 
invasion is controlled by cell density. Finally, cell cycle dynamics have been noted to be 
affected by the lack of cell-cell interaction, which causes retarded tissue growth 
(Streichan et al., 2014).  
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6.5 Drug discovery perspective on ReJI-produced high cell density hydrogels  
Drug discovery comprises a multi-step model that starts with the identification of the 
probable beneficial molecule or compound, in vitro testing, followed by in vivo and 
human clinical trials (I-IV) (Kuhlmann, 1997; DiMasi et al., 2003). In vitro assays are of 
capital importance as they must recapitulate the human environment to reliably assess the 
efficacy and toxicity of the new compound. For this, the industry still relies in 2D cell 
culture systems, which have been constantly reported to not be able to simulate the 
human environment (Edmondson et al., 2014; Duval et al., 2017). Lately, three-
dimensional (3D) cell culture techniques, such as spheroids, organoids, organs-on-chip or 
scaffold-based cell cultures, have been developed and show the ability to emulate from 
natural cell-cell interactions to human organs in a much smaller scale (Di Maggio et al., 
2011; Huh et al., 2011; Thoma et al., 2014; Thakuri et al., 2017; de Souza, 2018; Mosaad 
et al., 2018). However, all the 3D cell culture systems present problems over reliability 
and repeatability, but also in terms of tissue complexity, which makes them not ideal for 
high-throughput applications (Friedrich et al., 2007; Breslin and O’Driscoll, 2013; van 
Duinen et al., 2015; Junaid et al., 2017). The unique ReJI characteristics opens up new 
opportunities for drug development by producing fast and reliable tissue-like structures. 
Additionally, the lack of cell-cell interaction may inhibit the secretion of certain cytokines 
that are detrimental not only for tissue growth and maturation, but also necessary for the 
development of other cells in case of a multi-cellular constructs (Rørth, 2003; Cooper and 
Hausman, 2004; Lodish H et al., 2007). These issues cause poor biomimicry that most of 
the times is not detected due to the lack of reliable 3D models to compare with. 
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Chapter 7. Conclusion and future work 
7.1 Conclusion 
The research reported in this thesis demonstrated new concepts and methodologies 
applicable to inkjet printing and fabrication of high density cell laden hydrogels.  
 
7.1.1 Single cell coating using poly-L-lysine and reliable inkjet cell printing 
The work developed in this chapter demonstrated that PLL allows for the development of 
an efficient and temporary single cell coating. The coating minimized cell aggregation via 
electrical repulsion due the positively charged polymer on the cell membrane. This effect 
was successfully applied to inkjet bioprinting, avoiding nozzle blockage, and the 
reliability and repeatability of the process was improved. 
More specifically: 
• The methodology developed allows high-efficiency and tightly fitting coating; 
• Cell survival is dependent on PLL concentration. Increase on PLL 
concentration originates an increment on cell death rate; 
• The optimised PLL concentration allows good cell survival and does not affect 
cell karyotype; 
• The coating morphology is dependent on PLL concentration. Increasing PLL 
concentration leads to a more complete coating or even full encapsulation; 
• Cells can ingest and metabolise low PLL concentrations. High concentrations 
cause cell death; 
• Cells death is majorly caused by necrosis, which is related to the damage 
suffered due to PLL attachment; 
• Cell behaviour with PLL coatings depends on the cell type; 
• The optimised PLL coating reduced cell aggregation by 10 times, when 
comparing to non-coated cells; 
• Cell proprieties affect inkjet cell printing reliability; 
• Inkjet printing of coated cells demonstrated normal cell survival, attachment 
and phenotype.  
 147 
 
7.1.2 Reactive jet impingement technology for high cell density bioprinting 
The data present in chapter 5 indicated that ReJI system is the first drop-on-demand 
bioprinting system that can deposit cell-laden hydrogels with a high cell density. Cell 
density showed to be a crucial factor on the development of microtissues by increasing 
cell differentiation speed, as well as by improving cell-cell interaction. The optimised 
CAF hydrogel supported cell viability, proliferation, migration and differentiation. 
In particular: 
• ReJI offers high cell density, with high cell viability, within a viscous gel, at high 
volume deposition rates. This bioprinting technique allows rapid printing of 
precise structures; 
• CAF hydrogels are suitable for long-term incubation by losing only about 30% of 
its mass during any incubation period studied; 
• The fabricated CAF hydrogels have weak mechanical properties, however these 
show high uptake capability, which is essential for cell maintenance; 
• CAF hydrogels show porous structures which supports cell migration. The porous 
network is conserved after 14-day incubation period; 
• Cells survive the jetting and impingement processes showing high viability and 
normal cell phenotype; 
• Trilineage cell differentiation of primary hMSCs is achieved with printed CAF 
hydrogels; 
• Faster osteogenic cell differentiation is obtained with high cell density hydrogels.  
• Via gene expression, typical pre-osteoblastic behaviour is observed on low cell 
density hydrogels. On the other hand, common osteoblast behaviour is reported on 
high cell density hydrogels. 
 
7.2 Future work 
7.2.1 Single cell coating using poly-L-lysine and reliable inkjet cell printing 
• Polycationic single layered coatings and capsules are not often utilised due to the 
interaction between the positively charged polymer and the negatively charged 
membrane. Depending on the polycation structure, small or sizeable holes on the 
lipid membrane may be induced, which highly compromises cell survival. 
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Additionally, poly-l-lysine is a synthetic polymer that is often described as 
cytotoxic. The use of a layer-by-layer strategy would lead to an increase of cell 
survival, despite originating a slower methodology due to the extra steps needed. 
Furthermore, the use of natural polycations, such as chitosan, would increase cell 
survival after coating. However, a new procedure would need to be optimised for 
new polycations. 
• The different cell lineages were observed to ingest and metabolise the PLL. By 
TEM it was observed that the PLL uptake was through different endocytic 
pathways. To clearly identify these pathways, the use of pathway inhibitors, such 
as genistein or chlorpromazine, that inhibit caveolae-mediated uptake and 
clathrin-mediated endocytosis, respectively, would be essential. 
• Cell behaviour was shown to be different for the same PLL concentrations. 
Fibroblasts, for example, were able to ingest and metabolised the polycation much 
faster than the other two cell lineages. Moreover, different reliability patterns were 
observed during inkjet printing as a probable cause of what is reported above. This 
leads to the need for careful optimisation of the polycation concentration for each 
cell type in order to obtain similar results during inkjet printing.  
• Single cell printing is of interest in cell biology as it allows the precise location of 
cells in equally spaced positions, improving cell-cell interaction experiments. 
Single cell printing of osteosarcoma cells is attractive for use in cancer 
development studies.  
 
7.2.2 Reactive jet impingement technology for high cell density bioprinting 
• CAF hydrogels have poor mechanical properties. The addition of other 
biomaterial(s), such as PEG, could improve the hydrogel mechanical integrity. 
This would be crucial if fabricating constructs for implantation.  
• To show the clear difference between the produced cell-laden hydrogels, histology 
and the use of specific ECM markers for microscopy would be an important 
complement to the information already obtained. 
• The ability to bioprint different cells at the same time allows the design of specific 
disease models using ReJI bioprinting. This represents an opportunity to 
demonstrate the system potential on drug screening applications. 
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• To efficiently develop bone tissue, other cells and growth factors may be added to 
the cell-laden hydrogel.  
• Further repeats of gene expression experiments are important to validate the 
results exhibited in this work. 
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